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SYNOPSIS 
Age is associated with the development of multi-system function loss including the 
musculoskeletal, immune and cardiovascular system, as well as body composition changes. 
These age-related alterations lead to frailty development and disease progression, reducing 
quality of life. A major lifestyle change that is evident in later years is a reduction in physical 
activity. The studies outlined in this thesis sought to examine the associations between 
physical activity and multi-system function loss in a cohort of elderly individuals, and to 
better understand the neural mechanisms underpinning the circulatory responses to exercise. 
It was observed that high daily physical activity levels attenuate some but not all of the age-
related changes in elderly individuals. High physical activity was associated with superior 
physical functioning, lower total body fat and visceral adiposity, and plasma plasminogen 
activator inhibitor 1 (PAI-1) concentrations (a clotting agent). Left ventricular (LV) diastolic 
function was negatively associated with mean arterial pressure (MAP) and visceral adiposity, 
suggesting that elderly individuals with higher MAP and visceral adiposity may have inferior 
LV diastolic function. In terms of neural mechanisms related to circulatory responses to 
exercise, in models of metaboreflex over-activity whereby BP is elevated as observed in heart 
failure patients, left atrial systolic function is enhanced in order to maintain end-diastolic 
volume and SV. 
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This thesis is predominantly concerned with the examination of physical activity 
status and physiological functioning in an ageing population. Physical activity is reduced 
with age, and parallels multi-system function loss, frailty development and age-related 
disease progression. Physical functioning i.e. walk speed and balance is reduced along with 
exercise capacity. Body composition changes including increased adiposity, particularly in 
central areas, and muscle mass decreases. Immune system alterations are also present which 
causes increased chronic plasma inflammatory cytokines, known to be detrimental to 
cardiovascular function. Age-related changes to the cardiovascular system include cardiac 
and vascular stiffening and dysfunction, leading to reduced exercise capacity and increased 
risk of cardiovascular disease development. Research has shown that physical activity is 
associated with superior functioning of these systems in elderly individuals, however little is 
known about the associations between habitual physical activity and multi-system function 
loss in a single elderly cohort. 
The aim of this thesis is to investigate the associations between habitual physical 
activity, physical functioning, body composition, systemic inflammation and cardiovascular 
function in a single elderly cohort (Chapter 4). In addition, predictors of the variance in 
cardiac diastolic function will be examined in the same elderly cohort, including physical 
activity, body composition, systemic inflammation and cardiovascular risk factors (Chapter 
5). Lastly, neural and cardiac mechanisms of the circulatory responses to exercise will be 
investigated in young individuals, to better understand neural cardiovascular control during 
exercise and to inform future related studies conducted in elderly individuals (Chapter 6).
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2.1 Epidemiology of Ageing 
2.1.1 Population Ageing 
Population ageing is a major global issue (Egler 2000, Lloyd-Sherlock 2000, Shrestha 
2000). Globally, the proportion of individuals aged ≥60 years will increase from 10% in 
2000, to 21.8% in 2050 and incredibly 31.2% in 2100 (Lutz, Sanderson et al. 2008). 
Similarly, the United Nations indicated that by 2020 the global elderly population is expected 
to increase from 5.3% to 9.3% (Shrestha 2000) and Lakatta  has stated that nearly one in four 
individuals will be 65 years of age or older by the year 2035 (Lakatta 2002). 
Although overall global population ageing is occurring, the process is regionally 
heterogeneous. The United Kingdom (UK), along with Sweden, France, Norway, Denmark 
and Germany, were among the first to be confronted with the increase in longevity. As a 
result, very elderly populations (≥ 80 years of age) in these countries have grown and are now 
larger than other areas of the world such as Southern Europe (Jacobzone, Cambois et al. 
2000). The reasons for this increase in longevity are manifold, but include public health 
interventions, and improvements in health care and education (Salomon, Wang et al. 2012). 
The observed increase in life expectancy and longevity comes at a cost (Anderson 
2000). Although the statistics indicate that modern medicine has successfully attenuated 
mortality, this has not been accompanied by a parallel reduction in morbidity (Egler 2000, 
Jacobzone 2000, Shrestha 2000, Fulop, Larbi et al. 2010). There is now a larger proportion of 
the population who are living in medicated and diseased states because as life expectancy has 
increased, the proportion of the population with morbities has also increased (Jacobzone 
2000). As a consequence an individual spends an increased number of years in a frailty-
related diseased state (Jacobzone 2000). Elderly individuals require healthcare more 
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frequently and thus, population ageing causes significant financial stress on Government 
healthcare spending (Egler 2000). According to the International Longevity Centre UK Think 
Tank, the rise in projected health care spending in the UK is parallel to the increase 
population ageing, forecasting a rise of £36bn between 2016/2017 and 2061/2062. Costs not 
only include those associated with medication and treatment, but also care home costs and 
disability support. Ideally, the best outcome for population ageing is morbidity compression, 
whereby the rise in life expectancy is maintained and accompanied with decreased morbidity 
(Jacobzone 2000). This would release the financial stress of Government costs and enhance 
quality of life. A potential strategy to facilitate morbidity compression is to increase physical 
activity. Physical activity is typically reduced with age, and physical inactivity has been 
estimated to cause 6% of the burden of disease from coronary heart disease, 7% of type 2 
diabetes, 10% breast cancer, 10% colon cancer and 9% of premature mortality worldwide 
(Lee, Shiroma et al. 2012). Improved health can therefore be acquired through adopting an 
active lifestyle (Jacobzone 2000, Lee, Shiroma et al. 2012). It has been shown that elderly 
individuals who remain physically active have a better quality of life, maintained 
physiological function and reduced morbidity. Gill et al. (2006) conducted a randomized 
clinical trial of a home-based program designed to prevent functional decline in a high-risk 
group of physically frail, elderly persons who lived at home (Gill, Baker et al. 2002). They 
found that the home-based activity program was effective in preventing frailty-related 
functional decline. As such, increasing daily physical activity among the elderly population 
could be a successful, cost-effective strategy to prevent the functional decline observed with 
ageing. 
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2.1.2 Age-related Frailty 
Age-related frailty is a term that has been used to loosely describe a range of 
conditions, such as general debility and cognitive impairment, occurring in older individuals 
(Lally and Crome 2007). In the elderly population (≥65 years old), 7% are frail with this 
figure increasing to 20% in individuals >80 years (Walston 2004). As stated in section 2.1.1, 
frailty is related to diseases observed in an ageing population. Age-related morbidities 
include degenerative conditions such as Alzheimer’s disease, Parkinson’s disease and 
sarcopenia, and other diseases such as cancer, kidney disease, diabetes, autoimmune disease 
and cardiovascular disease. (Khansari, Shakiba et al. 2009). Frailty and chronic disease often 
occur hand in hand, with one potentially resulting in the other (Bergman, Ferrucci et al. 
2007). Although age-related frailty can occur without comorbidity, ‘disease-free’ frail 
individuals are still at increased risk of hospitalization (Fried, Tangen et al. 2001). The major 
difference between frailty and disease is that chronic disease requires appropriate diagnosis 
based on established guidelines, however frailty often remains undiscovered until disease is 
manifest, therefore lack of consensus on how to measure frailty still remains (Keevil and 
Romero-Ortuno 2015)The relationship between frailty and comorbidity has been investigated 
by a number of studies (Fried, Tangen et al. 2001, Boyd, Xue et al. 2005). It was concluded 
that frailty does not share the same characteristics as comorbidity, but is a risk factor for it, 
which eventually causes disability.  
Due to the cross-over between chronic disease states and frailty the diagnosis of 
frailty has mostly been subjective (Wilson 2004). To resolve this problem, using data from 
the Cardiovascular Health Study (CHS) Fried et al. defined the phenotype of frailty as the 
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presence of 3 or more of the following components: unintentional weight loss (10 lbs in past 
year), self-reported exhaustion, weakness (grip strength), slow walking speed (lowest 20% of 
participants’ time taken to walk 15ft), and low physical activity (lowest 20% of participants’ 
time taken to walk 15ft), (Fried, Tangen et al. 2001). Frailty is a complex syndrome 
comprised of multiple interrelated physiological components (Buchner and Wagner 1992, 
Fried, Tangen et al. 2001, Walston 2004) (Figure 2.1). The general consensus is that frailty 
results from complex interactions between a number of physiological processes, rather than a 
single cause (Adams, Linke et al. 2005) . It is thought that the core feature of frailty is 
increased vulnerability to stressors, which is due to impairments in multiple, inter-related 
systems (Bergman, Ferrucci et al. 2007). A recent review by Keevil et al. defined frailty as 
the decline in an individual’s homeostatic function, strength and physiologic reserve, leading 
to increased vulnerability (Keevil and Romero-Ortuno 2015). Frailty is associated with a loss 
of function from multiple systems in the body such as muscles, bones, brain (cognition), 
cardiovascular system including the heart and blood vessels, and the immune system. If these 
function losses are left unnoticed and untreated, the progression of the aforementioned age-
related diseases may occur, resulting in poor quality of life, increased medication use and 
therefore increased financial stress. Given these detrimental outcomes, low cost frailty 
prevention such as increased physical activity participation in elderly individuals would be 
highly advantageous to the UK population. Figure 2.1 represents a cycle of frailty based on 
associations between multiple systems, however this model still remains theoretical. 
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Figure 2.1: Cycle of Frailty (Fried et al. 2001) 
 
2.2 Ageing and Physical Function 
The development of age-related frailty is associated with a decline in physical 
function, i.e. mechanical performance, related to the musculoskeletal system and body 
composition changes (Buchner and Wagner 1992, Rockwood, Fox et al. 1994, Fried, Tangen 
et al. 2001). A loss of physical functioning results in disability onset and an increased 
dependence on others such as carers, impacting the quality of life. One of the attributes of 
age-related frailty identified by Fried et al. was slow walking speed, demonstrating inferior 
physical functioning, and was coupled with low physical activity (Fried, Tangen et al. 2001). 
Bendall et al. investigated the relationship between age, walking speed and calf strength in 67 
women and 58 men aged 65-90 years, and found that walking speed was positively associated 
with calf strength and negatively associated with age (Bendall, Bassey et al. 1989). Physical 
activity measured via steps/day was also positively associated with walking speed, suggesting 
LITERATURE REVIEW 
 
9	
	
beneficial and preventative effects of physical activity on aspects of functional decline 
observed with age. Pollock et al. performed a cross-sectional study in elderly cycling masters 
male and female athletes, with the aim to abolish any confounding effects of physical activity 
status in order to identify an independent marker of ageing (Pollock, Carter et al. 2015). 
However, the study failed to elucidate a physiological marker that could be used to reliably 
predict the age of any individual. It was confirmed that the physiological process of ageing is 
highly individualistic. 
It has been postulated that a loss of physical function with age, such as walking speed 
and hand grip strength, could be related with an age-associated loss of muscle strength and 
mass (Fiatarone, O'Neill et al. 1994). Larsson et al. measured quadriceps muscle strength in 
114 male participants aged 11-70 years old and found a significant decline in force generating 
capacity from the fifth decade (Larsson, Grimby et al. 1979). Aniansson et al. also observed 
marked strength loss over a period of only 5 years measured by knee extension, elbow 
extension and elbow flexion in 19 men and 21 women from the age of 70 years to follow up 
at 75 years (Aniansson, Sperling et al. 1983). The mechanism of muscle mass loss with 
increased age is not fully understood, however factors that play a role could include 
inflammageing (discussed further in Section 2.4.4), motorneuron death and fibre type change 
(Doherty, Vandervoort et al. 1993, Thomas 2007). One mechanism that is thought to play a 
role is a reduction of nutrient uptake of the skeletal muscles (Wagenmakers, Strauss et al. 
2015). Inflammatory cytokines which are increased in the ageing process disrupt the 
signalling cascade involved in glucose and protein uptake, resulting in reduced muscle 
protein synthesis (Wagenmakers, Strauss et al. 2015). There is good evidence that 
maintaining physical activity can offset age-related decrements in muscle strength and mass. 
Fiatarone et al. examined the effects of a 10-week resistance exercise training regime on 
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frailty measures (i.e. muscle strength and stair climbing ability) in 100 frail nursing home 
residents with a mean age of 87.1 ± 0.6 years (Fiatarone, O'Neill et al. 1994). Exercise 
training significantly improved muscle strength, muscle cross-sectional area and stair-
climbing power compared to the control participants, in whom muscle cross-sectional area 
actually decreased. It could be postulated that physical activity prevents age-related physical 
functional decline as a result of maintained neuromuscular control, muscle mass and strength. 
In addition to muscle strength and mass loss, cardiac reserve and exercise capacity are 
also greatly attenuated in elderly individuals. Peak aerobic fitness (VO2max) declines 
approximately 10% per decade after age 25-30 years in healthy sedentary adults (Tanaka and 
Seals 2008). Reduced VO2max is attributable to both central and peripheral factors, i.e. lower 
maximal cardiac output (central) and reduced maximal oxygen extraction from skeletal 
muscle (peripheral) (Saltin and Calbet 2006). With increased age maximum heart rate 
(HRmax) falls, and in addition to structural and functional deteriorations of left ventricular 
(LV) function, causes a reduction in maximal cardiac output (Lakatta 2002, Lakatta 2003). 
As explained in more detail below (section 2.6) reduced maximal oxygen extraction can 
occur as a result of both structural and functional changes in the vasculature (Ehsani, Spina et 
al. 2003). However, the age-related decline in exercise capacity can be reduced with exercise 
training (Hagberg 1987, Ehsani, Spina et al. 2003).  Elderly individuals who are able to 
perform activities of daily living with ease for longer are more able to live independently 
(Fries 1980, Fries 2002, Chakravarty, Hubert et al. 2008).  Maintaining physical functioning 
as we age is therefore important to prevent disability onset and improve quality of life (Fries 
1980, Fries 2002, Chakravarty, Hubert et al. 2008). 
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2.3 Ageing and Body Composition 
With increased age there is a characteristic decline in skeletal muscle mass 
(sarcopenia) and an increase in central fat stores (visceral adiposity) (Baumgartner, 
Heymsfield et al. 1995, Gallagher, Ruts et al. 2000, Harris 2002, Wannamethee, Shaper et al. 
2007). 
 
 
2.3.1 Ageing and Sarcopenia 
During the ageing process there is a significant loss of skeletal muscle mass and 
strength (Morley 2012). This progressive wasting of skeletal muscle is known as sarcopenia 
(Morley 2012). Sarcopenia is diagnosed when there is a less than expected muscle mass in an 
individual of a specified age, gender and race (Bauer and Sieber 2008). Specifically, 
sarcopenia is defined as an appendicular skeletal muscle mass divided by height in metres of 
more than 2 standard deviations below the mean value observed in young healthy individuals 
(Doherty, Vandervoort et al. 1993). Bauer et al. stated that the prevalence of sarcopenia has 
been calculated to be 7% for men and 11% for women above the age of 80 years in the US 
(Bauer and Sieber 2008). As muscle strength is proportional to skeletal muscle mass, 
sarcopenic individuals are often weak, which makes it more difficult to perform everyday 
activities. If activities of daily living are challenging to frail older individuals, loss of 
motivation to perform them can occur, escalating to a vicious negative feedback cycle of 
muscle and strength loss and reduced physical activity. If however, elderly individuals 
regularly participate in physical activity, muscle wasting can be at least partially reversed. 
Fiatarone et al. observed an improvement in stair climbing ability following a 10-week 
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resistance training intervention in elderly individuals, and also identified an increase in 
muscle strength and cross-sectional area (Fiatarone, O'Neill et al. 1994). They suggested that 
this increase in muscle strength and cross-sectional area may have aided advances in physical 
function. 
 
2.3.2 Ageing and Visceral Adiposity 
It is well established that with increased age there is a greater proportion of visceral 
adiposity. Song et al. composed a 2 year follow-up study examining body composition 
changes in elderly African American women (age at baseline 75.5 ± 5.1 years) with the use of 
Dual Energy X-ray Absorptiometry (DEXA) and found that with advancing age body fat 
increased and became centralized (Song 2004). Poehlman et al. conducted a large cross-
sectional study on men and women aged 18-88 years, and measured body fatness and central 
adiposity using hydrostatic weighing and waist circumference (Poehlman, Toth et al. 1995). 
They concluded that older individuals possessed significantly higher body fatness and central 
adiposity, particularly in women. Age-related increases in visceral adiposity, located in the 
central area of the body, are associated with age-related diseases such as cardiovascular 
disease and insulin resistance (Prineas, Folsom et al. 1993, O'Leary, Marchetti et al. 2006). 
Sutton-Tyrrell et al. observed a significant positive association between body fat measured by  
DEXA and peripheral quantitative computed tomography (pQCT), and aortic stiffness 
measured via pulse wave velocity (PWV), which is a precursor for atherosclerosis, in 2488 
elderly individuals with a mean age of 74 years (Sutton-Tyrrell, Newman et al. 2001). 
As in non-elderly individuals (<60 years old), physical activity has proven to be an 
effective strategy to reduce increases in adiposity in ageing, as well as the progression of age-
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related debilities such as reduced physical functioning and insulin resistance (Geffken, 
Cushman et al. 2001, O'Leary, Marchetti et al. 2006, Villareal, Chode et al. 2011). Villareal 
et al. conducted a 1-year interventional follow-up study examining the effects of an exercise 
intervention on physical functioning (walk speed, balance, VO2 max) in 107 elderly obese 
adults (65-74 years old). The results yielded significant positive effects of the exercise 
intervention on fat mass and physical functioning. O’Leary conducted an exercise 
intervention study in 16 elderly obese men and women (mean age 63 ± 1 year) and found that 
central fat mass was significantly reduced, coupled with an improvement in insulin resistance 
(O'Leary, Marchetti et al. 2006). This suggests that by targeting central visceral adiposity in 
elderly individuals via physical activity, progression of age-related diseases could also be 
potentially attenuated. Conversely, a recent longitudinal study in middle-aged and elderly 
overweight or obese individuals with type 2 diabetes contradicts these findings (Look, Wing 
et al. 2013). The participants in this study underwent either a weight loss intervention 
comprising of calorie restriction and increased energy output or a control trial, and were 
followed up based on occurrence of a composite cardiovascular outcome (median = 9.6 
years). Although the weight loss intervention group experienced greater weight loss (6%) 
compared to the control group (3.5%), cardiovascular morbidity rates were not significantly 
different. The expected benefits of increased physical activity via a weight-loss mechanism is 
not shown in this longitudinal interventional follow-up study, therefore care should be taken 
when discussing this potential explanatory pathway. 
Visceral adipose tissue is a source of inflammatory cytokine production (interleukins 
[IL]) which have strong associations with the development of cardiovascular dysfunction 
(Hotamisligil, Arner et al. 1995, Purohit, Ghilchik et al. 1995, Yudkin, Kumari et al. 2000, 
Fain 2006), possibly via ROS production and cytokine infiltration in to arterial walls (See 
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Sections 2.4.4-2.4.6). Geffken et al. (2001) conducted an epidemiology study analysing data 
obtained from the Cardiovascular Healthy Study in 5,888 men and women aged >65 years 
old, investigating the associations between self-reported physical activity levels, 
inflammatory markers and body mass index (BMI) (Geffken, Cushman et al. 2001). They 
concluded that, following multivariate analysis, higher levels of physical activity were 
associated with lower levels of inflammation, which may be mediated by BMI. Indeed, one 
potential cause of increased age-related inflammation is this increase in visceral adiposity 
(Wu 2007). 
 
2.4 Ageing, Immunity and Inflammation 
2.4.1 The Innate Immune System 
The innate immune system acts as the first line of defence against invading pathogens. 
Innate immunity includes several cell populations including but not limited to: monocytes, 
neutrophils, natural killer cells and mast cells, all of which function uniquely. Monocytes are 
one of the most fundamental cells of the innate immune system, their distinct role being to 
clear infection via chemotaxis to the site of infection. They perform this movement using cell 
surface receptors to detect a chemoattractant gradient. Monocyte chemotactic protein 1 
(MCP-1) is the chemoattractant cytokine most commonly associated with monocytes. MCP-1 
is detected by chemokine receptors and moves via adhesion to endothelial cells (Taylor and 
Gordon 2003, Shi and Pamer 2011). Here, receptor pathogen recognition occurs, inducing 
superoxide release from mitochondria and inflammation via cytokine production to kill 
bacteria (Shi and Pamer 2011). The secreting nature of monocytes not only induces 
inflammation, but also attracts more monocytes by releasing cytokines such as MCP-1. 
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However, this highly inflammatory and secretory action of monocytes may potentially be 
detrimental and harmful during the ageing process, due to the development of age-related 
immune dysfunction (Bruunsgaard and Pedersen 2003). 
 
2.4.2 Ageing and Immunity 
Immunosenescence describes the biological ageing of the immune system, whereby 
its functional role deteriorates (Caruso, Buffa et al. 2009, Panda, Arjona et al. 2009, Simpson 
2009). Research suggests that age-related disease onset may be due to the development of 
immune dysfunction, causing increased infection and susceptibility to disease (Pawelec 2002, 
Caruso, Buffa et al. 2009, Simpson 2009). In addition to this, there is an increase in chronic 
levels of inflammation and oxidative stress observed in the ageing process, also related to 
disease onset (Stadtman 2006, Khansari, Shakiba et al. 2009). 
 
2.4.3 Immunosenescence 
Immunosenescence commonly occurs with age and describes an inability of the 
immune system to respond to new pathogens (Derhovanessian, Larbi et al. 2009). It is known 
to be most prevalent in the adaptive immune system (Gruver, Hudson et al. 2007), whereby 
there are a reduced number of naive T cells and increased number of memory T cells. There 
is therefore an increased demand on the innate immune system for a new adaptive response, 
producing an increased number of monocytes (Gruver, Hudson et al. 2007). A greater 
monocyte population causes higher basal levels of inflammatory cytokines such as 
Interleukin (IL)-1, IL-6 and tumour necrosis factor-alpha (TNF-α) due to constant cytokine 
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secretion at low levels without stimulation (Sadeghi, Schnelle et al. 1999, Hearps, Martin et 
al. 2012). This age-related increase in inflammation is also known as “inflammageing”. The 
overall age-related immune dysfunction leads to the increased susceptibility to infection, 
malignancy and disease onset (High 2002). 
 
2.4.4 Inflammageing 
Inflammageing describes an increased pro-inflammatory status in the elderly (Caruso, 
Buffa et al. 2009, Derhovanessian, Larbi et al. 2009, Panda, Arjona et al. 2009). This chronic 
low-grade systemic inflammation is a result of low-level infection, increased innate immune 
activation and inflammatory cytokine release (IL-6, IL-1, TNF-α) (Bruunsgaard and Pedersen 
2003, Forsey, Thompson et al. 2003, Ershler 2007). Chronic inflammation such as 
inflammageing, is associated with cardiovascular disease, sarcopenia, metabolic syndrome 
and long-term tissue damage, and is strongly related to increased disability in frail elderly 
individuals (Pawelec 2002, Panda, Arjona et al. 2009). An increased number of cytokine 
secreting immune cells at areas of endothelial damage causes atherosclerotic plaque 
formation, potentially resulting in major coronary events such as myocardial infarction or 
stroke (Merino, Buendia et al. 2011). Inflammatory cytokines (IL-6 and TNF-α) are known to 
produce reactive oxygen species (ROS) (Panda, Arjona et al. 2009, Metsios, Stavropoulos-
Kalinoglou et al.), which have been implicated in the cell death associated with myocardial 
infarction (Sorescu and Griendling 2002). IL-6 has frequently been shown to increase with 
age and frailty (High 2002, Ershler 2007), however whether age increases TNF-α release is 
equivocal. Despite this, many reports suggest an increased basal TNF-α secretion (Delpedro, 
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Barjavel et al. 1998) and respiratory burst (Antonaci, Jirillo et al. 1984) as a result of 
heightened innate immunity and increased monocytes. 
 
2.4.5 Other Mechanisms of Inflammageing 
As mentioned in section 2.3.1, another potential cause of increased age-related 
inflammation in addition to heightened innate immunity is an increase in visceral adiposity 
(Wu 2007). One of the many detrimental effects of increased visceral adipose tissue is the 
production of inflammatory cytokines and markers of cardiovascular risk (IL-6, IL-8, TNF-α, 
plasminogen activator inhibitor 1 [PAI-1], and macrophage migration inhibitory factor 
[MIF]) (Hotamisligil, Arner et al. 1995, Purohit, Ghilchik et al. 1995, Yudkin, Kumari et al. 
2000, Fain 2006). 
 
2.4.6 Inflammation and Cardiovascular Function 
There is mounting evidence that higher levels of circulating inflammatory cytokines 
and ROS with age may be associated with the development of cardiovascular dysfunction. 
Low-grade chronic systemic inflammation in healthy elderly individuals has been directly 
linked with arterial stiffness and vascular dysfunction, and harmful coronary events (Metsios, 
Stavropoulos-Kalinoglou et al.). ROS production via inflammatory cytokines such as TNF-α, 
has been shown to contribute to the development of endothelial dysfunction, via the 
suppression of endothelial-dervied NO (Figure 2.6) (Goodwin, Pendleton et al. 2007, 
Metsios, Stavropoulos-Kalinoglou et al.). 
2.4.7 Physical Activity and Inflammation 
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Long-term habitual exercise has been associated with reduced chronic low-grade 
inflammation observed in the elderly frail population (Mattusch, Dufaux et al. 2000, Taaffe, 
Harris et al. 2000, Geffken, Cushman et al. 2001). Exercise is thought to mobilize T cells 
from the immunological compartment in to the periphery, leading to the generation of naive 
T cells and increasing the naive T cell repertoire (Simpson 2009). Ford conducted a large 
cross-sectional study in 13,748 US citizens (age ≥ 20 years old), examining physical activity 
status and plasma C-reactive protein (C-RP) levels, which rise in response to inflammation 
(Ford 2002). Those participants who were more physically active had significantly lower C-
RP levels across all age ranges. In addition to the potential changes within the immune 
compartment itself, habitual exercise has modulatory effects on body fat distribution that are 
known to change with age, whereby an increase in central adiposity occurs. Geffken et al. 
analysed data obtained from the Cardiovascular Healthy Study of 5,888 men and women 
aged >65 years old to investigate the associations between self-reported physical activity 
levels, inflammatory markers and BMI (Geffken, Cushman et al. 2001). Following 
multivariate analysis, higher levels of physical activity were associated with lower levels of 
inflammation, which have been mediated by BMI. Exercise reduces adipose tissue, which 
secretes IL-6 and TNF-α. A reduction in the production and release of inflammatory 
cytokines would result in a reduction in the production of ROS. A consistent finding in the 
literature is that regular exercise relates to decreased systemic inflammation in both healthy 
and diseased populations, and results in prevention of endothelial dysfunction and 
atherosclerosis (Simpson 2009), presented in Figure 2.2. 
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Figure 2.2: Schematic diagram highlighting the mechanisms between adiposity, inflammation 
and cardiovascular disease 
 
2.5 Ageing and the Cardiovascular System 
The prevalence and incidence of cardiovascular disease increases with advancing age, 
including diseases such as hypertension, stroke, atherosclerosis and chronic heart failure 
(CHF) (Lakatta 2002). In 2010, National Statistics for Death in the US showed the leading 
cause of mortality were diseases of the heart, where 24.2% of all individuals who died during 
that year, died due to heart disease (Murphy, Xu et al. 2013). 
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2.6 The Heart 
With age the heart undergoes a number of structural, functional and regulatory 
alterations that may in part account for the age-related increase in cardiovascular risk 
(Lakatta and Levy 2003). 
 
2.6.1 Age-related Structural Changes of the heart 
The heart increases in mass by an average of 1g/yr in men and 1.5g/yr in women 
between the ages of 30-90 years. These changes include an increase in wall thickness, heart 
mass, chamber dimension, cardiomyocyte dimension and collagen, and occur in healthy 
elderly individuals without the presence of hypertension (Lakatta 2002, Lakatta and Levy 
2003). Left ventricular hypertrophy (LVH) is caused by myocytes becoming larger with 
ageing (Song, Yao et al. 1999). Song et al. studied older hospitalized patients without 
diagnosed or apparent cardiovascular disease and observed at autopsy that the cardiac 
myocyte number was decreased and the size enlarged compared to young patients (Song, Yao 
et al. 1999). The decrease in myocyte number is thought to be caused by apoptosis and results 
in a stretching of the existing cardiac cells, the functional consequence of which is a 
prolongation in ventricular contraction duration (Lakatta and Levy 2003). 
In addition to cardiomyocyte hypertrophy, alterations in the connective tissue layers 
of the heart, which contain the matrix protein collagen, also occur. These include the 
epimysium which surrounds the whole cardiac muscle, the perimysium which surrounds 
groups of cardiac muscle fibres, and the endomysium which enwraps individual 
cardiomyocytes (Figure 2.3) (Biernacka and Frangogiannis 2011). The development of 
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fibroblasts to myofibroblasts in these connective tissue layers leads to perivascular, 
endomysial and perimysial fibrosis, collectively known as cardiac fibrosis (Song, Yao et al. 
1999, Lakatta 2003, Orlandi 2004, Burkauskiene, Mackiewicz et al. 2006, Biernacka and 
Frangogiannis 2011). This age-related increase in cardiac collagen results in a progressive 
increase in myocardial stiffness. LV compliance is therefore compromised and can impair LV 
diastolic function (Biernacka and Frangogiannis 2011). Attenuated LV relaxation and 
prolonged contraction duration leads to impaired LV filling and a reduction in cardiac output 
(CO) at high heart rates, which can limit exercise tolerance in healthy elderly individuals and 
lead to premature fatigue (Vanoverschelde, Essamri et al. 1993, Kitzman, Gardin et al. 2001, 
Lakatta 2003). As discussed in section 2.2, this age-related reduction in CO plays a vital role 
in physical function loss in elderly individuals, reducing quality of life. 
 
 
Figure 2.3: Diagram representing physiology of the cardiac muscle 
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2.6.2 Age-related Functional Changes of the heart 
By the age of 80 years, early LV diastolic filling rate is reduced by approximately 
50% (Lakatta 2002). Studies have shown this by using the well-established technique of 
Doppler echocardiography (Spirito and Maron 1988, Arbab-Zadeh, Dijk et al. 2004). Over 
the last three decades, Doppler echocardiography has emerged as the diagnostic modality of 
choice for the assessment of diastolic function (Garcia, Firstenberg et al. 2001). Two-
dimensional (2D) echocardiography has become well accepted as a reliable, reproducible and 
practical noninvasive method for both diagnosis and longitudinal follow-up for patients with 
diastolic dysfunction (Nishimura and Tajik 1997). 
Diastolic function comprises an interrelated complex sequence of events. Factors 
including ventricular relaxation, diastolic suction, erectile coronary effect, viscoelastic forces 
of the myocardium, pericardial restraint, ventricular interaction and atrial contribution, all 
determine how the LV fills with blood. However, simplistically we can divide LV diastole in 
to four separate processes. These are: isovolumetric relaxation, rapid filling, slow filling and 
atrial contraction (Little and Downes 1990). 
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Figure 2.4: Diastolic filling of the left ventricle. LAP = left atrial pressure; LV compliance = 
left ventricular end-diastolic pressure–volume relation; LVP = left ventricular pressure; Vp 
= early propagation velocity of mitral inflow (Prasad, Popovic et al. 2007). 
Ventricular relaxation represents the rate and duration of the decrease in LV pressure 
following systolic contraction. The LV undergoes passive relaxation, creating a pressure 
gradient between the left atrium (LA) and the LV. Blood is then sucked from the LA and is 
known as LV early filling or in Doppler echocardiography, E wave velocity. Following this, 
the remaining volume of blood in the LA is then forced in to the LV via atrial contraction, 
and is known as A wave velocity. In young healthy hearts, a majority of LV filling occurs in 
the early phase, as the heart is elastic and able to passively relax with ease. During LA 
contraction, the young compliant LV stretches to accommodate the remaining blood volume. 
In Doppler echocardiography, this early-to-late filling relationship is known as E/A ratio. A 
typical healthy young heart will have an E/A ratio of around 2:1, representing a higher rate of 
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LV filling during passive relaxation. High E/A ratios are associated with healthy LV 
function. With ageing however, due to the increase in collagen content the LV loses elasticity 
and compliance. Therefore there is less passive relaxation and a smaller pressure gradient, so 
early filling of the LV is reduced. Because of this, a larger proportion LV filling occurs in the 
late phase during atrial contraction. The LA has to contract with more force to push the blood 
in to the LV, and the reduced compliance of the LV is less able to accommodate the blood 
volume, creating a higher preload pressure (Arbab-Zadeh, Dijk et al. 2004). In Doppler 
echocardiography, this produces an augmented A wave (diastole), which decreases the E/A 
ratio.  This is thought to be the most dramatic change in cardiac pump function with ageing 
(Lakatta 2002), and is usually the earliest manifestation of a disease process (Nishimura and 
Tajik 1997). 
Resting ejection fraction (EF) does not appear to be compromised with healthy 
ageing. This is partly due to a more vigorous atrial contraction which results in more filling 
occurring during late diastole, with maintained LV systolic function (Lakatta 2002). 
 
2.6.3 Age-related Regulatory Changes to the Heart 
Resting HR does not appear to be altered as a function of age. During aerobic exercise 
however, the HR max achievable declines by approximately 30% between the ages of 20 and 
85 years (Lakatta and Levy 2003). This lower HR max in ageing is in part explained by a 
reduction in the sensitivity of the β-receptors to sympathetic stimulation. β1-adrenergic 
receptors increase HR in response to the neurotransmitter noradrenaline, released by the 
sympathetic nervous system (Lakatta and Levy 2003). Indeed, Yin et al. showed that the 
increase in HR in response to the administration of isoproterenol, a β-adrenergic agonist, was 
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attenuated in the elderly compared to adult dogs (Yin, Spurgeon et al. 1979). De-sensitization 
of β-adrenergic receptors has also been identified in humans. White et al. observed a 
profound decrease in cardiac β-adrenergic responsiveness with age, when 26 non-failing 
donor hearts aged between 1-71 years were subjected to pharmacological investigation 
(White, Roden et al. 1994). A consequence of reduced sensitivity of β-receptors is chronic 
elevated sympathetic nerve activity, which is associated with many age-related physiological 
changes (e.g. hypertension, congestive heart failure, insulin resistance and obesity) (Seals and 
Esler 2000). With a reduced post-synaptic response of these receptors on the heart, HR will 
not increase to the same extent in the healthy elderly heart as when compared to a healthy 
young heart in response to strenuous dynamic exercise. With a lower HRmax, maximal cardiac 
output and therefore aerobic exercise capacity is attenuated with age. It has been shown that 
exercise capacity has prognostic effects on mortality in elderly individuals, and that 
augmented exercise capacity is associated with reduced risk of mortality (Nylen, Kokkinos et 
al. 2010). This again plays a role in the reduced physical functioning observed with ageing, 
negatively affecting quality of life. 
 
2.6.4 Physical Activity and the Heart 
Habitual physical activity pattern could be an important modifier of the development 
of age-related cardiac stiffening and LV diastolic dysfunction. Arbab-Zadeh et al. (Arbab-
Zadeh, Dijk et al. 2004) examined the effects of physical activity on LV compliance in 
elderly individuals. Twelve healthy sedentary men and women (mean age 69.8 ± 3 years) and 
12 age-matched male and female Masters athletes (mean age 67.8 ± 3 years) participated. LV 
compliance was significantly lower in sedentary elderly individuals compared to Masters 
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athletes. However, the LV compliance of Masters athletes was similar to a sedentary group of 
young individuals. Stratton et al. examined cardiac function in healthy young and elderly 
individuals before and after 6 months endurance training (Stratton 1994). An increase in EF, 
end-diastolic volume (EDV) and CO were observed. This suggests that physical activity in 
later life may have beneficial effects on LV function, indicated by a more compliant LV and 
higher end-diastolic volume and CO. Achieving higher CO would increase exercise capacity 
in elderly individuals enabling better physical function performance, improving dependency 
and quality of life. 
 
2.6.5 Ventricular-Arterial Coupling 
A concept known as ventricular-arterial coupling describes the relationship between 
the heart and vasculature (Frenneaux and Williams 2007). Increased large artery stiffness 
poses an increased afterload on the heart as systolic wall stress is increased. When the heart 
ejects blood through the aorta, increased aortic stiffness causes increased pressure and stress 
that the LV has to overcome to force blood out of the ventricle. In response, the heart appears 
to increase in stiffness, potentially via a fibrosis response. Animal models have shown that 
cardiac fibrosis is a reactive process in response to LV pressure overload. Robert et al. 
induced hypertension in rat hearts by continuous infusion of aldosterone for 2 months. They 
found that this was associated with development of fibrosis (Robert, Besse et al. 1997). This 
initial fibrosis is accompanied by cardiomyocyte hypertrophy and is a part of an adaptive 
response aimed at preserving cardiac output while normalizing wall stress (Biernacka and 
Frangogiannis 2011). Leite-Moreira et al. found that in rabbits, a large acute increase in 
afterload resulted in a significant slowing of active relaxation and impaired LV diastolic 
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filling (Leite-Moreira, Correia-Pinto et al. 1999). This suggests that the progressive 
hypertrophy and stiffening of the ageing heart may be a consequence of peripheral vascular 
stiffening. 
 
2.7 Ageing and the Vasculature 
The vasculature undergoes a multitude of age-related changes that leave us at an 
increased risk of developing vascular diseases such as hypertension and atherosclerosis. The 
vasculature may be divided in to two regions, the macro-vasculature that includes the large 
arteries and veins (> 200 µm), and the microvasculature including arterioles, venules and 
capillaries (< 200 µm). The conduit arteries of the macro-vasculature carry oxygenated blood 
from the heart to the organs. Proximal to the target organs, the vascular network divides into 
smaller arterioles and forms capillaries at the target organs. The capillary network is the site 
of oxygen and nutrient exchange and is vital to an organs functional ability. 
 
2.7.1 Macro-vascular Ageing 
With age, large arteries dilate and their walls become thicker, by a process referred to 
as intima-medial thickening (IMT) (thickening of the intima and medial artery layers) 
(Lakatta 2002). Nagai et al. used data from the Baltimore Longitudinal Study of Aging 
(BLSA) (Shock, Greulich et al. 1984) and found that carotid IMT was significantly increased 
in 261 men (age 64 ± 15.7 years) and 246 women (age 57.8 ± 15.6 years) compared to data 
collected when participants were aged 30 years (Nagai, Metter et al. 1998). Najjar et al. states 
that arteries also widen with age, increasing the size of the lumen (Najjar, Scuteri et al. 2005), 
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which have been shown by cross-sectional studies (Lakatta 1993). The putative underlying 
mechanisms for these changes are explained below. 
 
 
Figure 2.5: Diagram of age-related changes in macro-vasculature (arteries). A: young 
artery; B: aged artery. 
Age-dependent increases in large artery stiffness is also well established (Avolio, 
Chen et al. 1983, Benetos, Laurent et al. 1993, Frenneaux and Williams 2007). The increase 
in stiffness results from a depletion of elastin due to the repeated cycles of distensions and 
elastic recoils of the arterial wall, in addition to deposition of collagen (Najjar, Scuteri et al. 
2005). The increased collagen content is due to fibrosis of the vascular smooth muscle layer, 
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a similar process to fibrosis of the cardiac myocytes.  Furthermore, the reduced arterial 
distensibility in the periphery results in an increase in blood pressure (BP), as the vessels are 
unable to cushion the increase in blood flow which has been pumped from the LV (Lakatta 
and Levy 2003). These alterations attenuate the buffering capacity of the large arteries in 
response to pressure changes. Pressure waves are reflected back from the periphery and form 
with the forward going wave to produce the characteristic waveform. Normally, in young 
compliant vessels, the reflected pressure wave arrives in the central arteries following closure 
of the aortic valve. However, with vascular stiffening the reflected wave arrives earlier and 
augments central systolic pressure (Asmar, Benetos et al. 1995), a major risk factor for the 
development of cardiovascular disease. Pulse wave velocity (PWV) increases with ageing, 
which is an indicator of peripheral and central arterial stiffness (Lakatta and Levy 2003). 
 
Figure 2.6: Diagram presenting pressure wave and reflected wave from the radial artery in 
young (A) and elderly (B) 
If the aorta was an open-ended tube providing a simple resistance to flow then there 
would be a single pressure wave present. However, the network of arteries with all the 
bifurcations and vascular beds produces reflected waves. As the primary pressure wave 
travels along the arteries, reflected waves are generated from each bifurcation and from the 
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peripheral vascular beds. These small reflected waves return to the heart, summing to create a 
reflected wave as shown in Figure 2.6, initiating even before the end of systole. The pressure 
in the aortic root is the sum of the outgoing and reflected wave, indicated by the green line in 
Figure 2.6A, presented as the Augmentation Index (AIx). The speed of the outgoing and 
reflected waves is dependent on the stiffness of the arteries along which they are travelling. 
Less compliant stiffer arteries cause the waves to travel out and back quicker, arriving back 
earlier at the heart (Figure 2.6B). The speeds of the waves in the central (aorta) and peripheral 
(e.g., brachial) arteries are referred to as central and peripheral pulse wave velocity (cPWV 
and pPWV) and indicate arterial stiffness. 
The apparent increase in arterial stiffness observed with ageing is not only attributable 
to structural changes in the vessel wall, but also to impaired endothelial regulation of the 
vascular smooth muscle surrounding the arteries (Lakatta and Levy 2003). Endothelial cells 
were once thought to be ‘inert’ with no physiological function (Cines, Pollak et al. 1998). 
However, it is now known that endothelial cells play a very important role in regulating 
arterial responses to blood flow (via shear stress) (Najjar, Scuteri et al. 2005). Endothelial 
derived nitric oxide (NO) dilates the arteries in response to an increase in shear stress. A 
reduction in NO production and bioavailability occurs with ageing, which has been 
associated with a disruption in the upstream production of endothelial nitric oxide synthase 
(eNOS), the rate limiting enzyme for endothelial NO production (Seals, Desouza et al. 2008). 
ROS and inflammatory cytokines increase with age, as mentioned in Section 2.2.6. 
Under normal conditions, oxygen radicals are produced endogenously, and levels are 
increased during oxidative stress. The most common and more reactive radicals are 
superoxide and hydrogen peroxide (Schnackenberg 2002). Superoxide is produced during 
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mitochondrial respiration and also by nicotinamide adenine dinucleotide phosphate-oxidase 
(NADPH oxidase). In ageing, the amount of radicals produced exceeds the resources for 
metabolism, so oxidative stress occurs which is damaging. Animal studies have shown that 
superoxide interferes with the production of NO (Versari, Daghini et al. 2009) as NO is 
susceptible to oxidative scavenging (Beckman and Ames 1998). ROS quench NO after its 
production and consequently reduces its bioavailability (Versari, Daghini et al. 2009). 
Superoxide reacts with NO to form peroxynitrite, impairing NO bioavailability, ultimately 
leading to endothelial dysfunction (Metsios, Stavropoulos-Kalinoglou et al.). A reduction in 
NO production and bioavailability results in an attenuated vasodilatory response to an 
increase in blood flow (Celemajer 1994). Endothelial dysfunction is apparent in both the 
macro- and microcirculations, and is associated with major cardiovascular risk factors, such 
as the progression of atherosclerotic disease (Versari, Daghini et al. 2009). 
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Figure 2.7: Diagram representing the release of NO from the endothelium, and the inhibition 
of this process via inflammation and ROS. 
In addition to impaired vasodilation of the vasculature, the inflammatory cytokine 
TNF-α upregulates the expression of vascular adhesion molecules, such as vascular adhesion 
molecule-1 (VCAM-1) (Metsios, Stavropoulos-Kalinoglou et al.). As a result of impaired 
vasodilation and increased expression of adhesion molecules, low-grade chronic 
inflammation is involved in the development of atherosclerosis, ultimately leading to 
cardiovascular disease. Atherosclerosis is an inflammatory disease of the arteries, and 
involves the development of atherosclerotic lesions which eventually form plaques (Hansson 
2001). The lesions impinge on the lumen of the artery, decreasing the blood flow, which 
results in damage to the tissue that is served by the artery due to oxygen starvation. The 
lesions of atherosclerosis are responsible for changes in the heart that can lead to myocardial 
infarction, in the brain to cerebral infarction or stroke, and in the peripheral vasculature to 
loss of function (Ross 1995). 
One of the earliest changes in the endothelium associated with atherosclerosis is the 
formation of adhesion molecules VCAM-1 and inter-cellular adhesion molecule-1 (ICAM-1), 
which adhere to T cells (Ross 1995). T cells are a type of leukocyte and form part of the 
adaptive immune system, which release cytokines in response to threat or damage. Following 
adhesion, leukocytes transmigrate through the endothelial layer in to the intima of the smooth 
muscle layer leading to increased IMT (Hansson 2001). The atherosclerotic lesions are 
developed in these thickened regions, and contain large numbers of immune cells, 
particularly macrophages and T cells. Most of the T-cells present in the lesions are CD4+ and 
CD3+ memory cells (Hansson 2001), which increase with ageing. Interactions between 
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macrophages and T cells lead to replication and migration of vascular smooth muscle cells 
(VSMCs) in to the lesion, increasing the lesion size (Ross 1995) 
Sympathetic nerve activity is chronically elevated, not only in the heart as stated 
earlier, but also in the vasculature, with advancing age (Seals and Esler 2000). Although a 
reduction in β-receptor sensitivity to sympathetic firing has been suggested as a potential 
mechanism, a number of central factors have also been implicated, including NO. Nitric 
oxide synthase (NOS) isoforms are expressed within the central nervous system, and it is 
suggested that NO restrains sympathetic outflow (Thomas 2001, Fisher, Young et al. 2009, 
Young, Fisher et al. 2009). Increased ROS with age may attenuate the production and 
bioavailability of central NO as in the endothelium. With this reduced NO bioavailability, 
restraint of sympathetic nerve activity would be suppressed, therefore increasing sympathetic 
drive. Increased sympathetic nerve activity has also been identified as a contributor, causing 
increased vasoconstriction (α-adrenergic receptor stimulated) (Dinenno 2001). Dinenno 
examined the effects of local phentolamine infusion of the femoral artery, which blocks the 
α-adrenergic receptors, on resting femoral blood flow in healthy young men (mean age = 28 
± 2 years) and older men (mean age = 64 ± 2 years) (Dinenno 2001). Resting femoral artery 
blood flow and vascular conductance in the older group were significantly lower than the 
younger group. Local α-adrenergic receptor blockade with phentolamine significantly 
increased these variables in both groups; however this increase was significantly greater in 
the old compared with the young men. Importantly blocking sympathetic stimulation of the 
vascular smooth muscle (VSM) of the femoral artery accounted for approximately 75% of the 
reduction in resting blood flow in the elderly sample. This observation suggests that other 
mechanisms are involved with the higher levels of vasoconstriction and lower blood flow in 
LITERATURE REVIEW 
 
34	
	
ageing. The remaining 25% of the difference is likely explained by the impaired NO 
production and bioavailability and changes in arterial structure. 
 
 
2.7.2 Micro-vascular Ageing 
In addition to the large arteries of the macro-circulation, the micro-circulation also 
exhibits age-related alterations. Cutaneous (skin) microcirculation is comparable to skeletal 
muscle microcirculation, and is more accessible than the skeletal muscle vasculature for 
assessment with non-invasive techniques. Tew et al. investigated the microcirculation of the 
skin in elderly sedentary and fit, and young sedentary individuals (Tew, Klonizakis et al. 
2010). In response to a reactive hyperaemia test, young and elderly fit individuals had a 
significantly higher peak cutaneous perfusion compared to the elderly sedentary group. 
Iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP) paired with laser 
Doppler Flowmetry at the volar aspect of the forearm was also used to assess cutaneous 
blood flow. In response to ACh (endothelial-dependent dilator) and SNP (endothelial-
independent dilator) administration, the young group had significantly higher peak flows 
compared to the elderly sedentary group also. This study shows that elderly individuals have 
an attenuated endothelial dependent dilator function in the cutaneous circulation compared to 
young sedentary counterparts. Schnackenburg et al. examined the renal microvasculature in 
rabbits, and suggested that ROS, more specifically superoxide caused vasoconstriction 
(Schnackenberg and Wilcox 2001). It appears that the microvasculature may also be affected 
by the age-related increase in ROS. It has been suggested that the microcirculation may be 
even more susceptible to the deleterious effects of ROS and inflammation due to the smaller 
size of the vessels (Wagenmakers, van Riel et al. 2006). 
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2.7.3 Consequences of Vascular Ageing 
The consequences of macro- and micro-vascular dysfunction with ageing are 
multiple. Large artery dysfunction not only exposes individuals to an increased risk of 
hypertension and atherosclerosis, but also negatively impacts delivery of blood towards target 
organs (Ross 1995, Hansson 2001, Versari, Daghini et al. 2009). Micro-vascular dysfunction 
causes impairments in the delivery of oxygen and nutrients carried in the blood. In terms of 
skeletal muscle, a lack of oxygen and nutrient delivery has detrimental effects on exercise 
capacity. Age-related reductions in skeletal muscle blood flow are apparent, and may lead to 
reductions in exercise capacity (Proctor, Koch et al. 2004). Glucose and fatty acids are 
essential for energy metabolism of skeletal muscle. As well as energy metabolism, building 
of new muscle via protein synthesis is also affected. Amino acids are essential for muscle 
protein synthesis for repair of damaged muscle and also for building new muscle. Decreased 
delivery of amino acids results in a decrease of protein synthesis. This, coupled with protein 
breakdown, progressively results in muscle wasting, muscle weakness, and an increased risk 
of instability and frailty development (Marzetti, Calvani et al. 2013). Ultimately, age-related 
sarcopenia occurs, a muscle wasting disease. 
 
 
2.7.4 Physical Activity and Vascular function 
Physical activity in elderly populations has been associated with superior vascular 
function (Tew, Klonizakis et al. 2010). Tanaka et al. investigated large central artery 
compliance both cross-sectionally and via an exercise intervention (Tanaka, Dinenno et al. 
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2000). In the cross-sectional study 151 healthy men aged 18-77 years were examined and 
separated into groups of sedentary (n = 54), recreationally active (n = 45) and endurance 
trained (n = 53). Central artery stiffness measurements were acquired via B-mode ultrasound 
and applanation tonometry. Central arterial compliance was lower in middle-aged and older 
men compared to young men in all 3 activity groups. There were no significant differences in 
central arterial compliance between sedentary and recreationally active individuals at any 
age, however endurance trained middle-aged and elderly individuals had significantly higher 
arterial compliance compared to the other 2 activity groups of their age-matched 
counterparts. Following this cross-sectional study, central arterial compliance was examined 
before and after a 3-month aerobic exercise intervention in the sedentary middle-aged and 
elderly groups. Results showed that central arterial compliance was significantly increased in 
both groups following the intervention. Cross-sectional studies have demonstrated that 
endothelial-dependent dilation, which is dilation via NO release, is improved in older men 
who regularly perform aerobic exercise compared with their sedentary counterparts. 
Interventional studies have also shown that endothelial-dependent dilation is improved in 
previously sedentary older healthy men following a 3-month aerobic training programme of 
moderate intensity exercise (Seals, Desouza et al. 2008). This enhanced NO bioavailability 
and endothelial dependent dilation may be due to a reduction in ROS, which has been 
documented to be a result of aerobic exercise training and regular physical activity (Adams, 
Linke et al. 2005). 
Evidence suggests that physical activity has beneficial effects on micro-vascular 
function with age as well as in the macro-vasculature. Tew et al. also included a fit elderly 
group when examining endothelial dilator function in the cutaneous circulation (Tew, 
Klonizakis et al. 2010). Elderly fit individuals had comparable peak flow in response to ACh 
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administration to young sedentary individuals, which was significantly higher than their 
sedentary elderly counterparts. This study not only shows that elderly individuals have an 
attenuated endothelial dependent dilator function, but also that fit elderly individuals maintain 
their dilator function in the cutaneous circulation. 
Exercise training has been shown to reduce the development of atherosclerosis and 
endothelial dysfunction by a number of ways. Shear stress resulting from exercise training is 
known to upregulate endothelial-derived NO bioavailability and improve endothelial-
dependent dilation (Tinken, Thijssen et al. 2010). An important long-term adaptation to 
exercise is the improvement in the resistance to oxidative stress. The enzyme superoxide 
dismutase (SOD) decomposes ROS and is significantly increased as a result of habitual 
physical activity (Metsios, Stavropoulos-Kalinoglou et al.). With reduced ROS, NO 
quenching decreases, allowing the conversion of L-arginine to NO resulting in vasodilation. 
 
2.8 Cardiovascular Responses to Exercise 
 In order for exercise to be maintained, it is paramount that appropriate cardiovascular 
adjustments are made to meet the increased metabolic demand of exercising skeletal muscles. 
This is orchestrated by both central and peripheral neural mechanisms, including feed-
forward signals from higher brain centres (i.e. central command) and reflex feedback from 
group III and IV sensory afferents within the working skeletal muscle in response to 
mechanical (i.e. muscle mechanoreflex) or metabolic stimuli (i.e. muscle metaboreflex) 
(Krogh and Lindhard 1913, Alam 1937, Coote, Hilton et al. 1971, McCloskey and Mitchell 
1972, Kaufman, Longhurst et al. 1983), resulting in a complex integrated cardiovascular 
response. Central command represents parasympathetic (vagal) nerve activity responsible for 
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a reduction in HR, ventricular contractility (inotrophy), stroke volume and therefore cardiac 
output (Fisher, Young et al. 2015). Feedback reflexes including the muscle mechano- and 
metaboreflex constitute the exercise pressor reflex, and induce sympathetic nerve activity 
(SNA), activation of which increases HR (chronotropy) and ventricular contractility 
(inotropy).   
Upon initiation of exercise, cardiac parasympathetic withdrawal occurs and explains 
the initial increase in HR observed. Sympathetic activation occurs shortly after 
parasympathetic withdrawal, allowing HR, ventricular contractility, stroke volume and CO to 
increase further (Fisher, Young et al. 2015). With regards to the vasculature, sympathetic 
activation causes vasoconstriction of areas of the body with less metabolic demand (e.g., the 
splanchnic circulation and non-exercising muscles), causing a redistribution of CO toward 
exercising skeletal muscles. The precise contribution of central command and skeletal muscle 
afferent feedback to these autonomic alterations is an area of intense research focus, 
particularly in age and disease (Fisher, Young et al. 2015).  
Appropriate autonomic regulation of the cardiovascular system is vital for exercise 
performance. Populations who have autonomic dysfunction cannot perform even light 
exercise as failure of increasing central blood volume and cardiac output (CO) occurs, which 
can lead to exercise intolerance and even syncope (Marshall, Schirger et al. 1961).  
Conversely, high peripheral SNA can reduce skeletal and cardiac muscle blood flow in 
disease states and could contribute to exercise intolerance in these populations (Michelini, 
O'Leary et al. 2015). Ageing is associated with altered resting autonomic regulation, 
specifically a reduction in parasympathetic nerve activity and vasomotor sympathetic 
responsiveness (Barnett, Morin et al. 1999, Kuo, Lin et al. 1999). Reduced sensitivity of α-
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receptors in the skeletal muscle vasculature and β-receptors in the heart are postulated to lead 
the higher basal SNA and sympathodominance in the elderly (Lakatta 1993, Smith, Voyles et 
al. 2007). The reduced sensitivity of cardiac β-receptors is also responsible for the reduced 
maximum heart rate observed with ageing, contributing to decreased exercise capacity. In the 
vasculature, an increased muscle vasoconstrictor tone could lead to a reduction in muscle 
blood flow, an augmented BP response, and again may contribute to the attenuated exercise 
tolerance (Lakatta 1993, Smith, Voyles et al. 2007).  
A large body of scientific interest has been focused on the metaboreflex, due to its key 
role in cardiovascular regulation during exercise (Crisafulli, Salis et al. 2006, Boushel 2010, 
Crisafulli 2011). It is well established that the muscle metaboreflex increases SNA and BP 
(Alam 1937, Mark, Victor et al. 1985), however whether the latter is attributable to an 
increase in CO (O'Leary 1998, Crisafulli, Scott et al. 2003, Sala-Mercado, Hammond et al. 
2006, Crisafulli 2011), total peripheral resistance (TPR) (Bastos, Williamson et al. 2000, 
Lykidis, White et al. 2008) or both (Bonde-Petersen 1982, Crisafulli, Salis et al. 2006) is 
equivocal in young populations, and certainly is not currently understood in ageing. To begin 
to investigate these mechanisms, the importance of understanding what occurs in ‘normal’ 
physiological functioning under stress is the first key step, (i.e. a healthy young population). 
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2.9 Summary of literature review 
Life expectancy and the average age of the UK population are increasing; however 
elderly individuals are spending an increased number of years in a frailty-related diseased 
state. Ageing is coupled with the development of frailty and age-related diseases due to 
multiple function loss of the immune, musculoskeletal and cardiovascular system, reducing 
the quality of life of elderly individuals and inflating the costs needed for medical care. There 
is an age-related fall in physical activity, which may make a significant contribution to the 
multiple function loss observed with ageing (Rantanen, Guralnik et al. 1999). Conversely, it 
may be the loss of functioning that reduces our ability to perform physical activity as we age 
(Rantanen, Guralnik et al. 1999). Figure 2.7 presents a simplified representation of the 
complex relationship between ageing and cardiovascular dysfunction, and possible 
mechanistic associations. Ageing is observed with an increase in physical inactivity, 
inflammation and central and visceral adiposity. Each of these age-related variables has also 
been shown to be related with one another and may have causal mechanistic links, resulting 
in cardiovascular dysfunction. 
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Figure 2.8: Age-related factors contributing to development of cardiovascular dysfunction. 
Physical activity participation in the elderly has been associated with improved 
cardiovascular function both at the cardiac and vascular levels, and may prevail via an 
inflammatory and central adiposity lowering mechanism. Maintaining or increasing physical 
activity would be expected to prevent the age-related decline in physiological function. 
Reduced central adiposity and increased cardiovascular function increases physical 
functioning of elderly individuals, convalescing quality of life. At present there is limited 
information regarding the effects of physical activity on the function of multiple body 
systems in a large cohort of elderly individuals with a wide range of physical activity levels 
to thus elucidate which of these functions contribute to the development of components of 
frailty. The majority of research has focussed on separate entities of ageing (e.g. physical 
limitations, inflammation, immune function, cognition, body composition and cardiovascular 
function) as individual dependent variables of physical activity. This approach, therefore, 
fails to elucidate the complete holistic picture of the mechanisms by which gradual decreases 
in physical activity with ageing lead to the development of components of frailty. It is 
currently unknown what the associations are by which reduced habitual physical activity 
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leads to the components of frailty in the ageing population. Therefore, against this 
background the aims of this thesis are to: 
• Determine the physical activity range of a sample of elderly individuals in the 
Birmingham and Black Country 
• Investigate the associations between physical activity, cardiovascular function, 
inflammation and body composition in this cohort 
• Investigate the associations between LV diastolic function, physical activity, 
inflammation and body composition in this cohort 
• Better understand the neural mechanisms underpinning the ‘normal’ cardiovascular 
responses to exercise in a healthy young population
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3.1 Ethical Approval 
Ethical approval was granted from National Research Ethics Service (NRES) 
Committee West Midlands - The Black Country. 
 
3.2 Design and Recruitment 
A cross-sectional cohort study involving 211 60-80 year olds was performed. 
Recruitment into the Physical Activity and Healthy Ageing (PAHA) study was through the 
Primary Care Research Network for Central England (PCRN-CE). The PCRN-CE established 
first contact between members of the research team at the University of Birmingham and 
research nurses appointed to the larger general practitioner (GP) Surgery’s in the Birmingham 
and Black Country (BBC) area. The total number of Primary Care Trusts (PCTs) in the BBC 
area covered by PCRN-CE is 54 and the total number of GP surgeries is 432. GP surgeries 
complete a search using the inclusion criteria (see below) using the updated former Midland 
Research Practices Consortium database. Through this route, the PCRN-CE suggested that 
for every 10 surgeries enrolled around 3000 eligible candidates would be identified. Of this, 
approximately 10-15% would be interested and 50% of these recruited. Thus for every 10 
surgeries enrolled approximately 150 – 200 participants would be recruited. Each PCT was 
associated with a Townsend score provided to the research team by the PCRN-CE, which is a 
socio-demographic indication of the local area. This score was used in selection of which GP 
surgeries to approach in order to recruit approximately equal numbers of individuals from 
differing socioeconomic backgrounds. 
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Eligible candidates were approached by their GP surgeries with an invitation letter 
explaining the aims of the study and a brief summary of the experimental protocol the 
participants would be involved in. Those with a potential interest were asked to complete a 
reply slip and return it by freepost to the researchers at the University of Birmingham. 
Potential participants were then contacted by the research team and the study procedures and 
aims explained in detail by phone and/or email. Participant information sheets were then sent 
by post to those that confirmed interest. Candidates were then invited to the Wellcome Trust 
Clinical Research Facility (WT-CRF) at the Queen Elizabeth Hospital Birmingham. Through 
this recruitment process a total of 211 participants were recruited into the study (Figure 3.1).  
Inclusion Criteria: 
1. Aged 60-80 years old 
2. Able to walk for 2 minutes or 50 metres without stopping 
3. Able to provide written informed consent 
Individuals were ruled out of participation if they met any of the exclusion criteria: 
Significant medical history in the last 3 years of: 
1. Dementia, Parkinson disease, stroke, TIAs, liver disease, cancer 
2. Heart Disease, specifically previous myocardial infarct, cardiomyopathy or valvular 
disease 
3. Chest pain (angina pectoris). History of recurrent (no more than 1 or 2 episodes per 
month over the last 6 months) or sudden chest pain typically radiating to the left arm 
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or left side of the neck (unless associated with recent cold, cough or episode leading 
to bruising 
4. Blood Pressure >190/120 or tendency to faint 
5. Pulmonary disease including asthma/COPD leading to significant lung function loss 
and prescription of corticosteroids. Other medication is permitted. 
6. Rheumatoid or osteoarthritis leading to severe stiffness and exercise intolerance (mild 
stiffness is allowed if exercise criterium above is met. 
7. Current use of corticosteroids 
8. Type 1 or 2 diabetes (raised blood sugar when measured on capillary sample is 
allowed) 
9. History of leg pain on exertion, sufficient to limit walking ability to less than 50 
metres or <2 mins 
10. Any cause to consult the G.P. or report of feeling unwell in the previous 10 days 
11. Inability to give informed consent 
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Figure 3.1: Recruitment process of participants into the PAHA study from the Birmingham 
Black Country (BBC) area. 
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3.3 Measured Variables 
3.3.1 Anthropometric Measurements 
Body weight was determined using a calibrated electronic scale, and height was 
measured with a portable stadiometer, both of which were performed with the participant in 
the standing position facing backwards during the height measurement and forwards during 
the weight measurements; and wearing light clothing and no shoes. Values were rounded to 
the closest centimetre and 100g. From these measurements, BMI (kg/m2) was calculated 
using the following equation: 
BMI = mass (kg2) ÷ height (m) 
Waist and hip circumference was measured using a flexible graduated measuring tape 
with the participant in the standing position and the tape placed against the skin. 
 
3.3.2 Fasting Blood Glucose 
Participants were asked to not consume any food or drink other than water in the 10-
hours prior to arrival at the clinic. Blood glucose was measured using a calibrated monitor 
(Accu-Check Performa). Following cleansing of the selected finger with a 70% alcohol wipe, 
the skin was punctured using an Accu-Check Lancet, and the blood allowed to form a small 
globule. This initial blood sample was cleaned away and a second blood sample allowed to 
develop, which was used to assess blood glucose. If fasted blood glucose levels were below 
the General Medical Council (GMC) recommendations of risk of diabetes (7mmol/L), 
participants were accepted into the study. 
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3.3.3 ‘Office’ Blood Pressure and Heart Rate 
After the participants were seated for at least 15 minutes ‘office’ BP and HR 
measurements were taken using a GH Pro200 Dinamap sphygmomanometer, previously 
validated (O'Brien, Pickering et al. 2002), performed by the WT-CRF research nurses. A BP 
cuff was wrapped round the upper left arm of each participant, ensuring the artery index was 
positioned over the brachial artery. Participants were asked to have their feet flat on the floor 
with their measurement arm in a relaxed, supinated position. A minimum of 3 measurements 
were taken and the mean calculated. 
 
3.3.4 Blood Sample for Plasma Biomarkers 
In the fasted state, participants had approximately 40 ml of venous blood taken from a 
vein at the antecubital fossa into evacuated vacuum tubes coated with either sodium heparin 
or EDTA as an anticoagulant or clotting factor for serum (Becton-Dickinson, Oxford, UK). 
Plasma and serum was frozen at -80°C for later analysis. Peripheral blood mononuclear cells 
were isolated using density gradient centrifugation and frozen in fetal calf serum (FCS) + 
10% dimethyl sulfoxide (DMSO) and stored at -80°C for future analysis of cell compositions. 
Complete differential counts of EDTA treated whole blood were completed using a calibrated 
coulter counter within 3 hours after bloods were taken. All blood samples were taken by a 
phlebotomy trained research nurse. 
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3.3.5 Assessment of Body Composition 
Total and regional bone and body composition assessments were made using dual-
energy x-ray absorptiometry (DEXA) and peripheral quantitative computed tomography 
(pQCT). Both techniques provide information on bone and body composition from minimal 
radiation exposure and were completed by NHS radiographers. Specifically assessments of 
total body fat percentage, estimated visceral fat mass, and total lean mass was gained by the 
DEXA scan. Cross-sectional area, density and muscle mass of the distal radius and tibia was 
gained by the pQCT. The principle of DEXA is the measurement of transmission of x-rays 
with high and low energy photons within the body. The different tissues i.e. bone, muscle, fat 
and skin have different chemical compositions and different densities. X-rays with the same 
photon energy will pass through the different tissues at different transmissions, so detection 
of  bone, muscle and fat mass that composes the body is enabled (Crabtree, Leonard et al. 
2007).  Arm and leg muscle cross-sectional area and muscle density were measured using 
pQCT. 
 
3.4 Resting Cardiovascular Function 
3.4.1  Heart Rate and Blood Pressure 
Participants were laid in the supine position. A standard 3-lead electrocardiogram 
(ECG) (Morgan 509, P.K. Morgan Ltd, Rainham, Kent, England) was used to measure HR. 
BP was measured in the left brachial artery using a standard automated device (Ohmeda 2300 
Finapress, Amsterdam, Netherlands) previously validated (Collen, Manhem et al. 2012), 
whilst beat-to-beat BP was measured using finger photoplethysmography. Participants were 
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allowed to rest in the supine position for 3 minutes before data collection commenced, and a 
total of 5 BP measurements were taken during the 5 minute data collection period. HR and 
beat-to-beat BP were converted from analogue-to-digital signals at 1 kHz and captured for 
offline analysis (Chart v5.2 and Powerlab, ADInstruments, Bella Vista, NSW, Australia). 
Participants were asked to relax and breathe normally, and not talk for 5 minutes.  
 
3.4.2 Arterial Stiffness 
The most widely used techniques at present due to their good reproducibility and ease 
of use are pulse wave analysis (PWA) and PWV (Wilkinson, Fuchs et al. 1998). Non-
invasive assessment of PWA and PWV were recorded using an applanation tonometer 
(SphygmoCor Px, ScanMed Medical Instruments, UK). Whilst participants remained in the 
supine position, brachial BP (mmHg) and distance from the suprasternal notch to recording 
sites (mm) were measured. Recording sites included the location at which the pulse could be 
felt from the radial artery at the radial notch, carotid artery at the neck and femoral artery at 
the groin. Following this the pressure transducer was applied to the desired anatomical 
locations. Central (cPWV) and peripheral (pPWV) pulse wave velocity and aortic AIx 
produced (Hecker, Qiu et al. 2004).  For cPWV pressure waveforms at the carotid and 
femoral arteries were assessed whilst for pPWV the carotid and brachial arteries were 
assessed. Timing of the produced waveforms were matched to the R wave of the concomitant 
3-lead ECG measurements in order to control and normalize to HR, with the arterial path 
length and values obtained expressed as blood flow in meters per second (m/s). AIx was 
measured at the radial artery only and is expressed as a percentage (%) of how much the 
original waveform is augmented from the reflected pressure wave. Several measurements 
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were taken at each site, and the highest 3-5 measurements in terms of signal quality (i.e. 
operator index ≥80) were used for analysis, and averaged. 
 
3.5 Left Ventricular Function 
Resting LV cardiac function was assessed by Doppler ultrasound echocardiography 
using an iE33 ultrasound system capable of both 2D and 3-dimensional (3D) images with an 
X5-1 transducer probe (Philips Medical System, Surrey, UK) (Hascoet, Brierre et al. 2010). 
All images were obtained and analysed by an experienced sonographer (myself) and stored 
on an external storage device for offline analysis using the Xcelera and QLab software 
system. Three standard limb lead spot electrodes were placed on the chest to obtain HR. All 
2D measures were collected over 3 consecutive cardiac cycles, using a sample volume of 
15mm. Participants laid in a semi-supine position leaning towards the left hand side, with the 
left arm resting above the head, and  supported by cushions to ensure maximum comfort. 
This position results in the rib cage opening at the apex, widening the echocardiographic 
window allowing the best quality images. The Doppler probe was placed at 2 different 
locations on the chest for different images. For apical 4 and 5 chamber images, the probe was 
placed between the 9th-12th rib spaces. For parasternal long-axis images, the probe was placed 
just left of the sternum in the mid-chest area. A small amount of transduction gel was placed 
on the Doppler probe in order for images to be transduced. 
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3.5.1 Aortic Outflow 
To quantify flow through the aortic valve during systole, an apical 5 chamber view 
was used (Brothers 2008). The velocity profile of the aortic outflow was obtained using 
pulsed-wave Doppler. Sampling of the flow was taken over the aortic valves at the opening of 
the aortic orifice. The flow was quantified automatically using the velocity time integral 
(VTI), which represent the mean distance through which blood travels in the aortic outflow 
tract during ventricular contraction. Aortic root diameter was measured in the parasternal 
long-axis view. During post-acquisition analysis SV and CO were calculated using the 
following formulae (Lewis, Kuo et al. 1984): 
SV (ml) = VTI (ms) × aortic root area (cm2) 
CO (L·min-1) = SV (ml) × HR (b·min-1) 
 
3.5.2 Mitral Inflow Velocities 
Mitral inflow velocities were assessed from the apical 4 chamber view using pulsed 
wave Doppler positioned over the mitral valve leaflet tips. From these, data measurements 
were obtained of the peak inflow velocity during the early phase of LV relaxation (E), which 
provides an index of LV passive relaxation (Hatle 1993, Cohen 1996, Brothers 2008), and 
during LA contraction (A), which provides an index of LV compliance and LA systolic 
function (Cohen 1996, Brothers 2008). These values were subsequently used to further assess 
diastolic function by calculation of the E/A ratio. 
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3.5.3 Tissue Doppler Imaging (TDI) 
Measurements of peak septal mitral annular early diastolic (E’), late diastolic (A’), 
and systolic (S’) velocities were obtained to provide indices of left ventricular diastolic 
function (Prasad, Popovic et al. 2007), left atrial systolic function (Nagueh 2001), and left 
ventricular systolic function (Brothers 2008), via standard TDI techniques (Prasad, Popovic 
et al. 2007). TDI measurements were obtained from the apical 4 chamber view, with the pulse 
wave positioned at the junction of the septal mitral annulus and the left ventricular wall. The 
E’ value was subsequently used for a calculation of E/E’ ratio, which is an indication of LV 
filling pressure (Nagueh, Middleton et al. 1997). 
 
3.5.4 Left Ventricular Dimensions 
In the parasternal long axis, LV dimensions (Inter-ventricular septum diameter, LV 
internal diameter during systole and diastole, LV posterior wall diameter) were measured 
using M-mode Doppler, positioning the Doppler wave just below the mitral valve tips. LV 
mass was calculated according to Devereux formula (Devereux and Reichek 1977), and EF 
was also calculated. 
 
3.5.5 3D Doppler Ultrasound Imaging 
An apical 4 chamber caption was collected over 4 consecutive cardiac cycles, which 
are then stitched together to make 1 full cardiac cycle of the whole heart. From this, end 
diastolic LV volume, end systolic LV volume, ejection fraction, stroke volume, cardiac 
output, end diastolic LV mass, and end systolic LV mass were measured.
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Table 3.1 Reproducibility Study of Echocardiography Measurements 
Values are presented as mean ± SD in 5 participants.  
Reproducibility tests of echocardiography measurements were performed in order to 
elucidate which measurements would be most reliable. Physiological relevance was also 
taken in to account when deciding upon which measurements were used for analysis. 
Generally, a coefficient of variation (CoV) % of ≤5% is considered highly reliable, whereas a 
CoV ≥10% is considered less reliable. IVRT is particularly challenging to both measure and 
analyse. IVRT has a CoV of 33.7%, indicating that it should not be used as a measure of LV 
function.  
Variable Visit 1 Visit 2 Paired T-Test  Coefficient of 
Variation (%) 
2D     
EF (%) 68.12 ± 3.9 59.66 ± 3.7 0.198 11.8 
FS (%) 38.5 ± 3 32 ± 2.6 0.177 16 
IVRT (s) 0.078 ± 0.006 0.066 ± 0.01 0.305 33.7 
E/A ratio 2.2 ± 0.3 1.9 ± 0.2 0.438 12.3 
SV (ml) 51.5 ± 2.7 52.5 ± 3.3 0.85 10.3 
3DQ     
EDV (ml) 127.4 ± 16 121 ± 9.7 0.525 8.4 
ESV (ml) 56.1 ± 10 54.4 ± 7.1 0.806 14.1 
ES Mass (g) 157.6 ± 43 165 ± 37 0.471 11 
ED Mass (g) 122 ± 25 112 ± 18 0.427 7.5 
3DQ adv     
EDV (ml) 128.2 ± 10.3 126.3 ± 16.5 0.9 10.5 
ESV (ml) 56.25 ± 9 52 ± 10.6 0.327 8 
EF (%) 56.8 ± 4 59.6 ± 5.5 0.389 4 
SV (ml) 72 ± 5 73 ± 26 0.919 15 
     
GENERAL METHODS 
 
56	
	
All Echocardiography data were compared to recommended guidelines from the 
British Society of Echocardiography (Appendix 3). Appropriate referral was carried out if 
clinical values were above or below the cut-off points, once technical issues had been ruled 
out (e.g., questionable image quality). E/A ratio, which is calculated from mitral inflow 
velocities was the measurement of LV diastolic function used in Chapter 5 of this thesis. 
Chapter 6 more extensively investigated cardiac mechanics and presents SV, CO, E wave, A 
wave, E/A ratio, E’ wave, A’ wave and E/E’ ratio.  
 
3.6 Functional |Mobility 
Functional mobility was assessed using the 6 metre timed-up-and-go (TUG) test as 
previously described (Thrane, Joakimsen et al. 2007, Nordin, Lindelof et al. 2008). Briefly, 
participants were required to stand from a seated position on a chair with arm rests, walk (at 
normal walk pace) a straight line distance of 3m, turn 180° around, walk back to the chair and 
successfully sit down. Participants were timed to completion of the protocol and the time was 
recorded. Functional manoeuvring ability was assessed using the Berg Balance Scale (BBS) 
(Muir, Berg et al. 2008, Muir, Berg et al. 2010). Briefly, the BBS involves the participant 
performing a number of balance related tasks and their performance being graded against 
specific criteria (e.g., amount of time a task takes, amount of distance participant can reach 
forwards) by the researcher, and recorded. These measurements were carried out by David 
Bartlett of the School of Immunity and Infection, so as to eliminate inter-observer variability. 
Selection bias was also eliminated as researchers were not aware of the physical activity 
status of participants at the time the measurements were taken. Physical activity was recorded 
in the seven days following the assessment day. 
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3.7 Assessment of Physical Activity Status 
Physical activity (PA) status was determined from seven continuous days of 
accelerometer wear (GT3X, Actigraph, FL, USA). Participants wore the GT3X around the 
waist above the non-dominant leg for seven days, except for when bathing (including water 
based activities). The GT3X was programmed to record data in three orthogonal planes 
(vertical [VT], antero-posterior [AP] and medio-lateral [ML]) every 60-seconds. Tri-axial 
vector magnitude (VM) was calculated from the total counts of each of the movement planes 
using the formula VM=√(VT2 + AP2 +ML2). VM has recently been shown as a reliable 
measure of PA and is thought to represent a more realistic measure of physical movements 
(Hazeldine, Hampson et al. 2012). Total time and percentage of time spent in sedentary, light, 
moderate, vigorous and very vigorous activity levels was assessed using cut-offs previously 
described (Freedson, Melanson et al. 1998). Other variables collected and computed by the 
software include energy expenditure, steps and mean metabolic equivalents (METs). 
 
 
 
 
3.8 Plasma Analysis 
3.8.1 Inflammatory Cytokines 
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Detection of serum free cytokines was measured using commercially available XMap 
multiplex Luminex kits (Bio-Rad, Hemel Hempstead, UK) according to manufacturer’s 
instructions. One kit was specific for type 1 cytokines which contained combinations of the 
following cytokines (IL-1b, IL-4, IL-6, IL-10, IL-13, IL-17A, TNFα, MCP-1 and vascular 
endothelial growth factor [VEGF]) whilst the second kit measured macrophage migration 
inhibitory factor (MIF).  Briefly, antibody coupled magnetic beads were added to a 96-well 
greiner NUNC plate. Serum was first centrifuged at 10,000 x g to remove platelets and cell 
debris and then diluted 1:4 with assay specific buffer before addition of 50 µL of sample and 
standards to each well. Plates were then sealed, foil covered and incubated for 30 minutes on 
an orbital shaker at 350 rpm. Following incubation, washing was performed 3 times before 
addition of the biotinylated detection antibody and incubated as before. Following incubation, 
washing was performed and streptavidin-RPE, which binds the detection antibody, was added 
and incubated as before but for exactly 10 minutes. Following washing and re-suspension 
plates were read on a Luminex200 instrument (Luminex Corp, Austin, TX, USA). The 
system identifies and quantitates cytokines based on bead colour and RPE fluorescence. The 
concentration of the cytokines is determined and automatically calculated by the Bio-Plex 
ManagerTM (Bio-Rad, Hemel Hempstead, UK) software using a standard curve derived from 
the recombinant cytokine standard. 
 
 
3.8.2 C-Reactive Protein 
Detection of serum free C-RP was determined by a commercially available high-
sensitivity Enzyme-Linked Immunosorbent Assay (ELISA) (IBL International, Hamburg, 
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Germany). Serum samples were centrifuged at 2,500 xg for 10 minutes to remove platelets 
before being diluted 1:1000 in kit dilution buffer. Wells pre-coated with monoclonal anti-C-
RP antibodies were incubated with 100 µL of either test serum or standards (0 – 10 mg.L-1). 
Plates were covered with adhesive film and incubated for 30 minutes. Following incubation, 
plates were washed 3 times using kit wash buffer. After patting excess fluid from the plate 
100 µL of C-RP conjugated to horseradish peroxidise (HRP) was added and incubated for 30 
minutes at RT. Wells were washed as before and 100 µL of chromogen solution containing 
3,3’,5,5’-tetramethylbenzidine (TMB) was added and incubated for 10 minutes at RT in the 
dark. Following incubation 50 µl of the stop solution containing 0.5M sulphuric acid 
(H2SO4) was added to each well. 
 
3.8.3 Adiponectin and Leptin 
Detection of plasma adiponectin/Acrp30 and leptin were completed independently 
using sandwich ELISA kits (R&D Systems, Abingdon, UK). Briefly, mouse anti-human 
adiponectin or leptin capture antibodies were diluted in sterile PBS to working concentrations 
of 2, 4 and 4 µg.ml-1 respectively. Wells were incubated overnight at RT with 100 µL capture 
antibodies. Following incubation wells were washed 3 times in 400 µL wash buffer 
(PBS/0.05% Tween® 20). Non-specific binding was reduced by blocking the wells with 300 
µl of reagent diluent [PBS + 1% protease free BSA (Fisher Scientific, Loughborough, UK)] 
for 1 hour at RT. Following this blocking plates were washed 3 times. Leptin (0 – 2000 
pg.ml-1) and adiponectin (0 – 4000 pg.ml-1) standards and test plasma were diluted in reagent 
diluent before incubating duplicates of 100 µL for 2 hours at RT. Plates were then washed 3 
times. Biotinylated mouse anti-human adiponectin, or leptin detection antibodies were diluted 
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in reagent diluent and 100 µL per well incubated for a further 2 hours at RT. Following 
incubation the washing was repeated before incubating wells with 100 µL of HRP conjugated 
Streptavidin for 20 minutes at RT in the dark. Following incubation the washing was repeated 
before addition of 100 µL TMB substrate solution and incubated for 20 minutes at RT in the 
dark. Reactions were stopped by addition of 50 µL 2N H2SO4 (Sigma-Aldrich). 
 
3.8.4 Plasminogen Activator Inhibitor-1 
Detection of plasma plasminogen activator inhibitor-1 (PAI-1) was completed using a 
sandwich ELISA kit (Life Technologies). Briefly, wells pre-coated with anti-PAI-1 
antibodies were incubated with 100 µL of standards and samples diluted 1:2 in the 
appropriate buffer provided, covered and incubated for 2 hours at RT. Following incubation, 
plates were washed 4 times using the kit wash buffer. After patting excess fluid from the 
plate 100 µL of biotinylated human PAI-1 biotin conjugate solution was added to each well 
(except the blank) and incubated for a further 2 hours as before. Plates were washed again 
before 100 µL of streptavidin-HRP working solution was added to each well and plates again 
covered and incubated at RT for 30 minutes. Following a similar wash, wells were incubated 
with 100 µL of chromagen solution in the dark for 30 minutes at RT before stopping the 
reaction with 100 µL of stop buffer. 
 
3.8.5 Macrophage Migration Inhibitory Factor and Endothelin-1 
Detection of serum MIF and plasma endothelin-1 were completed independently 
using sandwich ELISA kits (Abcam®, Cambridge, UK).  Briefly, wells pre-coated with anti-
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MIF or endothelin-1 antibodies were incubated with 100 µL of standards and samples diluted 
1:2 in the appropriate buffer provided, covered and incubated for 1 hour at RT. Following 
incubation, plates were washed 5 times using the kit wash buffer. After patting excess fluid 
from the plate 100 µL of HRP conjugated MIF or endothelin-1 working solution was added 
to each well and plates again covered and incubated at RT for 30 minutes. Following a 
similar wash, wells were incubated with 100 µL of chromagen solution in the dark for 30 
minutes at RT before stopping the reaction with 100 µL of stop buffer. 
 All plasma biomarkers were analysed by David Bartlett of the School of Immunity 
and Infection in the research laboratory of the Queen Elizabeth Hospital.  
 
3.9 Candidates contribution to experimental measures obtained 
 The multi-disciplinary nature of the study meant that data collection was a team effort 
between myself, my colleague from the School of Immunity and Infection (David Bartlett), 
and the Wellcome Trust Clinical Research Facility (WT-CRF) nurses (mentioned in the 
acknowledgements). With respect to my personal contribution to the general methods, I was 
involved with: logistical planning of the measurements; participant information sheet design; 
participant recruitment; resting HR via 3-lead ECG, BP and beat-to-beat BP; arterial stiffness 
via PWA and PWV, LV function via Doppler ultrasound echocardiography; and analysis of 
these measurements. There was no imputation of missing values throughout the 
measurements.  
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CHAPTER 4: 
PHYSICAL ACTIVITY AND HEALTHY AGEING (PAHA): 
THE INFLUENCE OF PHYSICAL ACTIVITY ON PHYSICAL 
FUNCTION, BODY COMPOSITION, INFLAMMATORY STATUS AND 
CARDIOVASCULAR FUNCTION IN AN ELDERLY COHORT 
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4.1 Abstract 
Age-related frailty is a multi-physiological syndrome affecting body composition, the 
musculoskeletal system, the immune system and the cardiovascular system. A reduction in 
habitual physical activity with increasing age has been proposed as one of the factors that 
make a substantial contribution to the development of frailty. 
The aim of this study was to test the hypothesis that elderly individuals who have high 
habitual physical activity levels will have superior physical functioning, lower total body and 
visceral fat mass, better cardiovascular function, and lower concentrations of plasma 
biomarkers  regarded to play a role in the mechanisms leading to cardiovascular disease. 
To test this hypothesis, a cohort of 211 elderly individuals was recruited. Their mean 
age, height and weight (mean ± standard deviation) were 67 ± 5 years, 167 ± 10 cm and 73 ± 
14 kg, respectively. Measures of physical function  (BBS, TUG test), body composition 
(DEXA), plasma proteins and peptides which are known to play a role in the mechanisms that 
lead to CVD (PAI-1, MIF, endothelin-1, C-RP, IL-1β, IL-4, IL-6, IL-10, IL-13, IL17a, MCP-
1, TNF-α, VEGF) and cardiovascular function  (HR, BP, central pulse pressure, central and 
peripheral arterial stiffness) were obtained. Based on a 7-day assessment of physical activity 
using accelerometry participants were split into quintiles (1 = 20% least active, 5 = 20% most 
active). 
The difference in physical activity level between the lowest and highest quintile was 
>2 fold (P<0.05). Individuals in the second highest quintile had significantly faster walking 
speeds and TUG times than those in the lowest quintile (2.9 ± 0.6 vs. 2.5 ± 0.5s ; 7.7 ± 1.4 vs. 
8.9 ± 1.7s; P=0.02. Total body fat, % body fat and estimated visceral fat mass were 
significantly lower in the highest 3 quintiles compared to the lowest, with 28% lower total 
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body fat, 8% lower % body fat, and 53% lower estimated visceral fat mass in the highest 
quintile compared to the lowest quintile. Habitual physical activity did not significantly 
influence plasma proteins and peptides, with the exception of PAI-1 (a clotting agent) which 
was lower in 1-3 quintiles compared to quintile 5(9.3 ± 6.6, 9.8 ± 7.3, 9.2 ± 6.6 vs. 13.8 ± 
11.4 ng/mL; P<0.05). Indices of cardiovascular function were not significantly different 
between the quintiles. 
In this cohort study physical function loss, visceral adiposity and PAI-1 concentration 
were attenuated by physical activity. However, lean muscle mass, inflammation and oxidative 
stress, and cardiovascular function were unaltered by physical activity. Despite these null 
findings, the data in the current study support the hypothesis that high daily physical activity 
levels is negatively associated with some of the age-related function losses that contribute to 
frailty in elderly individuals. 
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4.2 Introduction 
It is expected that by the year 2035, one in four individuals worldwide will be aged 65 
years or over (Lakatta 2002). With the observed increase in the mean age of the world 
population, an increase in life expectancy also exists (Branch, Guralnik et al. 1991, Guralnik, 
Land et al. 1993, Leveille, Guralnik et al. 1999). However, this increase in life expectancy is 
not coupled with an increase in healthy well-years, so a majority of these years are spent in an 
unhealthy frail state (Fulop, Larbi et al. 2010). Frailty is loosely described as a general 
decline in the functional ability of multiple bodily systems (Wilson 2004), and includes 
dysfunction of the brain (cognition), musculoskeletal system, immune system and 
cardiovascular system. Fried et al. conducted, defined and validated 5 attributes of reduced 
physical function that results in frailty onset: unintentional weight loss, muscle weakness, 
slow walking speed, exhaustion and a low physical activity (Fried, Tangen et al. 2001). 
Elderly individuals who lead physically active lifestyles are reported to offset the 
development of frailty and indeed morbidity and mortality (Gill, Baker et al. 2002, Gill, 
Baker et al. 2004, Wilson 2004, Chakravarty 2010, Chou, Hwang et al. 2012). For example, 
Chakravarty et al. conducted a longitudinal, self-administered disability questionnaire-based 
study in 284 runners and 156 sedentary individuals aged 50 years and older (Chakravarty 
2010). Over the 21-year follow up period elderly runners had significantly lower self-
declared disability scores and lower mortality rates than the sedentary age-matched controls. 
The beneficial effects of exercise on frailty have also been shown in interventional studies 
(Fiatarone, O'Neill et al. 1994). From these studies it is clear that regular physical activity and 
exercise can reduce and even reverse components of frailty in elderly individuals. Contrary to 
this, evidence is also available that shows that physical activity can be ineffective and even 
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harmful in elderly individuals (Latham, Anderson et al. 2003, Moayyeri 2008). Latham et al. 
failed to observe a positive effect of a 10-week home-based quadriceps resistance 
intervention on physical health, falls or physical performance in 243 frail individuals, and in 
addition found the individuals were at an increased risk of musculoskeletal injury (Latham, 
Anderson et al. 2003). Moayyeri conducted a meta-analysis of 13 cohort studies in elderly 
individuals with hip-fracture end-points (Moayyeri 2008).  It was concluded that there is an 
increased risk of falling in elderly individuals that are either sedentary or highly physically 
active compared to those who perform moderate physical activity. Thus the mode and 
intensity of physical activity in these studies and the increased fall-risk during high intensity 
exercise may explain the conflicting results, in addition to the health and age of the 
participants (Keysor 2003). Despite confounding findings, general consensus suggests the 
balance of evidence tips overwhelmingly towards beneficial effects of physical activity on the 
onset of age-related frailty. Given the diverse stimulus that physical activity provides and the 
complex nature of frailty, the exact mechanisms by which physical activity elicits a beneficial 
effect in the elderly is unclear. 
Important factors thought to be key to the development of components of frailty are 
increased levels of inflammatory cytokines (inflammageing) and presence of inflammatory 
diseases. Fried et al. reported significantly higher levels of inflammatory cytokines in further 
healthy frail individuals, particularly IL-6, TNF-α and CRP (Fried, Tangen et al. 2001). 
Inflammatory cytokines (e.g., IL-1, IL-4, IL-6, TNF-α) are known to contribute to the 
production of ROS. Evidence suggests age-related increases in concentrations of circulating 
inflammatory cytokines and ROS may contribute to both cardiovascular and skeletal muscle 
dysfunction (Pawelec 2002, Panda, Arjona et al. 2009). Several studies have however shown 
the beneficial effects of physical activity on inflammatory status in elderly individuals 
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(Mattusch, Dufaux et al. 2000, Taaffe, Harris et al. 2000, Geffken, Cushman et al. 2001, Ford 
2002). Physical activity has also been shown to offset the age-related decline in 
cardiovascular function (Franzoni, Plantinga et al. 2004). Here, the authors concluded that 
chronic aerobic training is associated with preserved endothelial function in the 
microcirculation and better antioxidant defences leading to a reduction in oxidative stress 
(Franzoni, Plantinga et al. 2004). Taddei et al. demonstrated this mechanism when examining 
endothelial function in whole limb forearm blood flow (Taddei, Galetta et al. 2000). Twelve 
young and elderly healthy sedentary) and 11 young and 14 elderly matched athletes were 
studied whereby forearm blood flow measured via strain-gauge plethysmography was 
examined during infusion of ACh (endothelial-dependent dilator) and NG-monomethyl-L-
arginine (L-NMMA), an NO synthase inhibitor. NO is a potent endothelial dependent 
vasodilator as explained in Section 2.7.1. In young sedentary subjects and young athletes, the 
blood flow response to ACh was blunted by L-NMMA. In both elderly subjects, the blood 
flow response to ACh was significantly lower than in both young groups. However, in elderly 
sedentary groups the blood flow response to ACh was resistant to L-NMMA. These results 
suggest that regular physical activity in elderly individuals can at least in part prevent the 
age-induced development of endothelial dysfunction, probably due to the restoration of NO 
availability consequent to prevention of production of oxidative stress via increase anti-
oxidant defence. It is also well established that with increased age there is a greater 
proportion of central adiposity (Poehlman, Toth et al. 1995, Song 2004). One of the many 
detrimental effects of increased central adipose tissue is the production of inflammatory 
cytokines and plasma proteins and peptides related to cardiovascular risk (IL-6, IL-8, TNF-α, 
PAI-1, MIF) (Hotamisligil, Arner et al. 1995, Purohit, Ghilchik et al. 1995, Yudkin, Kumari 
et al. 2000, Fain 2006). Indeed, one potential cause of increased age-related inflammation is 
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this increase in central adiposity (Wu 2007). As discussed above, physical activity has been 
shown to reduce age-related inflammation. It could be postulated that the inflammation 
lowering effects of physical activity in elderly individuals could be due to lowering central 
adiposity, therefore reducing production of these inflammatory markers. Geffken et al. (2001) 
conducted an epidemiology study analysing data obtained from the Cardiovascular Healthy 
Study in 5,888 elderly men and women, investigating the associations between self-reported 
physical activity levels, inflammatory markers and BMI (Geffken, Cushman et al. 2001). 
They concluded that, following multivariate analysis, higher levels of physical activity were 
associated with lower levels of inflammation, which may be mediated by BMI. 
Ageing is coupled with a functional decline of the cardiovascular system. The 
prevalence of cardiovascular disease (e.g., hypertension, atherosclerosis) increases with 
advancing age (Lakatta 2002).  Preceding the development of these age-related diseases is 
vascular fibrosis and the stiffening of the arteries (Avolio, Chen et al. 1983, Benetos, Laurent 
et al. 1993, Frenneaux and Williams 2007). Fibrosis describes an increased deposition of 
connective tissue in the arterial wall (Najjar, Scuteri et al. 2005). This contributes to a 
reduced arterial distensibility in the periphery, pulse wave amplification and an increase in 
BP (Lakatta and Levy 2003). Large arteries thus become more prone to shear stress-related 
endothelial damage. This signals a cascade of inflammatory responses resulting in 
atherosclerotic plaque formation. The process of fibrosis and atherosclerotic plaque 
development with age has been associated with age-related increases in inflammation and 
oxidative stress (Ross 1993, Alexander 1994, Geffken, Cushman et al. 2001). The apparent 
increase in arterial stiffness observed with ageing is not only due to structural changes in the 
vessel wall, but also to impaired endothelial regulation of the vascular smooth muscle 
surrounding the arteries (Lakatta and Levy 2003). NO, an endothelial dependent vasodilator 
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is quenched by ROS forming peroxynitrite. Decreased availability of NO attenuates 
vasodilation in response to shear stress (Beckman and Ames 1998, Seals, Desouza et al. 
2008, Versari, Daghini et al. 2009).  Conversely, shear stress resulting from exercise training 
is known to upregulate endothelial-derived NO and improve endothelial-dependent dilation 
(Tinken, Thijssen et al. 2010). A combination of age-associated increases in fibrosis, 
inflammation and oxidative stress results in vascular dysfunction, increasing the risk of 
diseases such as hypertension and atherosclerosis. 
Regular exercise and physical activity can improve cardiovascular function in elderly 
individuals. Interventional studies have shown that endothelial-dependent dilation is 
improved in previously sedentary older healthy men following a three-month aerobic training 
programme of moderate intensity exercise (Seals, Desouza et al. 2008). Such enhanced 
endothelial dependent-dilation and NO bioavailability may be due to a reduction in ROS, 
which has been documented to be a result of aerobic exercise training and regular physical 
activity (Adams, Linke et al. 2005). To reiterate what was shown by Geffken et al., a 
reduction of ROS via regular physical activity in elderly individuals may be a consequence of 
lower central adiposity (Geffken, Cushman et al. 2001). Thus it appears that the positive 
effects of physical activity on cardiovascular function in elderly individuals results from 
parallel reductions in central adiposity, inflammation and oxidative stress. Reducing the 
inflammatory burden of elderly individuals could also be linked to the positive effects 
physical activity has on other frailty attributes (Fulop, Larbi et al. 2010). Often occurring 
without diagnosis, the pathology of frailty in parallel leads to many age-related chronic 
diseases (e.g., metabolic syndrome, type 2 diabetes, many inflammatory diseases, 
autoimmune diseases, Alzheimer’s and cardiovascular disease) thus therapeutic strategies to 
increase physical activity would be expected to benefit elderly individuals by improving or 
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maintaining physiological function and a high quality of life (Fried, Tangen et al. 2001, 
Boyd, Xue et al. 2005, Bergman, Ferrucci et al. 2007, Landi, Abbatecola et al. 2010). 
Although the associations between physical activity, central adiposity, inflammation 
and cardiovascular function in elderly individuals have individually been previously 
identified as independent variables, there is presently limited information regarding the 
effects of physical activity on the function of multiple body systems in a large cohort of 
elderly individuals with a wide range of physical activity levels to thus elucidate which of 
these functions contribute to the development of components of frailty, as discussed in 
Section 2.9. This approach, therefore, fails to elucidate the complete holistic picture of the 
mechanisms by which gradual decreases in physical activity with ageing lead to the 
development of components of frailty. Therefore, the aim of the physical activity and healthy 
ageing (PAHA) study is to fill this current gap in knowledge. 
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4.3 Aims and Hypothesis 
The aim of this study was to investigate whether higher levels of physical activity are 
associated with elderly individuals superiorphysiological functioning. To achieve this, in a 
large cohort of elderly individuals physical activity, physical function, body composition, 
inflammatory status, and cardiovascular function including resting HR, BP, central pulse 
pressure and large artery stiffness  was assessed. 
It was hypothesized that compared to physically inactive elderly individuals: 
1) Elderly individuals that are more physically active would have better 
physical functioning, such as faster walking speeds and superior balance. 
2) More physically active elderly individuals would have lower whole body 
and visceral fat mass (%) and higher lean mass (%). 
3) Elderly individuals who lead physically active lives would have a lower 
inflammatory burden, indicated by lower plasma concentrations of 
inflammatory cytokines and inflammation related proteins with vascular 
effects and markers of oxidative stress. 
4) More physically active elderly individuals would have lower resting HR, 
BP, central pulse pressure and large artery stiffness. 
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4.4 Methods 
4.4.1 Participants 
Two hundred and eleven 60-80 year olds (100 males, 111 females) volunteered to 
participate in the study. Mean age, height and weight (mean ± standard deviation) were 67 ± 
5 years, 167 ± 10 cm and 73 ± 14 kg, respectively. 
 
4.4.2 Recruitment 
Participants were recruited from the local community through both active recruitment 
with flyers, and through the Birmingham and Black Country PCT GP Surgeries. Individuals 
were only approached if they met the inclusion criteria (see Section 3.2). 
 
4.4.3 Consent 
Participants were invited to the WT-CRF for a single visit to partake in the study. All 
the participants arrived in a 10-hour overnight fasted state. First the study details were 
explained by and written informed consent was obtained by a research nurse.  Then a series 
of functional measurements were made, which together took a maximum of 4 hours. All 
experimental procedures were performed in accordance with the Declaration of Helsinki and 
received approval from Birmingham and Black Country PCT Ethical Committee. 
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4.4.4 Experimental Measurements 
Height, weight, BMI, waist and hip circumference, blood glucose and BP were 
measured upon arrival (see Section 3.3.1, 3.3.2 and 3.3.3 for details). Participants were also 
asked to provide details of any medications they were currently using.  For measurement of 
inflammatory markers, participants had approximately 40 mL of blood taken from superficial 
vein at the antecubital fossa (see Sections 3.3.4 and 3.9 for details). Participants were then 
given a light breakfast. 
DEXA was then used to measure total body fat, total lean mass, estimated visceral fat, 
body fat %, while pQCT was used to determine arm and leg muscle cross-sectional area and 
muscle density (see Section 3.3.5 for details). Frailty was measured using the TUG test and 
BBS (see Section 3.7.2 for details) and walk speed was calculated from the TUG test. Arterial 
stiffness was measured via PWA and PWV, and central pulse pressure calculated (see Section 
3.4.2 for details).  Physical activity levels were measured using 7 day accelerometry data (see 
Section 3.8.1 for details). 
 
4.4.5 Physical activity quintiles 
To establish the range of physical activity levels in this cohort participants were 
ranked in to quintiles using SPSS statistical software, controlled for gender. Counts/hour was 
the physical activity measure chosen to quintile the data. Counts/hour takes in to account all 
body movements including the upper body, not just steps taken (Sasaki, John et al. 2011). 
The physical activity levels were divided in 5 groups (1 = 20% of cohort with lowest physical 
activity levels, 5 = 20% of cohort with highest physical activity levels). This approach was 
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used following extensive discussions and direction from the study statistician, who advised to 
split the physical activity levels in to separate groups and investigate differences between 
them in accordance with previously published data (Thøgersen-Ntoumani, Fox et al. 2005). 
 
4.4.6 Statistical analysis 
Multivariate Analysis of Variance (ANOVA) was employed to determine whether 
there were any significant differences in any of the age-related outcome variables we 
measured between the PA groups. Correlation analyses were also performed on the key 
dependent variables presented in this study, using physical activity measured via counts/hour 
as a continuous independent variable. The statistical tests were adjusted for age, gender and 
medication use. Distribution tests were performed to decipher normal and non-normally 
distributed data. Logarithmic transformation was applied to non-normally distributed data. 
Non-parametric tests were performed for non-normally distributed plasma biomarkers, as 
typically log transformation fails to ensure normal distribution for these variables. SPSS for 
Windows (IBM Corporation, Somers, NY, USA) was used for all statistical analyses. Data 
are presented as mean ± standard deviation (SD). 
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4.5 Results 
4.5.1 Subject Characteristics 
Tables 4.1 and 4.2 provide descriptive statistics of the study cohort and separately for 
men and women. As expected, in our cohort there were significant gender differences with 
height, weight, waist circumference and hip:waist ratio being significantly greater in men, 
and hip circumference being significantly greater in women (Table 4.1). Table 4.2 presents 
frequency statistics for medication use in our sample population. Less than half of our cohort 
was taking medication (41%). The most common medication used by our participants was 
anti-hypertensive drugs (28%) and statins (16%). 
 
4.5.2 Physical Activity 
Table 4.3 presents the differences in PA levels in the PA quintiles. As expected, PA 
levels presented as steps/day, steps/hour, counts/day and counts/hour were all significantly 
different across each PA group. There was a >2-fold increase from Physical Activity Level 
(PAL) group 1 to PAL group 5 in all of the physical activity variables presented, and each 
PAL group was significantly different to each other. Steps/ day F(24, 660) = 51.5, p < 0.001; 
Steps/hour F(24, 660) = 62.5, p < 0.001; Counts/day F(24, 660) = 145.8, p < 0.001; 
Counts/hour F(24, 660) = 236.6, p < 0.001. 
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4.5.3 Measures of Physical Functioning 
Results of the physical function tests are presented in Table 4.4. There were no 
significant differences between the PAL groups for the BBS score. However, post hoc tests 
indicated that PAL group 4 were significantly faster than PAL group 1 in the TUG and walk 
speed tests ; TUG test: F(12, 508) = 2.91, P = 0.016; walk speed test:  F(12, 508) = 2.63, p = 
0.022. Results of the correlation analyses are presented in Figures 4.1-4.3. A significant 
positive association between walk speed and physical activity (r=0.22, p<0.01), and a 
significant negative association between the TUG and physical activity (r=-0.24, p<0.01) 
were observed. Interestingly, correlation analyses also indicated a significant positive 
association between the BBS and physical activity (r=0.20, p<0.01).  
 
4.5.4 Body Composition 
Table 4.5 presents body composition data obtained from DEXA and pQCT analysis. 
Total fat, estimated visceral fat and body fat percentage were significantly lower in PAL 
groups 3, 4 and 5 compared to  PAL group 1; F(44, 399) = 4.63, p = 0.00; F(44, 399) = 5.32, 
p = 0.00; F(44, 399) = 4.50, p = 0.00. However there were no significant differences in whole 
body lean mass, single distal radius and tibia muscle density or single arm and leg muscle 
cross sectional area over the PAL groups. Correlation analyses found significant negative 
associations between total fat, body fat % and estimated visceral fat mass (r=-0.33, p<0.01; 
r=-0.23, p<0.01; r=-0.38, p<0.01). Interestingly, a significant positive relationship between 
leg muscle density and physical activity was also revealed (r=0.20, p<0.001). Leg muscle 
density and estimated visceral fat mass results are presented in Figures 4.4 and 4.5. No other 
significant correlations were observed between body composition and physical activity.  
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4.5.5 Plasma Markers of Inflammation, Oxidative Stress with a Mechanistic Link to 
Cardiovascular Risk 
Table 4.6 presents white blood cell counts, Table 4.7 presents plasma markers of 
inflammation and Table 4.8 presents markers of oxidative stress and anti-oxidative capacity. 
There were no significant differences in white blood cell counts including lymphocytes, 
monocytes and granulocytes between the quintiles in our cohort (Table 4.6). PAI-1 
concentration was significantly higher in the lowest PAL group compared to all other PAL 
groups, F(68, 611) = 2.45, p = 0.04 (Table 4.7). C-RP, interleukins, MCP-1, TNF-α and 
VEGF were not significantly different in our cohort across the PAL groups. There were also 
no significant differences in oxidative stress measured by protein oxidation and lipid peroxide 
plasma content, or antioxidant capacity in our cohort (Table 4.8).  The only significant 
correlation with physical activity that was observed was PAI-1, where a significant negative 
relationship was observed (r=-0.19, p<0.01), and presented in Figure 4.6. 
 
4.5.6 Arterial Stiffness 
Table 4.9 presents arterial stiffness measurements across the PAL groups including 
central and peripheral artery stiffness and central pulse pressure. AIx, pPWV and cPWV were 
not significantly different across the PAL groups. Central systolic, diastolic and mean pulse 
pressures were also not significantly different across the PAL groups. In addition, no 
significant correlations were observed between indices of arterial stiffness and PAL
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Table 4.1. Subject Characteristics 
 All (n=211) 
 
Men (n=100) Women (n=111) 
Age (yrs) 
 
67 ± 5 
(60 – 79; 7) 
68 ± 5  
(60-79; 7) 
66 ± 5  
(60-79; 6) 
Height (cm) 
 
167 ± 10 
(146 – 194; 14) 
175 ± 8  
(155-194) 
161 ± 6  
(146-180) 
Weight (Kg) 
 
73 ± 14 
(42 – 125; 19) 
80 ± 14  
(60-125; 17) 
66 ± 11  
(42-109; 14) 
BMI (Kg/m2) 
 
26 ± 4 
(19 – 40; 4) 
26 ± 4 
 (20-40; 4) 
26 ± 4  
(18-38; 5) 
Hip circumference (cm) 
 
103 ± 11 
(81 – 187) 
102 ± 9  
(83-126) 
103 ± 12  
(81-187) 
Waist circumference (cm) 
 
90 ± 12 
(62 – 125) 
95 ± 10  
(77-125; 15) 
85 ± 11  
(62-116) 
Waist:hip ratio 
 
0.88 ± 0.85 
(0.48 – 1.09; 12) 
0.93 ± 0.56  
(0.76-1.01) 
0.83 ± 0.76  
(0.48-0.98; 0.1) 
Systolic BP (mmHg) 
 
136 ± 17 
(96 – 195; 22) 
138 ± 16  
(96-195) 
134 ± 17  
(97-191; 23) 
Diastolic BP (mmHg) 
 
79 ± 11 
(48 – 113; 12) 
80 ± 10  
(50-113) 
78 ± 11  
(48-108) 
Mean BP (mmHg) 
 
98 ± 11 
(68 – 127) 
99 ± 10  
(68-123) 
97 ± 12  
(68-127) 
Blood Glucose (mmol/L) 
 
5.6 ± 0.6 
(3.9 – 7.0) 
5.7 ± 0.6  
(4.2-6.9) 
5.5 ± 0.6  
(3.9-7.0) 
 
Values are presented as mean ± SD (range; interquartile range). Interquartile range is presented for non-normally distributed variables. 
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Table 4.2 Medication use by the study cohort 
Medication 
 
Number of participants Percentage (%) 
No medication 86 41 
ACE inhibitor 14 6.6 
AT1 Blocker 1 0.5 
AT2 Blocker 6 2.8 
Ca2+ Blocker 19 9.0 
β-Blocker 5 2.4 
Diuretic 14 6.6 
Statin 34 16.1 
Anti-depressant 9 4.3 
Anti-Coagulant 11 5.2 
 
Values are presented as number of participants and percentage (%) of individuals who are on the specified medication. 
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Table 4.3. Physical activity ranges presented by selected accelerometry variables across PA quintiles 
 PA Level (counts/hour) F P Partial eta 
Squared 
 All 1 2 3 4 5    
Steps/day 7515 ± 2760 
(1518 – 19161) 
4564 ± 
1230 
 
6019 ± 1310* 7523 ± 
1802*† 
8856 ± 
2266*†‡ 
10318 ± 
2664*†‡# 
51.5 0.00 0.515 
Steps/hour 494 ± 170 
(115 – 1220) 
305 ± 84 
 
405 ± 71* 486 ± 112*† 575 ± 116*†‡ 683 ± 163*†‡# 62.5 0.00 0.563 
Counts/day 966406 ± 
296122 
(269122 – 
1793054) 
599930 ± 
105096 
766476 ± 
147382* 
969010 ± 
125387*† 
1107205 ± 
130177*†‡ 
1354589 ± 
214622*†‡# 
145.8 0.00 0.750 
Counts/hour 63658 ± 18430 
(20383 – 
114207) 
39895 ± 
5785 
51351 ± 
6816* 
62581 ± 
6674*† 
72569 ± 
6276*†‡ 
89743 ± 
11469*†‡# 
236.6 0.00 0.830 
 
Values are mean ± SD of 211 individuals. *P<0.05 vs. PAL group 1; †P<0.05 vs. PAL group 2; ‡P<0.05 vs. PAL group 3; #P<0.05 vs. PAL 
group 4. 
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Table 4.4. Functional frailty measures across PA quintiles 
 PA Level F P Partial eta 
Squared 
 All 1 2 3 4 5    
Berg Balance Scale 55.0 ± 1.7 
(46.0 – 56.0) 
54.6 ± 2.3 54.9 ± 2.0 55.1 ± 1.5 55.1 ± 1.3 55.4 ± 1.1 1.12 0.34 0.023 
Timed Up and Go (s) 8.1 ± 1.6 
(4.0 – 13.1) 
8.9 ± 1.7 8.2 ± 1.7 8.0 ± 1.4 7.7 ± 1.4* 7.9 ± 1.5 2.91 0.02 0.057 
Walk Speed (Km/hr) 2.8 ± 0.5 
(1.7 – 5.4) 
2.5 ± 0.5 2.7 ± 0.5 2.8 ± 0.5 2.9 ± 0.6* 2.8 ± 0.5 2.63 0.03 0.052 
 
Values are mean ± SD of 211 individuals *P<0.05 vs. PAL group 1 
 
 
 
 
 
 
 
Table 4.5. Body composition variables across PA quintiles 
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 PA Level F P Partial eta 
Squared 
 All 1 2 3 4 5    
Total Fat (g) 23314 ± 
7854 
28090 ± 9289 24958 ± 
6454 
22341 ± 
7997* 
21406  ± 6058* 20131 ± 6304* 4.63 0.00 0.140 
Total Lean 
(g) 
44817 ± 
9917 
46171 ± 11459 45701 ± 
9667 
42847 ± 
9896 
44785 ± 9612 45014 ± 8966 0.21 0.94 0.007 
Estimated 
Visceral Fat 
Mass (g) 
977 ± 791 1456  ± 1002 1072 ± 762 786 ± 641* 884 ± 790* 687 ± 359* 5.32 0.00 0.157 
Body Fat % 34 ± 8 37 ± 6 36 ± 8 34 ± 9* 33 ± 8* 31 ± 7* 4.50 0.00 0.136 
Arm Muscle 
Density 
(g/cm3) 
74.9 ± 1.8 74.8 ± 1.9 75.6 ± 1.8 74.4 ± 1.9 74.6 ± 1.9 75.4 ± 1.7 1.36 0.25 0.045 
Arm Muscle 
Area (mm2) 
3059 ± 
870 
3178 ± 859 3114 ± 952 2886 ± 845 3037 ± 943 3120 ± 799 0.13 0.97 0.005 
Leg Muscle 
Density 
(g/cm3) 
72.8 ± 2.8 72.0 ± 3.2 74.0 ± 1.9 72.7 ± 2.0 72.8 ± 2.4 73.0 ± 3.7 1.22 0.30 0.041 
Leg Muscle 
Area (mm2) 
6098 ± 
1302 
6343 ± 1417 6034 ± 1009 6154 ± 1108 5942 ± 1633 5983 ± 1094 0.69 0.60 0.024 
 
Values are mean ± SD of 211 individuals. *P<0.05 vs. PAL group 1. The first 4 values were obtained with DEXA and reflect whole body 
measurements; while the last 4 were obtained with pQCT and reflects values in one single arm muscle (distal radius) and one single leg muscle 
(distal tibia)
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Table 4.6. White blood cell (WBC) counts across PA quintiles 
 PA Level F P Partial eta 
Squared 
 All 1 2 3 4 5    
WBC count 
(x10^9/L) 
5.22 ± 1.41 5.63 ± 1.54 5.15 ± 1.18 5.19 ± 1.33 5.05 ± 1.67 5.13 ± 1.32 0.86 0.49 0.019 
Lymphocytes 
(x10^9/L) 
1.56 ± 0.58 1.69 ± 0.95 1.51 ± 0.41 1.51 ± 0.43 1.51 ± 0.59 1.59 ± 0.46 0.60 0.67 0.013 
Monocytes 
(x10^9/L) 
0.40 ± 0.15 0.43 ± 0.18 0.38 ± 0.14 0.40 ± 0.12 0.42 ± 0.18 0.39 ± 0.11 0.61 0.65 0.014 
Granulocytes 
(x10^9/L) 
3.27 ± 1.07 3.54 ± 1.05 3.26 ± 0.95 3.29 ± 1.09 3.12 ± 1.12 3.16 ± 1.14 0.75 0.56 0.016 
Lymphocytes 
(%) 
30.1 ± 7.4 29.7 ± 9.3 29.7 ± 7.2 29.5 ± 6.6 30.1 ± 6.4 31.8 ± 7.7 0.57 0.68 0.013 
Monocytes 
(%) 
7.9 ± 2.5 7.7 ± 2.6 7.4 ± 2.3 8.0 ± 2.4 8.5 ± 2.5 7.9 ± 2.7 0.75 0.56 0.017 
Granulocytes 
(%) 
62.1 ± 7.9 63.1 ± 9.5 62.8 ± 7.4 62.7 ± 7.3 61.6 ± 6.9 60.4 ± 8.4 0.60 0.66 0.013 
 
Values are mean ± SD of 211 individuals 
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Table 4.7. Plasma markers of cardiovascular risk factor levels across PA quintiles 
 PA Level F P Partial eta 
Squared 
 All 1 2 3 4 5    
PAI-1 
(ng/mL) 
1.1 ± 0.8 1.4 ± 1.1 1.2 ± 0.8 0.9 ± 0.7* 1.0 ± 0.7* 0.9 ± 0.7* 2.45 0.04 0.054 
MIF (ng/mL) 1.5 ± 2.2 1.6 ± 2.1 1.7 ± 2.2 1.1 ± 1.5 1.7 ± 2.9 1.6 ± 2.2 0.38 0.82 0.009 
Endothelin-1 
pg/mL) 
2.1 ± 5.31 2.3 ± 6.7 1.6 ± 4.5 1.2 ± 3.1 3.6 ± 7.7 1.7 ± 3.7 1.45 0.19 0.052 
CRP (mg/L) 1.4 ± 1.4 1.6 ± 1.4 1.3 ± 0.9 1.3 ± 1.3 1.8 ± 2.0 1.1 ± 1.0 1.41 0.23 0.032 
IL-1β (pg/mL) 0.04 ± 0.21 0.00 ± 0.02 0.05 ± 0.25 0.04 ± 0.17 0.06 ± 0.32 0.03 ± 0.14 0.36 0.84 0.008 
IL-4 (pg/mL) 0.03 ± 0.28 0.12 ± 0.64 0.02 ± 0.10 0.01 ± 0.07 0.00 ± 0.00 0.02 ± 0.1 0.961 0.43 0.022 
IL-6 (pg/mL) 1.12 ± 4.3 1.0 ± 3.2 1.6 ± 6.8 1.4 ± 5.0 0.8 ± 2.0 0.7 ± 1.4 0.31 0.87 0.007 
IL-10 
(pg/mL0 
1.7 ± 5.2 2.6 ± 6.6 1.0 ± 3.2 2.5 ± 6.0 0.8 ± 3.0 1.9 ± 6.3 0.94 0.44 0.022 
IL-13 (pg/mL) 0.97±  1.13 1.20 ± 1.19 0.95 ± 1.16 0.94 ± 1.28 0.97 ± 1.15 0.81 ± 0.81 0.50 0.74 0.011 
IL-17a 
(pg/mL) 
6.1 ± 15.2 10.3 ± 19.2 3.5 ± 8.4 8.3 ± 19.6 3.6 ± 10.9 5.4 ± 15.0 1.39 0.24 0.032 
MCP-1 
(pg/mL) 
24.1 ± 9.9 22.8 ± 8.6 24.9 ± 9.4 22.0 ± 8.0 26.7 ± 12.5 23.9 ± 10.2 1.31 0.27 0.030 
TNF-α 
(pg/mL) 
0.5 ± 1.5 0.1 ± 0.3 0.2 ± 0.7 0.6 ± 1.6 0.6 ± 2.1 0.9 ± 1.7 1.01 0.39 0.031 
VEGF 
(pg/mL) 
69.4 ± 57.1 80.0 ± 70.5 61.4 ± 50.6 69.6 ± 50.6 65.6 ± 48.3 72.8 ± 68.0 0.53 0.71 0.012 
 
Values are mean ± SD of 211 individuals *P<0.05 vs. PAL group 1 
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Table 4.8. Plasma oxidative stress markers and antioxidant capacity across PA quintiles 
 PA Level F P Partial eta 
Squared 
 All 1 2 3 4 5    
Protein 
oxidation 
5.1 ± 1.6 4.7 ± 1.2 5.3 ± 1.8 5.2 ± 1.4 4.6 ± 1.2 5.4 ± 2.0 1.89 0.12 0.041 
Total 
antioxidant 
capacity 
465.8 ± 94.5 496.1 ± 88.8 481.6 ± 114.2 449.3 ± 86.7 450.2 ± 78.9 453.2 ± 93.9 1.81 0.13 0.041 
Lipid 
peroxides/mL 
plasma 
337.1 ± 33.4 338.1 ± 35.3 334.0 ± 33.6 343.1 ± 32.5 341.2 ± 39.9 327.6 ± 20.5 1.14 0.34 0.026 
 
Values are mean ± SD of 211 individuals. 
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Table 4.9. PWA (AIx), PWV and central pulse pressure across PA quintiles 
 PA Level    
 All 1 2 3 4 5 F P Partial 
eta 
Squared 
Arterial 
Stiffness 
         
AIx @ 
75bpm 
29.8 ± 9.5 
(3.7 – 56.0) 
32.6 ± 6.9 28.7 ± 10.0 29.9 ± 10.1 29.6 ± 9.5 28.9 ± 10.2 0.56 0.69 0.018 
pPWV 8.7 ± 1.3 
(5.4 – 12.3) 
8.8 ± 1.6 8.6 ± 1.3 8.9 ± 1.4 8.6 ± 1.3 8.7 ± 1.1 0.33 0.86 0.010 
cPWV 8.7 ± 2.0 
(4.9 – 14.2) 
8.5 ± 2.0 8.8 ± 1.8 8.8 ± 1.8 9.0 ± 2.3 8.3 ± 1.8 0.56 0.69 0.018 
Central BP 
(mmHg) 
         
Systolic 123.0 ± 17.3 
(87.7 – 184.0) 
124.5 ± 20.0 117.0 ± 12.4 128.1 ± 21.3 120.7 ± 
12.1 
123.5 ± 17.1 1.87 0.12 0.042 
Diastolic 76.0 ± 9.1 
(46.3 – 105.0) 
76.1 ± 12.2 73.3 ± 7.1 78.5 ± 10.1 75.4 ± 6.8 76.0 ± 8.5 0.84 0.50 0.019 
Mean 95.5 ± 11.3 
(67.0 – 133.7) 
96.2 ± 14.0 91.4 ± 7.9 98.8 ± 14.7 94.0 ± 8.5 95.5 ± 11.3 1.33 0.26 0.030 
Heart Rate 
(bpm) 
         
Seated 67.2 ± 11.0 
(42.0 – 111.0) 
67.8 ± 10.8 70.1 ± 11.6 68.2 ± 11.4 65.1 ± 8.2 64.4 ± 11.8 1.87 0.11 0.040 
Supine 62.4 ± 9.8 
(37.6 – 109.5) 
63.3 ± 8.4 63.1 ± 9.8 62.9 ± 9.8 61.1 ± 7.7 61.9 ± 13.0 0.18 0.95 0.004 
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Values are mean ± SD of 211 individuals. 
 
 
 
Figure 4.1 Presents the significant positive association between physical activity measured via counts/hour and walk speed (r=0.22, p<0.01; left 
panel); Figure 4.2 Presents the significant negative association between physical activity and TUG (r=-0.24, p<0.01; right). 
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Figure 4.3 Presents the significant positive association between physical activity measured via counts/hour and the BBS (r=0.20, p<0.01; left). 
Figure 4.4 Presents the significant positive association between physical activity and leg muscle density (r=0.20, p<0.01; right). 
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Figure 4.5 Presents a significant negative association between physical activity measured via counts/hour and estimated visceral fat mass (r=-
0.38, p<0.01; left); Figure 4.6 Presents a significant negative association between physical activity and plasma PAI-1 concentration (r=-0.19, 
p<0.01; right). 
 
CHAPTER 4 
	
90	
	
4.6   Discussion 
The purpose of the present study was to investigate whether higher levels of physical 
activity were associated with superior physiological functioning in elderly individuals. The 
main findings were: individuals with higher physical activity levels demonstrated faster 
walking speeds and a faster completion of the TUG test indicative of better physical 
functioning. Higher levels of physical activity were associated with a lower total body fat, 
body fat % and estimated visceral fat mass. However, lean body mass measured with DEXA 
and the mass of the distal tibia muscle (leg) and distal radius muscle (arm) measured with 
pQCT was not significantly different across the PAL quintiles. High physical activity 
represented by PAL groups 3-5 presented significantly lower plasma levels of the 
cardiovascular risk factor PAI-1 compared to the lowest PAL groups, which is in agreement 
with the hypothesis. However, in contrary to the hypothesis the majority of plasma markers 
of inflammation with mechanistic links to the future development of cardiovascular disease 
(MIF, endothelin-1, C-RP, IL-1β, IL-4, IL-6, IL-10, IL-13, IL-17a) and markers of oxidative 
stress were not significantly different across the PAL quintiles, refuting our hypothesis that 
higher levels of physical activity in our cohort would result in significantly lower plasma 
levels of these markers. Contrary to our hypothesis, cardiovascular function represented by 
resting HR, BP, central pulse pressure and large artery stiffness were not significantly 
different across the physical activity quintiles. 
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4.6.1. Age, Physical Activity and Physical Function 
The development of age-related frailty is associated with a decline in physical 
function (Buchner and Wagner 1992, Rockwood, Fox et al. 1994, Fried, Tangen et al. 2001). 
One of the attributes of the inferior physical function identified by Fried et al. was that 
maintenance of a low PAL reduced habitual walking speed (Fried, Tangen et al. 2001). Other 
studies have shown that participation of elderly individuals in  exercise training interventions 
attenuated the physical function loss (Fiatarone, O'Neill et al. 1994, Campbell, Robertson et 
al. 1997, Gill, Baker et al. 2002, Chakravarty, Hubert et al. 2008). In agreement with previous 
research and our hypothesis, results from this cohort illustrate that maintenance of a higher 
physical activity level  was associated with faster walking speeds and faster completion of the 
TUG test in PAL group 4 compared to PAL group 1. Interestingly, although PAL group 5 
was numerically faster than PAL group 1, the difference was not significant. Elderly 
individuals who are able to perform activities of daily living with ease for longer are more 
able to live independently and maintaining physical function as we age is therefore important 
to prevent disability onset and improve quality of life (Fries 1980, Fries 2002, Chakravarty, 
Hubert et al. 2008). 
Balance measured by the BBS was not different among the PAL quintiles in this 
cohort. Fiatarone et al. who found an improvement in stair climbing ability following a 10-
week resistance training intervention in elderly individuals, also identified an increase in 
muscle strength and cross-sectional area (Fiatarone, O'Neill et al. 1994). They suggested that 
this may have aided advances in physical function. Differences in leg and arm muscle cross-
sectional area between the physical activity quintiles were not observed in this cohort . A 
cross-sectional study from the Cardiovascular Health Study showed that elderly individuals 
who had higher levels of fat mass reported higher levels of disability based on a time 
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administered 0.5 mile walk, and walking up 10 stairs, however no effect of fat-free mass was 
observed (Visser, Langlois et al. 1998). It is tempting to speculate that findings in this study 
of higher walking speeds with higher physical activity levels could be explained by lower 
levels of body fat, as carrying less body weight will enable faster walking speeds, but not 
necessarily affect balance. Correlation analysis however did expose a significant positive 
association between physical activity and leg muscle density in this cohort, which supports 
the positive association observed between physical activity and the BBS, and agrees with the 
findings of Fiatarone et al. (1994). 
 
4.6.2. Age, Physical Activity and Body Composition 
A noticeable change with age is the development of increased central adiposity. 
Previous research that has examined body composition in elderly individuals concluded that 
older individuals possessed significantly higher body fatness and central adiposity 
(Poehlman, Toth et al. 1995), particularly in women (Song 2004). It is well known that 
physical activity reduces body fat (DiPietro 1995). Slentz et al. conducted an exercise 
intervention study on 120 overweight men and women aged 40-65 years (Slentz, Duscha et 
al. 2004). Compared with controls, exercise groups significantly decreased abdominal 
skinfold fat, and hip and waist circumference measurements. Our findings support both 
previous research and our hypothesis, that elderly individuals who have higher physical 
activity will have lower body fat and estimated visceral fat mass compared to those who are 
more sedentary. In this cohort, elderly individuals in the highest 3 physical activity quintiles 
had significantly less total fat, % body fat and estimated visceral fat mass compared to 
individuals in the lowest physical activity quintile, controlled for gender. Central adiposity 
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poses the highest risk to cardiovascular disease development in both young and elderly 
individuals compared to other areas of adiposity (Prineas, Folsom et al. 1993).  Visceral 
adipose tissue located in the central region secretes inflammatory cytokines that are 
associated with cardiovascular disease development (Wisse 2004, Fain 2006). The 
significantly lower levels of estimated visceral fat in this cohort in the 3 highest physical 
activity quintiles may in part explain the significantly lower circulating plasma levels of PAI-
1 in the 3 highest physical activity quintiles vs. the lowest. 
 
4.6.3. Age, Physical Activity and Inflammation 
High levels of physical activity have been shown to counter-act the age-associated 
chronic increase in circulating inflammatory cytokines, which are mechanistically linked to 
future development of cardiovascular disease (Geffken, Cushman et al. 2001, Reuben, Judd-
Hamilton et al. 2003, Colbert, Visser et al. 2004).  Results from this cohort do not exhibit a 
significant effect of physical activity on circulating inflammatory cytokines. Some studies 
that have reported lower inflammatory cytokines in cross-sectional studies of elderly 
individuals have relied on self-assessment physical activity questionnaires (Geffken, 
Cushman et al. 2001, Colbert, Visser et al. 2004). However, self-report may not be an 
accurate representation of actual physical activity levels as participants have a tendency to 
over-estimate the amount of physical activity performed (Troiano, Berrigan et al. 2008). 
Reasons for the conflicting findings may therefore be due to the physical activity range in this 
cohort. A recent review by Chen et al. explaining the effects of physical activity on 
inflammatory and thrombotic status in both young and elderly individuals, highlighted that 
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the lowest amount of weekly exercise training volume needed to reduce inflammation may 
need to be individualized (Chen, Apostolakis et al. 2014). 
Significantly lower concentrations of plasma PAI-1 were detected in the higher PAL 
groups (3-5) compared to the lowest PAL group. PAI-1 is the major physiological inhibitor of 
plasminogen activator in plasma. An increase in PAI-1 is associated with an increased risk of 
thrombosis and atherosclerotic plaque growth and via this mechanism may lead to 
cardiovascular dysfunction and disease (Vaughan 2005). PAI-1 levels increase with age, 
however elderly individuals who live physically active lifestyles present significantly higher 
levels of tPA (tissue-type plasminogen activator) the antagonist compound of PAI-1 
(Vaughan 2005). Stratton et al. demonstrated that following a 6 month intensive endurance 
exercise intervention in elderly men PAI-1 concentration was significantly reduced (Stratton, 
Chandler et al. 1991). Inflammatory cytokines IL-1, IL-6, CRP and TNF-α stimulate PAI-1 
and promote vascular inflammation and atherosclerosis. However, in the present study we did 
not identify any increases in these inflammatory markers with higher physical activity. Chen 
et al. note however that there are other pathways that could account for the beneficial effects 
of physical activity on thrombotic agents such as PAI-1 and tPA which up-regulate 
fibrinolysis (Mazzeo 1991, El-Sayed, Lin et al. 1995, el-Sayed 1996, Wang, Jen et al. 1997, 
Wang and Chow 2004, Jahangard, Torkaman et al. 2009, Chen, Apostolakis et al. 2014). For 
example, another potential source of PAI-1 in elderly individuals is visceral adipose tissue 
(Vaughan 2005). The higher physically active elderly individuals in this cohort were 
observed to have significantly lower estimated visceral adipose tissue and PAI-1 
concentrations (See section 4.6.2). 
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4.6.4. Age, Physical Activity and Cardiovascular Function 
Physical inactivity is an independent risk factor for cardiovascular dysfunction and 
disease progression (Blair, Kohl et al. 1995, Thijssen, Maiorana et al. 2010). A reduction in 
the compliance of the large arteries is also an independent risk factor for the development of 
cardiovascular disease in well functioning older adults (Tanaka, Dinenno et al. 2000, Sutton-
Tyrrell, Najjar et al. 2005). Research has shown that partaking in regular physical activity is 
associated with reducing vascular dysfunction and vascular events in elderly men and women 
(Paffenbarger, Hyde et al. 1986, Hakim, Curb et al. 1999, Sesso, Paffenbarger et al. 2000, 
Tanaka, Dinenno et al. 2000, Myers, Prakash et al. 2002). However, the results of this cohort 
contradict previous research as central and peripheral arterial stiffness was not significantly 
associated with habitual physical activity levels between the groups. One possible 
explanation for the conflicting findings is that the difference in physical activity level 
between group 1 and 5 was too small to maintain cardiovascular function. Tanaka et al. 
examined central arterial compliance in healthy young and older males (18-77 years) of 
different physical activity levels for at least the previous 2 years (sedentary, recreationally 
active and endurance trained) (Tanaka, Dinenno et al. 2000).  They found no difference in 
central arterial compliance between sedentary and recreationally active men at any age. 
However, arterial compliance was significantly higher in the middle-aged and older 
endurance trained men compared to the less active groups. This group also performed a 3-
month aerobic exercise intervention study on 20 middle-aged men (53 ± 2 years), and found 
that central arterial compliance increased to levels similar to the endurance trained middle-
aged and older men. Although in our cohort there is a >2 fold increase from PAL group 1 to 
5, the range may not be great enough to detect alterations in arterial structure and function.  
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4.6.5. Methodological Considerations 
This study examined physical activity and a range of physical functions thought to be 
altered with age in a cohort of 211 elderly individuals. Although physical activity did have 
significant beneficial effects on walking speed, whole body and visceral adiposity, and 
thrombotic activity (PAI-1 concentration), no identifiable differences were observed for the 
remaining plasma peptides and proteins associated with increased cardiovascular risk, 
cardiovascular function or lean muscle mass. In this cohort 5.2% of individuals were taking 
anticoagulant medication, which is known to reduce PAI-1 concentrations (Hadigan, Meigs et 
al. 2001). However, medication use was selected as a covariate in the analysis, eradicating 
any confounding effects on PAI-1 concentration.  A chi-square test was performed to test for 
differences in anticoagulant medication, and confirmed no significant difference between 
quintiles, X2 (4, N = 202) = 3, p = 0.54.There are a number of methodological considerations 
that may partly give rise to the lack of effect of physical activity on these variables in this 
particular cohort. 
To note is the characteristics of the cohort and a possible selection bias. All 
participants were healthy elderly individuals (60-80 years old) with no apparent 
pathophysiology or disease. Although participants were deemed healthy, many were on anti-
hypertensive medication (28%). These medicated individuals could have fallen in to the less 
physically active groups, potentially masking the effect of inactivity on blood pressure and 
arterial stiffness. Chi-square tests were performed to test for differences between quintiles for 
all medication use (ACE inhibitor, AT2 blocker, Ca2+ blocker, β-blocker, Diuretic, Statin, 
Anti-depressant), and confirmed no significant difference; X2 (4, N = 202) 2.4, p = 0.67; X2 
(4, N = 202) 3.9, p = 0.42; X2 (4, N = 202) 0.34, p = 0.99; X2 (4, N = 202) 6.4, p= 0.17; X2 
(4, N = 202) 1.7, p = 0.80; X2 (4, N = 202) 1.8, P = 0.77; X2 (4 = 202) 1.7, p = 0.79. The 
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inclusion criteria for this cohort however allowed individuals with blood pressure less than 
190/120 mmHg (see section 4.4.2 for details), which would include hypertensive individuals. 
In many clinical trials comorbidities have been the main reason to exclude elderly 
individuals. However, if exclusion criteria are too restricted, it may compromise the 
generalizability of the results (Ferrucci, Guralnik et al. 2004). In addition it should be noted 
that the demographic of this cohort is taken from the Harborne area of the West Midlands, 
which are deemed a very healthy, active sample group. Therefore care should be taken when 
generalising these findings to the whole UK population. 
The physical activity range of this cohort is also a possible confounder. Although the 
physical activity levels between the least and most active individuals were significantly 
different (>2 fold increase), none of the cohort fell in to an extreme case of sedentary 
behaviour (0-159 counts/min) (Carr and Mahar 2012) or highly trained athletes. In the 
general population, physical activity levels in elderly individuals vary from completely 
sedentary to highly trained Masters athletes. Masters athletes present a unique sub-group of 
the over 70 population and demonstrate “exceptionally successful ageing”(Tanaka and Seals 
2008). As well as outstanding athletic performance, endurance-trained ageing runners show 
reduced disability and mortality compared to age-matched sedentary individuals 
(Chakravarty, Hubert et al. 2008). In contrast, at the other end of the physical activity 
spectrum many extremely sedentary elderly individuals are in diseased states. This feeds back 
in to the selection bias limitation of this study, in that the cohort was reasonably active. The 
physical activity range in this cohort may not be broad enough to detect minor perturbations 
of physiological homeostasis in healthy elderly individuals, despite total time and percentage 
of time spent in sedentary, light, moderate, vigorous and very vigorous activity levels being 
assessed using cut-offs previously described (Freedson and Miller 2000). However, the fact 
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that differences in physical functioning and body composition were present in the lowest and 
highest physical activity groups, suggests firstly that these age-related changes precede and 
possibly predict an increased risk of other functional loss such as cardiovascular dysfunction, 
and secondly that physical activity can attenuate these detrimental changes. An alternative 
approach to assess physical activity status in this elderly cohort would have been using a 
submaximal aerobic capacity test (Noonan and Dean 2000). Maximal aerobic capacity tests 
are the gold standard assessment for cardiorespiratory fitness, but do acutely increase the risk 
of an adverse cardiovascular event. Submaximal tests allow the prediction of 
cardiorespiratory fitness but with a reduced risk of complications (Noonan and Dean 2000). 
However, the study aims did not necessitate the quantification of cardiorespiratory fitness 
levels per sé, but to examine the range of habitual daily activity levels of an elderly cohort, 
warranting the utilization of 7-day accelerometry rather than an aerobic exercise test. 
The cross-sectional design of this cohort study is also a limitation. Cross-sectional 
studies provide only a snap shot of individuals’ lifestyle and physiological functioning. 
Longitudinal studies provide a superior indication of lifestyle on physiological functioning. 
Exercise intervention studies in elderly individuals have also provided positive findings on 
physical functioning, body composition and cardiovascular function (Fiatarone, O'Neill et al. 
1994, Tanaka, Dinenno et al. 2000, Slentz, Duscha et al. 2004). Ford (2002) conducted a 
cross-sectional study in elderly individuals and observed significant beneficial effects of 
physical activity on inflammatory status in elderly individuals, with a far greater sample size 
of 13,748. This cohort study may therefore be underpowered to identify effects of physical 
activity on certain age-related outcome measures. Post-hoc calculations revealed that the 
achieved statistical power was relatively low for a number of inflammatory markers and 
indices of cardiovascular function and thus the potential for a type II error is acknowledged. 
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For example, the observed partial eta squared for some of the key inflammatory (CRP=0.03) 
and cardiovascular variables (arterial stiffness=0.02) suggests that much larger sample sizes 
(13270 and 29845, respectively) would have been necessary order to identify PAL-associated 
differences in these variables in a cohort of elderly individuals. However, due to recruitment 
practicalities the cohort size was limited to 211.   
 
4.6.6. Conclusion 
In this cohort study physical function loss, visceral adiposity and PAI-1 
concentrations were associated with physical activity. However, lean muscle mass, 
inflammation and oxidative stress, and cardiovascular function including resting HR, BP, 
central pulse pressure and arterial stiffness were not associated with physical activity.  
Despite these null findings, the current study provides some information regarding the effects 
of daily physical activity on age-related function loss in a cohort of elderly individuals. 
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5.1 Abstract 
Chronic heart failure (CHF) is a major health concern for the elderly population in 
many elderly people. In a significant proportion of CHF cases, systolic function is preserved 
and is entirely attributable to a diastolic abnormality (i.e., diastolic heart failure) with 
preservation of systolic function under resting conditions. Age-related diastolic function loss 
is associated with the future development of diastolic heart failure. 
The aim of this study was to test the hypothesis that in elderly individuals LV 
diastolic function loss would be associated with increased visceral adiposity, inflammation, 
oxidative stress, arterial stiffness, and cardiovascular risk factors and reduced physical 
activity. 
To test this, 175 elderly individuals from the PAHA cohort were selected (age, height 
and weight 60 ± 5 years, 167 ± 10 cm, and 72 ± 14 kg, respectively [mean ± SD]). Measures 
of LV diastolic function (E/A ratio), body composition (DEXA, BMI, Waist:Hip ratio), 
inflammation (plasma C-RP concentration), oxidative stress (plasma  lipid peroxide 
concentration), central arterial stiffness (cPWV), cardiovascular risk factors (resting MAP, 
HR, TPR), and physical activity (counts/hour via accelerometry) were obtained.  Multiple 
Hierarchical Regression analysis was employed to statistically test the associations between 
these variables and LV diastolic function. 
When age, gender and anti-hypertensive medication were statistically controlled for 
there was a significant negative association between LV diastolic function and visceral 
adipose tissue mass (P<0.05, t = -2.14), and LV diastolic function and MAP (P<0.05, t = -
2.44). No association was observed between LV diastolic function and the following 
CHAPTER 5 
	
102	
	
variables: BMI, Waist:Hip ratio, C-RP, lipid peroxides, central arterial stiffness, HR, TPR 
and physical activity.. 
In this cohort MAP and visceral adiposity revealed a significant negative association 
with LV diastolic function (measured as E/A ratio). It could be possible that a number of 
predictor associations have been missed in this cohort as the sample size may be too small, 
and underlying pathologies such as renal dysfunction and variety of inflammatory diseases 
may have been missed. 
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5.2 Introduction 
The prevalence of cardiovascular disease increases with advancing age, including 
diseases such as hypertension, stroke, atherosclerosis and CHF (Lakatta 2002). In 2010, the 
National Statistics for Death in the US reported that the leading cause of mortality was 
diseases of the heart, where 24.2% of all individuals who died during that year did so as a 
result of  heart disease (Murphy, Xu et al. 2013). There is growing evidence that a significant 
proportion of CHF is caused predominantly by an abnormality in diastolic function (i.e. 
diastolic heart failure),(Vasan, Benjamin et al. 1995, Aurigemma, Gottdiener et al. 2001, Zile 
and Brutsaert 2002). Studies suggest that 30% of elderly patients with CHF have diastolic 
heart failure, whereby ejection fraction (systolic function) is maintained (Senni, Tribouilloy 
et al. 1998, Gottdiener, Arnold et al. 2000, Baxter and Gray 2002). In the absence of 
cardiovascular disease in apparently healthy ageing, impairments in LV diastolic function can 
still prevail and may be a risk factor for the future development of diastolic heart failure 
(Prasad, Popovic et al. 2007, Biernacka and Frangogiannis 2011). 
Abnormalities of the LV include increased stiffness which may or may not be coupled 
with a reduction in relaxation (Zile and Brutsaert 2002). Classically in ageing, early LV 
diastolic filling or E wave velocity is reduced, and late diastolic filling or A wave velocity is 
increased (Lakatta 2003). Therefore, the ratio of E wave to A wave (E/A ratio – measure of 
LV diastolic function) decreases. Reduced E/A ratio corresponds to a majority of left 
ventricular filling occurring in the late phase during atrial contraction, as opposed to the early 
phase during LV active relaxation. It is speculated that this is due to LV stiffening with 
ageing, resulting in an attenuated ability to actively relax and draw blood from the LA via the 
Frank Starling mechanism (Lakatta 2003, Frenneaux and Williams 2007, Prasad, Popovic et 
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al. 2007). Enhanced atrial contribution to LV filling corresponds to greater cardiac work 
required to force the larger remaining LA volume in to the LV and is associated with age-
related LA enlargement (Lakatta 2003). Manifestation of LA enlargement in elderly 
individuals is harmful and a risk factor for the future development of atrial fibrillation and 
stroke (Vaziri, Larson et al. 1995). 
Mechanisms of LV stiffening with advancing age are thought to be due to a multitude 
of physiological changes that occur in the cardiovascular system (Arbab-Zadeh, Dijk et al. 
2004, Kass 2005). These often develop prior to cardiovascular disease onset and result in the 
development of LV diastolic dysfunction. A hallmark of ageing is the progressive deposition 
of collagen in both the vascular walls and cardiac tissue. This process is known as fibrosis 
(Song, Yao et al. 1999, Lakatta 2003, Orlandi 2004, Burkauskiene, Mackiewicz et al. 2006, 
Biernacka and Frangogiannis 2011). Cardiac fibrosis is a major cause of increased 
myocardial stiffness (Biernacka and Frangogiannis 2011) and major contributor to the 
observed LV hypertrophy. Despite a reduction in the number of cardiomyocytes there is an 
increase in LV mass (Olivetti, Melissari et al. 1991) due to the increased collagen deposition. 
Initially, fibrosis is accompanied by cardiomyocyte hypertrophy as part of an adaptive 
response aimed at preserving CO while normalizing wall stress (Biernacka and Frangogiannis 
2011). In combination with a reduction in relaxation this leads to impaired LV filling, 
limiting the exercise tolerance in healthy elderly individuals and reducing quality of life 
(Vanoverschelde, Essamri et al. 1993, Kitzman, Gardin et al. 2001, Lakatta 2003). 
The onset of cardiac fibrosis may be a reactive process in response to LV pressure 
overload (i.e. hypertenstion) (Robert, Besse et al. 1997). Robert et al. induced hypertension in 
rats by a chronic 1 month infusion of aldosterone-salt and this was associated with the 
development of fibrosis. It could be hypothesised that the progressive fibrosis leading to 
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hypertrophy and stiffening of the ageing heart may also (at least in part) be a consequence of 
peripheral vascular stiffening.  
Age-dependent increases in vascular stiffening are well established (Avolio, Chen et 
al. 1983, Benetos, Laurent et al. 1993, Frenneaux and Williams 2007). Structurally, the 
diameter of the lumen increases and the walls become thicker, known as intima-medial 
thickening (thickening of the intima and medial artery layers) (Lakatta 2002). Fibrosis of the 
vascular smooth muscle layer occurs also, as it does in the cardiac myocytes, resulting in 
stiffening of the arteries. Arterial stiffness, measured in this study as cPWV, causes an 
increased cardiac afterload and consequently an increase in systolic wall stress (Chen, 
Nakayama et al. 1998, Frenneaux and Williams 2007). The left ventricle must therefore 
contract with more force to eject the LV EDV into the less compliant aorta. In addition to 
increasing cardiac afterload, arterial stiffening also leads to hypertension, a major risk factor 
for the development of cardiovascular disease (O'Rourke 1990, Laurent, Boutouyrie et al. 
2001, Boutouyrie, Tropeano et al. 2002). 
Another age-related factor that could in the long term lead to impairments in vascular 
and cardiac function is chronic systemic inflammation, which occurs in many elderly 
individuals and therefore has been given the name “inflammaging”. Inflammaging describes 
a chronic increase in inflammatory cytokines such as C-Reactive Protein (C-RP), interleukin-
6 (IL-6), IL-1, tumour necrosis factor-alpha (TNF-α) and reactive oxygen species (ROS) 
(Fubini and Hubbard 2003). Inflammatory cytokines and ROS have direct pathological 
effects on the vasculature to include impaired vasodilation in response to physiological 
stimuli (insulin and exercise) and increased basal levels of vasoconstriction (Lakatta 2002). 
Bioavailability of the potent vasodilator NO derived from the endothelial layer of the 
vasculature is reduced as chronic inflammation activates NADPH oxidase and increases ROS 
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production. ROS react with NO to produce peroxynitrite which is one of the mechanisms 
leading to vasodilation (Kojda and Harrison 1999). A combination of impaired NO 
bioavailability and reduced vasodilation with increased vasoconstriction and arterial stiffness, 
increases the afterload and TPR and is thought to play an important role in the development 
of chronic hypertension and LV diastolic dysfunction (Panza, Casino et al. 1994, Perticone, 
Ceravolo et al. 2001). Age-related chronic inflammation and the development of fibrosis may 
be causally linked. Increased age-related systemic inflammation leads to the local delivery of 
cytokines and growth factors that stimulate collagen synthesis (Wagenmakers, van Riel et al. 
2006). Orlandi et al. induced atherosclerosis (a vascular inflammatory disease) in rabbits by 
causing hypercholesterolemia via a 9-month hyperlipemic diet. VCAM-1 (an adhesion 
molecule expressed in response to cytokine activation) increased and there was a dramatic 
reduction of coronary endothelial cell eNOS activity leading to reduced NO bioavailability 
(Orlandi 2004). Furthermore, in addition to the onset of atherosclerosis, cardiac fibrosis was 
also noted. This implies that vascular and cardiac tissue may have a common starting point of 
leukocyte adhesion and penetration in to both the deeper macrovascular layers and 
interstitium of the cardiac tissue. 
A potential mechanism for age-related chronic inflammation is an increase in visceral 
adiposity. It is well established that in later life body fat becomes centralized (Song 2004). 
This may be due to the reduction in physical activity with age (Jae, Heffernan et al. 2009), 
although it is debated whether total adipose tissue mass changes, or is merely re-distributed to 
central areas. Visceral adipose tissue produces pro-inflammatory cytokines which as 
discussed above can have detrimental effects on the cardiovascular system both at the 
vascular and cardiac level. Libhaber et al. examined the independent contribution of indexes 
of adiposity on LV diastolic function (E/A ratio) (Libhaber, Norton et al. 2009). Waist 
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circumference (an indicative measure of central adiposity) was a significant negative 
predictor of E/A ratio. Palmeiri et al. investigated LV mass in 1,577 overweight and non-
overweight men (mean age 53 ± 12 years) (Palmieri, de Simone et al. 2001). Investigators 
found that overweight individuals with LV hypertrophy also presented hypertension. 
Although the causative links between these factors may be debated, these results show that 
excess adipose tissue is associated with development of hypertension and LV hypertrophy in 
older men. 
A habitual physical activity pattern could be an important modifier of the 
development of age-related cardiac and vascular stiffening, LV diastolic dysfunction, 
inflammation and central adiposity. Arbab-Zadeh et al. examined the effects of physical 
activity on LV compliance in elderly individuals (Arbab-Zadeh, Dijk et al. 2004). Twelve 
healthy sedentary men and women (mean age 69.8 ± 3 years) and 12 age-matched male and 
female Masters athletes (mean age 67.8 ± 3 years) participated. LV compliance was 
significantly lower in sedentary elderly individuals compared to Masters athletes. However, 
the LV compliance of Masters athletes was similar to a group of young sedentary individuals. 
This suggests that physical activity in later life may have beneficial effects on LV function, 
indicated by a more compliant LV. Physical in activity has also been shown to be related to 
the age-associated increase in inflammatory status (Mattusch, Dufaux et al. 2000, Taaffe, 
Harris et al. 2000, Geffken, Cushman et al. 2001). A large cross-sectional study in 13,748 US 
citizens (age ≥ 20 years old) was conducted examining physical activity status and plasma C-
RP levels (Ford 2002). Those participants who were more physically active had significantly 
lower C-RP levels across all age ranges. The inflammation lowering effects of physical 
activity in elderly individuals could be a consequence of decreased central adiposity. Geffken 
et al. conducted an epidemiology study analysing data obtained from the Cardiovascular 
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Healthy Study in 5,888 men and women aged >65 years old, investigating the associations 
between self-reported physical activity levels, inflammatory markers and BMI (Geffken, 
Cushman et al. 2001). Following multivariate analysis, higher levels of physical activity were 
associated with lower levels of inflammation, which may be mediated by BMI. Elderly 
individuals who appear healthy may have underlying dysfunction of the heart (i.e., LV 
diastolic dysfunction); that may eventually result in development of heart disease such as 
congestive heart failure and coronary artery disease. LV diastolic dysfunction has been 
shown to be predictive of diastolic heart failure (Aurigemma, Gottdiener et al. 2001). Given 
the high mortality rates associated with heart disease (Murphy, Xu et al. 2013) the detection 
of LV diastolic dysfunction and development of effective interventional strategies is critical. 
Although tentative evidence suggests the positive effects of physical activity in elderly 
individuals on LV diastolic function, inflammatory status and visceral adiposity, there is 
limited information regarding the associations between these variables in a single cohort, and 
secondarily it is unclear which (if any) of these variables is the main driving factor for LV 
diastolic dysfunction in the elderly population. 
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5.3 Aims and Hypothesis 
The aim of this study was to investigate the associations between LV diastolic 
function and the following variables: central adiposity, inflammation, resting HR, MAP and 
TPR, and physical activity in an elderly cohort. 
It was hypothesized that in this elderly cohort: 
1) LV diastolic function would be negatively associated with body composition 
measured by estimated visceral fat mass, waist:hip ratio and BMI. 
2) LV diastolic function would be negatively associated with inflammatory status and 
oxidative stress, as indicated by plasma C-RP and leptin:adiponectin ratio, and lipid 
peroxide concentration. 
3) LV diastolic function would be negatively associated with arterial stiffness, TPR, 
resting HR and MAP. 
4) LV diastolic function would be positively associated with high physical activity 
measured as accelerometer counts/hour. 
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5.4. Methodology 
5.4.1. Participants 
One hundred and seventy five healthy elderly individuals from the cohort of 211 had 
valid left ventricular diastolic function measures of E/A ratio, which were included in this 
analysis. Their mean age, height and weight (mean ± standard deviation) were 67 ± 5 years, 
167 ± 10 cm and 73 ± 14 kg, respectively. 
 
5.4.2. Recruitment 
Participants were recruited from the local community through both active recruitment 
with flyers, and through the Birmingham and Black Country Primary Care Trust (PCT) 
General Practice (GP) Surgeries. Individuals were only approached if they met the inclusion 
criteria (see Section 3.2). 
 
5.4.3. Consent 
Participants were invited to the Wellcome Trust Clinical Research Facility (WT-CRF) 
for a single visit to partake in the study. Testing took a maximum of 4 hours. All the 
participants arrived in a 10-hour overnight fasted state. The study details were explained by 
research nurses and written informed consent was obtained. All experimental procedures 
were performed in accordance with the Declaration of Helsinki and received approval from 
Birmingham and Black Country PCT Ethical Committee. 
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5.4.4. Experimental Measurements 
Height, weight, BMI, waist and hip circumference, blood glucose and BP were 
measured upon arrival (see Section 3.3.1, 3.3.2 and 3.3.3 for details). Participants were also 
asked to provide details of any medications they were currently using.  For inflammatory 
marker measurements, participants had approximately 40 mL of blood taken from superficial 
vein at the antecubital fossa (see Sections 3.3.4 and 3.9 for details). Participants were then 
given a light breakfast. Visceral adiposity was measured using DEXA, and presented as 
estimated visceral fat mass, (see Section 3.3.5 for details). Plasma CRP was used as the main 
marker of systemic inflammation, as it has been identified as a strong predictor of 
cardiovascular risk in previous research (Koenig, Sund et al. 1999), (see section 3.9.2 for 
details).  Arterial stiffness was measured via PWV (see Section 3.4.2 for details). Central 
pulse wave velocity (cPWV) was selected in this analysis as a measure of vascular function 
due to the predictive effects on cardiovascular mortality (Laurent, Boutouyrie et al. 2001). 
LV diastolic function was measured using 2D Doppler ultrasound echocardiography (see 
Section 3.5 for details), and presented as E/A ratio (see Section 3.5.2 for details). Physical 
activity was determined from the acceloremeter recordings on seven continuous days (see 
Section 3.8.1 for details). Counts/hour was used to represent physical activity as it takes in to 
account all significant movements of the whole body, not solely steps (Sasaki, John et al. 
2011). 
 
5.4.5. Statistical Analyses 
Multiple Hierarchical Regression was employed to test the main hypotheses and 
determine the relative importance of physical activity, inflammation, visceral fat mass and 
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resting HR, MAP and TPR in predicting the variance in E/A ratio in the study cohort. 
Distribution tests were performed to test for normal and non-normally distributed data. 
Logarithmic transformation was applied to non-normally distributed data. Non-parametric 
tests were performed for non-normally distributed plasma biomarkers, as typically log 
transformation fails to ensure normal distribution for these variables. Initially, correlation 
analysis was performed on the selected predictor variables to ensure collinearity assumptions 
were met.  Univariate analysis was then performed on each predictor variable against the 
dependent variable (E/A ratio) to highlight any significant predictors. The significant 
predictors were then included in the Multiple Hierarchical Regression models. SPSS for 
Windows (IBM Corporation, Somers, NY, USA) was used for all statistical analyses. Data 
are presented as mean ± standard deviation (SD). 
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5.5 Results 
5.5.1. Subject Characteristics 
Table 5.1 provides descriptive statistics of the study cohort separately for men and 
women. As expected, in this cohort there were significant sex differences in height, weight 
and waist circumference being significantly greater in men. Table 5.2 presents frequency 
statistics for anti-hypertensive medication use in our sample population that could affect LV 
diastolic function. More than half of this cohort was taking anti-hypertensive medication 
(59%). The most common anti-hypertensive used by our participants was calcium blockers 
(19%). 
 
5.5.2. Preliminary Analyses 
Descriptive statistics for the dependent variable E/A ratio, and predictor variables 
(Resting HR, MAP, TPR, cPWV, BMI, Waist:Hip ratio, Visceral fat mass, Counts/hour, 
plasma C-RP and lipid peroxide concentrations and the plasma leptin:adiponectin ratio are 
presented in Table 5.3 for the whole sample and for men and women separately. 
 
5.5.3. Predicting Left Ventricular Diastolic Function 
Univariate and multivariate hierarchical analyses were employed to examine whether 
potential cardiovascular risk factors could predict the variance in LV diastolic function (E/A 
ratio), presented in Table 5.4. In Model 1 (unadjusted) univariate analysis indicates that MAP 
was a significant negative predictor of 28% of the variance in E/A ratio, and physical activity 
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(counts/hour) was a significant positive predictor of 2% of the variance in E/A ratio over and 
above all other measured variables (i.e. resting HR, TPR, cPWV, BMI, Waist:Hip ratio, 
visceral fat mass, plasma C-RP and lipid peroxide concentration, Leptin:Adiponectin ratio). 
Although a 2% predictor was statistically significant, the physiological and clinical relevance 
is questionable. This means that a higher MAP and a lower physical activity level (PAL), 
predict a lower E/A ratio, demonstrating a stiffer LV and worse diastolic function. The 
multivariate analysis shows that MAP and PAL both predict 5% of the variance in E/A ratio 
in our cohort. MAP is a stronger predictor of E/A ratio, as MAP has a higher t value 
compared to PAL (-2.31 vs. 2.14). 
In Model 2 (adjusted for age and gender), univariate analysis indicates that MAP, 
BMI and visceral fat mass are significant negative predictors of the variance in E/A ratio 
(6%, 5 % and 7% respectively), over and above all the other variables. This means that the 
higher the MAP, BMI and visceral fat mass, the lower the E/A ratio and therefore diastolic 
function. BMI and visceral fat mass are collinearly related, so are not independently 
predicting E/A ratio. Visceral fat has a higher R2 value than BMI (0.07 vs. 0.06), so was 
included in the mutually adjusted multivariate model instead of BMI. The multivariate 
analysis shows that MAP and visceral fat mass are significant negative predictors of 11% of 
the variance in E/A ratio in our cohort. MAP has a higher t value than visceral fat indicating 
that this is a stronger predictor. 
In Model 3 (adjusting for age, gender, and anti-hypertensive medication) univariate 
analysis shows that MAP significantly negatively predicts 7% of the variance in E/A ratio, 
and visceral fat mass significantly negatively predicts 9% of the variance in E/A ratio, over 
and above all other predictor variables. This means that the higher MAP and visceral fat 
mass, the lower the E/A ratio and therefore diastolic function. The mutually adjusted 
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multivariate analysis shows MAP and visceral fat mass significantly negatively predict 12% 
of the variance in E/A ratio in our cohort. MAP has a higher t value than visceral fat 
indicating that this is a stronger predictor. The ultimate predictor in our cohort for the 
variance in E/A ratio, when taking in to account age, gender and anti-hypertensive 
medication, is MAP. MAP significantly predicts the variance in E/A ratio in our cohort, over 
and above other cardiovascular risk factors. 
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Table 5.1 Subject characteristics 
 All (n=168) 
 
Male (n=75) Female (n=93) 
Age (yr) 
 
60 ± 5 
(60 – 79) 
67 ± 5 
(60-79) 
66 ± 5 
(60-79) 
Height (cm) 
 
167 ± 10 
(146 – 194) 
175 ± 8 
(156 – 194) 
161 ± 6 
(146-180) 
Weight (Kg) 
 
72 ± 14 
(42 – 121) 
80 ± 13 
(61-121) 
66 ± 11 
(42-109) 
Hip circumference (cm) 
 
103 ± 11 
(81 – 187) 
102 ± 9 
(83-126) 
103 ± 12 
(81-187) 
Waist circumference (cm) 
 
90 ± 11 
(62 – 118) 
95 ± 10 
(77 – 118) 
86 ± 11 
(62 – 116) 
Systolic BP (mmHg) 
 
136 ± 17 
(96 – 195) 
137 ± 16 
(96-195) 
135 ± 18 
(97-191) 
Diastolic BP (mmHg) 
 
78 ± 10 
(48 – 108) 
77 ± 9 
(50-99) 
78 ± 11 
(48 – 108) 
Blood Glucose (mmol/L) 
 
5.6 ± 0.6 
(3.9 – 7.0) 
5.6 ± 0.6 
(4.2 – 6.9) 
5.6 ± 0.6 
(3.9 – 7.0) 
 
Values are presented as mean ± SD 
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Table 5.2 Anti-hypertensive medication use by the study cohort 
 
Drug 
All 
(Absolute,%) 
Males 
(Absolute,%) 
Females 
(Absolute,%) 
Calcium Blocker 19, 9 8, 8 11, 9.9 
ACE inhibitor 14, 6.6 8, 8 6, 5.4 
AT1 Blocker 1, 0.5 1, 1 0, 0 
ATII blocker 6, 2.8 2, 2 4, 3.6 
Beta Blocker 5, 2.4 1, 1 4, 3.6 
Diuretics 14, 6.6 6, 6 8, 7.2 
 
Values are presented as frequency and percentage (%) of individuals who are on the specified medication 
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Table 5.3 Descriptive statistics of the dependent variable (E/A ratio) and predictor variables in this Cohort 
 
Variables 
All 
(Mean ± SD, Range) 
Males 
(Mean ± SD, Range) 
Females 
(Mean ± SD, Range) 
E/A ratio 1.10 ± 0.29 (0.59-2.50) 1.13 ± 0.28 (0.67-2.30) 1.08 ± 0.30 (0.59-2.50) 
Resting HR (bpm) 68 ± 12 (42-111) 66 ± 13 (42-111) 70 ± 10 (50-93) 
MAP (mmHg) 98 ± 11 (68-127) 99 ± 10 (68-123) 97 ± 12 (68-127) 
TPR (mmHg/L/min) 486 ± 189 (175-1302) 539 ± 215 (175-1302) 441 ± 150 (208-979) 
cPWV (m/s) 8.72 ± 1.96 (4.90-14.17) 9.43 ± 2.12 (4.90-14.17) 8.38 ± 1.78 (5.05-13.77) 
BMI (kg/m2) 25.80 ± 3.74 (18.46-39.55) 26.10 ± 3.52 (20.24-39.55) 25.54 ± 3.92 (18.46-37.65) 
Waist:hip ratio 0.87 ± 0.09 (0.48-1.09) 0.93 ± 0.06 (0.76-1.09) 0.83 ± 0.08 (0.48-0.98) 
Visceral fat (g) 1009 ± 780 (19-3620) 1401 ± 866 (188-3620) 679 ± 506 (19-2492) 
Counts/hour 63292 ± 18557 (20383-114207) 61388 ± 18719 (20383-114207) 65018 ± 18326 (32910-
104528) 
Plasma C-RP (mg/L) 1.41 ± 1.39 (0.06-8.33) 1.33 ± 1.38 (0.08-8.33) 1.48 ± 1.40 (0.06-6.64) 
Plasma leptin:adiponectin ratio 4.04 ± 3.41 (0.06-18.48) 3.03 ± 3.16 (0.06-15.65) 4.94 ± 3.39 (0.21-18.48) 
Plasma lipid peroxides (units per ml) 3345 ± 34 (260-439) 334 ± 30 (266-414) 336 ± 36 (260-439) 
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Values are presented as mean ± SD 
Table 5.4 Univariate and Multivariate hierarchical analyses for predicting LV diastolic function 
 Model 1 
 
Model 2 Model 3 
Variables 
E/A ratio 
 
β 
 
 
t 
 
P 
 
R2 
 
 
β 
 
t 
 
P 
 
R2 
 
 
β 
 
t 
 
P 
 
R2 
 
Univariate             
Resting HR -0.14 -1.90 .059 0.01 -0.12 -1.63 .105 0.04 -0.12 -1.63 .106 0.05 
MAP -0.18 -2.50 .013* 0.28 -0.18 -2.51 .013* 0.06 -0.18 -2.44 .016* 0.07 
TPR 0.06 0.68 .500 -0.00 0.04 0.42 .677 -0.00 0.05 0.53 .599 0.01 
cPWV -0.07 -0.73 .465 -0.00 -0.04 -0.48 .634 0.01 -0.06 -0.65 .520 0.02 
BMI -0.12 -1.64 .104 0.01 -0.14 -1.98 .049* 0.05 -0.11 -1.45 .149 0.05 
Waist:Hip 0.00 0.01 .992 -0.01 -0.13 -1.43 .154 0.04 -0.13 -1.45 .150 0.05 
Visceral fat -0.17 -1.89 .061 0.02 -0.24 -2.49 .014* 0.07 -0.21 -2.14 .034* 0.09 
Counts/hour 0.17 2.20 .029* 0.02 0.14 1.86 .065 0.05 0.14 1.79 .075 0.05 
C-RP -0.13 -1.68 .095 0.01 -0.11 -1.56 .122 0.05 -0.08 -1.10 .272 0.05 
Leptin:Adiponectin -0.10 -1.32 .188 -0.14 -0.09 -1.20 .233 0.04 -0.05 -0.59 .558 0.04 
Oxidative Stress -0.10 -1.30 .196 0.00 -0.09 -1.18 .241 0.04 -0.10 -1.30 .197 0.05 
Mutually Adjusted             
MAP -0.17 -2.31 .022*  -0.21 -2.37 .019*  -0.20 -2.33 .021*  
Counts/hour 0.16 2.14 .034* 0.05 - - -  - - -  
Visceral Fat - - -  -0.21 -2.22 .028* 0.11 -0.18 -1.86 .065 0.12 
             
Note: Gender was coded as 1 = males and 2 = females. *P<0.05
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5.6. Discussion 
The aim of this study was to examine the relationships between LV diastolic function, 
physical activity, inflammation, visceral adiposity, resting arterial stiffness, HR, MAP and 
TPR. The main findings of this study were when controlling for age, gender and anti-
hypertensive medication use, LV diastolic function was negatively associated with estimated 
visceral fat mass, while waist:hip ratio and BMI were not significantly associated with LV 
diastolic function. LV diastolic function was not associated with inflammatory status or 
oxidative stress, as index using plasma C-RP and lipid peroxide concentration, and plasma 
leptin:adiponectin ratio. LV diastolic function was not significantly associated with arterial 
stiffness, TPR or resting HR, however it was significantly and negatively associated with 
MAP. LV diastolic function was not significantly associated with physical activity. 
The prominent finding resulting from this study was that MAP was the major negative 
predictor of LV diastolic function, above all other variables examined including waist:hip 
ratio, BMI, plasma C-RP and lipid peroxide concentration, plasma leptin:adiponectin ratio, 
physical activity, resting HR, TPR and arterial stiffness. When controlling for age, gender 
and anti-hypertensive medication, estimated visceral adipose tissue mass also has a 
significant negative association with LV diastolic function, second only in importance to 
MAP. 
 
5.6.1 Age, LV Diastolic Function and Body Composition 
It is well known that central and visceral adiposity increases as we age. Poehlman et 
al. (Poehlman, Toth et al. 1995) conducted a large cross-sectional study on men and women 
CHAPTER 5 
	
121	
	
aged 18-88 years, and measured total body fat mass using hydrostatic weighing and central 
adiposity  using waist circumference. It was concluded that older individuals possessed a 
significantly higher body fat mass and central adiposity, particularly in women. Song et al. 
conducted a 2 year follow-up study examining body composition in elderly African American 
women (age at baseline 75.5 ± 5.1 years) using DEXA and found that with advancing age, 
their total body fat mass increased and became centralized, as previously discussed (Song 
2004). Visceral adiposity produces more inflammatory cytokines due to the abundance of 
macrophages compared to other adipose tissue stores (Berg and Scherer 2005), and has been 
shown to support a causal role for the development of LV hypertrophy (LVH) (MacMahon, 
Wilcken et al. 1986, Devereux and Alderman 1993). Hense et al. investigated the relationship 
between body size, body composition, and LV mass (LVM) in 653 men and 718 women aged 
25 to 74 years, and observed that total fat mass had a positive relationship with LVM in both 
men and women (Hense, Gneiting et al. 1998). It could therefore be expected that, as 
adiposity increases with age, it would be related to changes in the LV, potentially via an 
increase in inflammation and promotion of cardiac fibrosis. 
To the best of my knowledge, this study is the first to measure visceral adipose tissue 
mass and LV diastolic function via E/A ratio in a single elderly cohort, and is also the first to 
show that visceral adipose tissue mass is an independent predictor of the variance in LV 
diastolic dysfunction. Where previous studies have observed a negative association between 
whole body fat mass and LV mass, this cohort study suggests a negative association 
particularly of the visceral adipose  tissue mass on LV function (MacMahon, Wilcken et al. 
1986, Devereux and Alderman 1993, Hense, Gneiting et al. 1998). This observation is 
important as there is convincing published evidence that up to 60% of the cells in visceral 
adipose tissue are macrophages and that both the macrophages and the adipose tissue cells in 
CHAPTER 5 
	
122	
	
this compartment are an important source of inflammatory cytokines, PAI-1 and MCP-1 
(Berg & Scherer (2005), Gustaffson et al 2007, Andersen et al 2008).  It is probably for this 
reason that central adiposity poses the highest risk to cardiovascular disease development in 
both young and elderly individuals compared to other areas of adiposity (Prineas, Folsom et 
al. 1993).  Visceral adipose tissue located in the central region secretes inflammatory 
cytokines that are associated with cardiovascular disease development (Wisse 2004, Fain 
2006). 
 
5.6.2 Age, LV Diastolic Function, Inflammation and ROS 
Inflammation is known to increase with age and has detrimental effects on the 
cardiovascular system (Pawelec 2002, Berg and Scherer 2005, Panda, Arjona et al. 2009). In 
ageing, inflammation has been proposed to result from increased visceral adiposity. Given 
that in this cohort, estimated visceral fat mass had a significant negative association with LV 
diastolic function, it might be expected that a similar relationship between plasma markers of 
inflammation and LV diastolic function would be observed. Plasma C-RP was determined as 
it is the gold standard inflammatory risk factor associated with cardiovascular disease onset 
(Ballou and Kushner 1992, Sowers, Jannausch et al. 2002). However, there was no significant 
association between plasma C-RP concentration and LV diastolic function in this cohort.  
The lack of an association between these variables is difficult to understand given that 
this contradicts earlier studies in large cohorts. For example, Schrager et al. used data from a 
large cross-sectional study on elderly individuals in Italy (InCHIANTI study), to examine the 
effects of central adiposity measured via anthropometry, on inflammatory markers (Schrager, 
Metter et al. 2006). From the analysis it was found that elderly individuals with higher waist 
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circumference (as an index marker of central adiposity), had higher levels of inflammation, 
specifically plasma C-RP and IL-6. A potential reason for the current study failing to observe 
plasma C-RP as a significant predictor of LV diastolic dysfunction could be the population 
studied. In this cohort the mean waist circumference was 90 cm, compared to 96 cm in the 
study by Schrager et al.  In the study of Schrager et al individuals who had a significantly 
higher plasma C-RP and IL-6 had a mean waist circumference of 103 cm. This raises the 
possibility that there was a smaller number of individuals in this cohort with a large enough 
visceral adipose tissue mass to produce a significant increase in plasma C-RP concentrations. 
Increased oxidative stress has been related to diseases observed with ageing such as 
cardiovascular disease (CVD) (Heitzer, Schlinzig et al. 2001), and is associated with vascular 
dysfunction (further explained in section 5.6.3). Oxidative stress describes a state at which 
production of ROS overloads the intrinsic ability to quench them, for example a reduction in 
anti-oxidants and anti-oxidative capacity (Monaghan, Metcalfe et al. 2009). It therefore was 
expected that in this cohort ROS would be negatively associated with LV diastolic function. 
However, ROS production measured as the plasma concentration of lipid peroxides, was not 
significantly associated with LV diastolic function. As a substantial amount of the ROS 
production may have occurred in endothelial cells and the vascular smooth muscle layer (see 
section 5.2) plasma lipid peroxides may not have been the best biomarker. Another possible 
explanation is the measurement of ROS in this study (plasma concentration of lipid 
peroxides). ROS have short half-lives meaning the appearance of them is labile in nature, and 
consequently difficult to measure (Monaghan, Metcalfe et al. 2009). Therefore, it is more 
common to measure the damage caused by ROS, rather than ROS per se (Monaghan, 
Metcalfe et al. 2009). Lipid peroxide concentration is not a direct measure of ROS, but a 
consequence of its actions. Although this may be seen as a limiting factor, ultimately the 
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damage being caused by ROS is detrimental to the cardiovascular system rather than the ROS 
themselves, giving this method some justification. The chosen method however only 
measures the damaging effects of ROS systemically, rather than directly at the affected site 
(e.g. the heart, vascular wall). Utilizing plasma concentrations of ROS damage however is 
less invasive and easily applicable compared to tissue sampling. 
 
5.6.3 Ageing, LV Diastolic Function and Cardiovascular Risk Factors 
Several cardiovascular variables/risk factors were examined and their potential effect 
on LV diastolic function in this cohort (i.e., HR, MAP, TPR and large central artery 
stiffness). Resting HR is not observed to increase as a function of age per se, but  research 
suggests that it increases as a result of poor physical fitness (Erikssen, Liestol et al. 1998, 
Lakatta 2003). MAP, TPR and arterial stiffness however are observed to increase during the 
ageing process. In this cohort MAP was significantly and negatively associated with LV 
diastolic function, whereas no association with HR, TPR and large central artery stiffness was 
observed. The finding that MAP was negatively associated with LV diastolic dysfunction, but 
TPR and arterial stiffness were not was somewhat unexpected. Indeed, an increase in blood 
pressure has been found to be a result of increased arterial stiffness in elderly individuals 
(O'Rourke 1990). Arterial stiffness is associated with an increase in inflammatory cytokines 
and oxidative stress. Kuwahara et al. performed a study in hypertensive rats, measuring 
MAP, E/A ratio, inflammation and fibrosis over 28 days in aortic constricted rats and sham 
controls (Kuwahara, Kai et al. 2004). Aortic constriction was employed to provide a pressure 
overload stimulus in order to mimic hypertension. Aortic constriction caused an increase in 
MAP and perivascular macrophage accumulation after 1 day and fibrosis was observed at day 
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3. Accumulation of macrophages in the vascular wall leads to the local production of 
inflammatory cytokines such as C-RP, TNF-α and IL-6. In addition to causing this 
inflammatory response, E/A ratio also decreased in rats with aortic constriction. It was 
suggested that myocardial fibrosis is also triggered by a macrophage-mediated inflammatory 
process that is generated by the arterial wall in response to pressure overload. This suggests 
that increases in MAP may precede significant increases in inflammation, oxidative stress, 
fibrosis and TPR, potentially explaining the null findings of this study in terms of the links 
between inflammatory cytokines, oxidative damage and central arterial stiffness. 
Arterial hemodynamic stress is associated with production of proinflammatory 
cytokines around the arterial wall (Nicoletti and Michel 1999). Indeed an increase in arterial 
pressure itself is potentially a strong signal for activation of macrophage infiltration, and 
activates NADPH oxidase, which produces superoxide anions (ROS) (Wagenmakers, van 
Riel et al. 2006). In hypertensive states, production of ROS and induction of inflammatory 
cytokines have been shown in the arterial wall (Hisashi, Fumitaka et al. 2005). Figure 5.1 
details the effects of inflammation on vasodilatation. Inflammatory cytokines are associated 
with an increase in ROS (Nagai, Anzai et al. 2011), which quench endothelial NO before 
vasodilatation occurs. In the reaction between superoxide anions (produced by 
NADPHoxidase) and NO peroxynitrate is produced as a bi-product (Figure 5.1). A reduction 
of NO synthesis and arterial fibrosis reduces compliance of the arteries leading to arterial 
stiffness. Decreased vascular compliance is associated with ageing and hypertension 
(McVeigh, Burns et al. 1991). Given the evidence it would be expected that in this cohort, 
inflammation, oxidative stress, arterial stiffness and TPR would be significantly associated 
with LV diastolic function, however these associations were not significant. This potentially 
suggests an alternative mechanism for the association between MAP and LV diastolic 
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function. It has been postulated that renal mechanisms may give rise to the onset of 
hypertension, in elderly individuals (Sarnak, Levey et al. 2003, Vanholder, Massy et al. 
2005). Most cardiovascular disease risk factors, such as older age, diabetes mellitus, 
hypertension, LVH, and low high-density lipoprotein (HDL) cholesterol, are highly prevalent 
in chronic kidney disease (CKD). In CKD patients, hypertension results in pressure overload 
and leads to LVH, which may lead to diastolic dysfunction (Sarnak, Levey et al. 2003). 
Dysfunction of the renal system results in reduced removal of extra fluid, potentially 
increasing blood pressure (Sarnak, Levey et al. 2003, Vanholder, Massy et al. 2005). Renal 
dysfunction in this elderly cohort may therefore play a role in the association between MAP 
and LV diastolic function. 
 
Figure 5.1: Diagram of the effects of inflammation and ROS on NO bioavailability and 
consequentially vasodilation. Endothelial Cells (ECs); Vascular Smooth Muscle Cell 
(VSMcs). TNF-α and IL-6 bind to receptors on the luminal site of the ECs and lead to 
induction of NADPHoxidase in EC's and production of superoxide anions (most reactive 
Endothelial	
Cells 
Vascular	Smooth	
Muscle	Cell 
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species of ROS) which quenches NO in the ECs. Peroxynitrite is a bi-product of ROS 
quenching NO. NO activates Gunanylate cyclase, converting GTP to cGMP resulting in 
VSMc relaxation. The attenuated bioavailability of NO reduces this activation cascade, so 
vasdilation is decreased. 
 
5.6.4 Ageing, LV Diastolic Function and Physical Activity 
In this cohort study it was hypothesized that physical activity would be positively 
associated with LV diastolic function, possibly via a central adiposity lowering mechanism. 
Given previous evidence (Arbab-Zadeh, Dijk et al. 2004), it would be expected that physical 
activity be positively associated with LV diastolic function, therefore the lack of association 
between physical activity and LV diastolic function in this cohort was unexpected. The 
reason for conflicting findings of Arbab-Zadeh et al. and the present study could be due to the 
extreme conditioned state of masters athletes, compared to our recreationally active healthy 
elderly individuals. Masters athletes are considered to be a model of “exceptionally 
successful ageing” and strive to maintain their physiological performance (Tanaka and Seals 
2008). Gates et al. examined LV diastolic function represented by E/A ratio in 138 healthy 
young (18-37 years), middle-aged (38-57 years) and older (58-77) men (Gates, Tanaka et al. 
2003). Participants were classed as either sedentary, recreationally active or endurance 
trained. An ageing effect of LV diastolic function was present in the participants, and 
physical activity status did not prevent this ageing effect. This study concurs with the 
findings of this cohort, although this cohort is larger (175 vs. 138 participants), in that 
recreational and even endurance physical activity had no significant effect on LV diastolic 
function, potentially supporting the concept that the positive effects of exercise on LV 
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diastolic function are only detected in extremely highly trained masters athletes, as in the 
study by Arbab-Zadeh et al.  The same group examined the effects of central fat mass on LV 
diastolic function, and found that increases in total adiposity have an important contribution 
to the age-related development of LV diastolic dysfunction (Gates, Gentile et al. 2003). This 
relays to the findings of this cohort study in that estimated visceral fat mass was significantly 
negatively associated with LV diastolic function, second only to MAP, suggesting that the 
age-related increase in visceral adiposity may a contributing mechanism to age-related LV 
diastolic dysfunction, rather than physical activity per se, contrary to the study hypothesis. 
 
5.6.5 Methodological Considerations 
 The first limitation to note in this study is the characteristics of the cohort and a 
possible selection bias. All participants were healthy elderly individuals (60-80 years old) 
with no apparent pathophysiology or disease. Although participants were deemed healthy, 
many were on anti-hypertensive medication (28%). These medicated individuals could 
naturally have high blood pressure due to inactivity, and could potentially mask the effect of 
physical activity on LV diastolic function. However, anti-hypertensive medication use was 
selected as a covariate in the analysis presented in Model 3, eradicating any confounding 
effects on LV diastolic function. The inclusion criteria for this cohort allowed individuals 
with blood pressure less than 190/120 mmHg (see section 3.2 for details), which would 
include hypertensive individuals. In many clinical trials comorbidities have been the main 
reason to exclude elderly individuals. However, as explained in Chapter 4 section 4.6.5, if 
exclusion criteria are too restricted, it may compromise the generalizability of the results 
(Ferrucci, Guralnik et al. 2004). 
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As in Chapter 4, the physical activity range of this cohort is also a possible 
confounder. None of the cohort fell in to an extreme case of sedentary behaviour or highly 
trained athletes, despite the physical activity levels between the least and most active 
individuals being significantly different (5-fold increase), Tanaka and Seals revealed the vast 
range of physical activity levels in elderly individuals from completely sedentary to highly 
trained masters athletes (Tanaka and Seals 2008). Endurance-trained ageing runners show 
reduced disability and mortality compared to age-matched sedentary individuals 
(Chakravarty, Hubert et al. 2008). In contrast, many extremely sedentary elderly individuals 
are in diseased states. This feeds back in to the selection bias limitation of this study, in that 
the cohort was reasonably active. As explained in Section 4.6.5 of Chapter 4, again the 
physical activity range in this cohort may not be broad enough to detect minor differences of 
physiological function in healthy elderly individuals or LV diastolic impairments. 
 Another limitation may be the technique used to examine LV function. Two-
dimensional echocardiography was utilized; however an alternative technique would be 
Magnetic Resonance Imaging (MRI) scanning. Arbab-Zadeh et al. validated their 
echocardiography measurements with cardiac magnetic resonance imaging (MRI) 
measurements (Arbab-Zadeh, Dijk et al. 2004) and yielded an excellent correlation between 
the methods (r=0.9; slope 0.9; P<0.001; coefficient of variation, 12.5%). So although the use 
of MRI for LV diastolic function measures would be an alternative method, 
echocardiography is more than adequate and has been robustly used in many studies of LV 
diastolic function (Spirito and Maron 1988, Prasad, Popovic et al. 2007, Libhaber, Norton et 
al. 2009). Reliability of the measurement of E/A ratio could also be a limiting factor. 
Reproducibilty tests for the measurement of E/A ratio were performed before commencement 
of the study, and produced a CoV of 12.3%. As mentioned previously in Section 3.5.5, a CoV 
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of >10% is regarded as having reduced reliability. However, E/A ratio was chosen as the 
measurement of choice for LV diastolic function as it is thought to be the most dramatic 
change in cardiac pump function with ageing and is usually the earliest manifestation of a 
disease process, as discussed in Section 2.6.2 (Nishimura and Tajik 1997, Lakatta 2002). 
Additionally, if the mean value is typically low, such as is the case for E/A ratio which 
generally ranges from 1.2-2.1, the CoV tends to be higher, which should be taken in to 
account when interpreting this CoV value.  
 
5.6.6 Conclusion 
In this cohort MAP and visceral adiposity had a significant negative association with 
LV diastolic function (measured as E/A/ratio). However, no significant associations were 
observed between LV diastolic function and BMI, Waist:Hip ratio, plasma C-RP and lipid 
peroxide concentration, central arterial stiffness, resting HR and TPR and physical activity 
levels measured with accelerometers.   In this same cohort, as presented in Chapter 4 higher 
visceral adiposity has been shown to have a negative association with physical activity. It 
could be possible that a number of predictor associations have been missed in this cohort as 
the sample size was too small and as we may have missed underlying pathologies such as 
renal dysfunction and variety of inflammatory diseases 
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6.1 Abstract 
We sought to determine how the mode of muscle metaboreflex activation influences 
the central hemodynamic response and cardiac inotropic and lusotropic function in healthy 
humans. 
Ten healthy males performed isometric handgrip (IHG) with and without post 
exercise ischemia (PEI) to examine the influence of isolated muscle metaboreflex activation, 
and rhythmic handgrip (RHG) with and without ischemia to examine the influence of 
enhanced muscle metaboreflex activation. HR and BP were continuously monitored. Stroke 
volume (SV, Doppler echocardiography) was measured, cardiac output (CO = HR×SV) and 
total peripheral resistance (TPR = mean BP/CO) calculated, and indices of LV systolic and 
diastolic function were obtained (TDI). 
During isolated muscle metaboreflex activation with PEI following IHG, mean BP 
(+23±3 mmHg) and TPR were elevated from baseline resting (P<0.05), while HR, SV and 
CO were unchanged. Enhanced muscle metaboreceptor activation during ischemic RHG 
augmented the increase in mean BP, CO and HR (P<0.05 ischemic vs. free-flow RHG), 
while SV and TPR were unchanged from baseline. Neither isolated (PEI) nor enhanced 
muscle metaboreflex activation altered left ventricular systolic function (systolic myocardial 
velocity, S’), but left atrial systolic function (late diastolic myocardial velocity, A’) was 
enhanced. 
These findings indicate that the mode of muscle metaboreceptor activation (during vs. 
post handgrip) determines whether the resultant pressor response is flow (CO) or 
vasoconstriction (TPR) mediated, and that while left ventricular systolic function is 
unchanged, enhanced left atrial systolic function likely aids the preservation of SV during 
muscle metaboreflex engagement. 
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6.2 Introduction 
The increased metabolic demand of the exercising skeletal muscles is accompanied by 
a complex integrated cardiovascular response. This is orchestrated by both central and 
peripheral neural mechanisms, including feed-forward signals from higher brain centres (i.e. 
central command) and reflex feedback from group III and IV sensory afferents within the 
working skeletal muscle in response to mechanical (i.e. muscle mechanoreflex) or metabolic 
stimuli (i.e. muscle metaboreflex) (Krogh and Lindhard 1913, Alam 1937, Coote, Hilton et 
al. 1971, McCloskey and Mitchell 1972, Kaufman, Longhurst et al. 1983). Although it is well 
established that the muscle metaboreflex increases sympathetic nerve activity and BP (Alam 
1937, Mark, Victor et al. 1985), whether the latter is attributable to an increase in CO 
(O'Leary 1998, Crisafulli, Scott et al. 2003, Sala-Mercado, Hammond et al. 2006, Crisafulli 
2011), TPR (Bastos, Williamson et al. 2000, Lykidis, White et al. 2008) or both (Bonde-
Petersen 1982, Crisafulli, Salis et al. 2006) is equivocal. Germane to this debate is the issue 
of how the mode of muscle metaboreflex activation (i.e. during vs. following exercise) effects 
SV and cardiac chronotropic, inotropic and lusitropic function in humans. 
The majority of studies that have examined the hemodynamic effects of muscle 
metaboreflex activation in humans have used a PEI manoeuvre, whereby a cuff is inflated 
around the exercising limb to a supra-systolic level just before the end of exercise, trapping 
the metabolites within the muscle (Alam 1937). Maintaining cuff inflation following exercise 
isolates the metaboreflex, in the absence of mechanoreflex or central command activation. 
During this manoeuvre the exercise-induced elevation in sympathetic nerve activity and BP 
remain high, whereas HR typically returns towards resting levels (Alam 1937, Mark, Victor 
et al. 1985). This may be explained by the reactivation of cardiac parasympathetic tone, due 
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to baroreflex activation and/or loss of the inhibitory effect of central command and the 
muscle mechanoreflex, which masks any potential sympathetic chronotropic effect (O'Leary 
1993, Nishiyasu, Tan et al. 1994, Iellamo, Massaro et al. 1999, Fisher, Seifert et al. 2010). 
The observation that HR rapidly returns towards resting levels during PEI has led some to 
suggestion that the muscle metaboreflex has little influence on the heart (Freund, Hobbs et al. 
1978, Mark, Victor et al. 1985, Victor, Seals et al. 1987, Rowell and O'Leary 1990). 
Similarly, several studies have observed that SV is also unchanged during PEI (Pawelczyk, 
Pawelczyk et al. 1997, Bastos, Williamson et al. 2000, Crisafulli, Salis et al. 2006, Lykidis, 
White et al. 2008), suggesting that the elevated BP during PEI is not attributable to an 
increase in CO, but is secondary to an increase in TPR. However, this has not been a 
consistent finding and several investigations utilizing thoracic impedance cardiography have 
reported that the BP elevation during PEI occurs secondary to an increase in CO due to an 
elevation in SV in humans (Crisafulli, Scott et al. 2003, Crisafulli, Salis et al. 2006, Crisafulli 
2011). This elevation in SV during PEI has been attributed in part to a muscle metaboreflex 
mediated increase in myocardial contractility and relative increase in diastolic filling time 
coincident with a reduction in HR below baseline levels (Crisafulli, Scott et al. 2003, 
Crisafulli, Salis et al. 2006, Crisafulli 2011). Although PEI is an effective and established 
means of isolating the actions of the muscle metaboreflex the accompanying autonomic 
alterations, and the absence of central command and muscle mechanoreflex activation, means 
that any observed effects of PEI on SV may not be representative of the effects of 
metabolically sensitive muscle afferents during exercise. 
An alternative means of studying the actions of the metaboreflex is to engage it during 
exercise by partially or completely restricting perfusion to the exercising skeletal muscle 
(O'Leary 1998, Shoemaker, Mattar et al. 2007, Coutsos, Sala-Mercado et al. 2010, Crisafulli 
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2011). This enhances the metaboreflex, and perhaps because central command and the 
muscle mechanoreflex are also activated, both BP and HR increase due to heightened 
sympathetic activity and to a lesser extent the inhibition of cardiac parasympathetic tone 
(O'Leary 1993, Hartwich, Dear et al. 2011, Fisher, Adlan et al. 2013). In a recent canine 
study, partial restriction of hindlimb perfusion during treadmill exercise evoked a significant 
elevation in BP attributable to an increase in CO secondary to an increase in HR, while SV 
and peripheral vascular conductance remained unchanged (Spranger, Sala-Mercado et al. 
2013). Notably, the chronotropic response was accompanied by an increase in LV 
contractility and rate of relaxation, suggesting that the muscle metaboreflex affects multiple 
facets of myocardial performance. In contrast, the effect of enhancing metaboreflex during 
exercise on SV and myocardial function remains incompletely understood in humans. 
Doppler echocardiography provides an attractive means of assessing how the mode of muscle 
activation (i.e. during vs. following exercise) affects cardiac inotropic and lusitropic function 
in humans, and thus may help explain the resultant changes in SV. Quantification of mitral 
inflow velocities and the velocity of left ventricle contraction and relaxation along its 
longitudinal axis using pulse-wave TDI have been used to assess cardiac systolic and 
diastolic function during isometric handgrip exercise (Muller 2013), but the specific 
contribution of the metaboreflex has not been determined. 
Much scientific interest has been focused on the metaboreflex, due to its role in 
cardiovascular regulation during exercise (Crisafulli, Salis et al. 2006, Boushel 2010, 
Crisafulli 2011), but also its over-activation in heart failure patients, which consequentially 
limits exercise capacity (O'Leary, Sala-Mercado et al. 2004, Ansorge, Augustyniak et al. 
2005, Crisafulli, Salis et al. 2007, Piepoli, Dimopoulos et al. 2008). As well as in heart failure 
patients, exercise capacity in elderly individuals is limited, and has prognostic effects on 
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cardiovascular mortality (Nylen, Kokkinos et al. 2010). As discussed in Section 2.8 of this 
thesis, ageing is associated with altered resting autonomic regulation, specifically a reduction 
of parasympathetic nerve activity and vasomotor sympathetic responsiveness (Barnett, Morin 
et al. 1999, Kuo, Lin et al. 1999). Reduced sensitivity of α-receptors in the skeletal muscle 
vasculature and β-receptors in the heart occurs, and are believed to lead the higher basal SNA 
and sympathodominance in the elderly (Lakatta 1993, Smith, Voyles et al. 2007).The reduced 
sensitivity of cardiac β-receptors is also responsible for the reduced HRmax observed with 
ageing, contributing to decreased exercise capacity. In the vasculature, increased muscle 
vasoconstrictor tone could lead to a reduction in muscle blood flow, an augmented BP 
response, and again may contribute to attenuated exercise tolerance (Lakatta 1993, Smith, 
Voyles et al. 2007). The metaboreflex increases sympathetic nerve activity and BP, which are 
characteristics of ageing. Mechanisms by how the metaboreflex increases BP during exercise 
in ageing may be different than in young due to increased arterial stiffness, reduced LV 
diastolic function and HRmax achievable. Therefore, understanding the mechanisms of 
metaboreflex over-activity on the BP response to exercise in young individuals is the first key 
step to understanding potential mechanisms of reduced exercise capacity in elderly 
individuals.  
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6.3 Aims and Hypothesis 
Our primary aim was to investigate how the mode of muscle metaboreflex activation 
(i.e. during vs. following handgrip) affects the central hemodynamic response and cardiac 
systolic and diastolic function in healthy humans determined using echocardiographic 
imaging. We hypothesised that SV would only be increased by the muscle metaboreflex 
when it was activated in isolation during PEI and not when it was augmented during ischemic 
exercise. 
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6.4 Methodology 
6.4.1 Ethical Approval 
The study protocol and procedures conformed to the Declaration of Helsinki and were 
approved by the local ethics review committee (University of Birmingham). Subjects were 
informed of the study purpose and potential risks before providing written informed consent 
for participation. 
 
 
6.4.2 Subject Recruitment 
Ten male participants recruited from the undergraduate population of the University 
of Birmingham, UK took part in the study (age 20 ± 1 yr; height 181 ± 7 cm; weight 78 ± 10 
kg; mean ± SD). The sample size was determined in accordance with recently published 
studies in the area (Muller, Mast et al. 2013). No subjects were taking any medications and 
all were free from cardiovascular, pulmonary, renal, metabolic and neurological conditions. 
An initial visit to the laboratory served to accustom subjects to the laboratory environment 
and procedures. Prior to testing subjects refrained from strenuous exercise and alcohol intake 
for 24 hours, caffeine intake for 12 hours, and food intake for 2 hours.  All experiments were 
conducted in the same room with a mean ambient temperature of 23 ± 1 °C. 
 
 
6.4.3 Experimental Measurements 
Heart rate (HR) was measured using an ECG and beat-to-beat BP was measured non-
invasively from the left hand via finger plethysmography (Portapress Finapres Medical 
Systems, Amsterdam, The Netherlands). The left forearm and hand were supported on an arm 
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rest raised to the level of the heart. The arterial pressure waveform was integrated on a beat-
to-beat basis to obtain MAP. A handgrip dynamometer was held in the right hand, and force 
was displayed on a computer screen to provide visual feedback to the subject relating to the 
grip force generated. HR, BP and force were converted from analogue-to-digital signals at 1 
kHz (1401, Cambridge Electric Design, Cambridge, UK) and captured for offline analysis 
(Spike 2, Cambridge Electric Design). 
 
 
6.4.4 Echocardiography 
Echocardiographic images were acquired using ultrasound equipment (Sonos 5500, 
Philips Medical Systems Andover, MA, USA), using an S3 two-dimensional transducer (1-3 
MHz). All images were obtained and analysed by an experienced sonographer (CM) and 
stored on an external storage device for offline analysis. 
Aortic Outflow: To quantify flow through the aortic valve during systole, an apical 5 
chamber view was used. The velocity profile of the aortic outflow was obtained using pulsed-
wave Doppler with a sample volume of 2.0 mm placed in the LV outflow tract at the opening 
of the aortic orifice. The LV outflow tract diameter was measured in the parasternal long axis 
view. Trans-aortic flow, representing SV was calculated from the cross sectional area and 
VTI, which represents the mean distance through which blood travels in the aortic outflow 
tract during ventricular contraction. 
Mitral Inflow Velocities: Mitral inflow velocities were assessed from the apical 4 
chamber view using pulsed wave Doppler with a sample volume of 2.0 mm positioned over 
the mitral valve leaflet tips. From these, data measurements were obtained of the peak inflow 
velocity during the early phase of LV relaxation (E), which provides an index of LV diastolic 
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function, and during LA contraction (A), which provides an index of LA systolic function 
(Hatle 1993, Cohen 1996). These values were subsequently used to further assess diastolic 
function by calculation of the E/A ratio, and left atrial systolic function by calculation of the 
relative contribution of A to left ventricular filling during diastole, using the following 
formula: [A/(E + A)] ×100 (Hatle 1993, Prasad, Popovic et al. 2007, Brothers 2008). 
TDI: Measurements of peak septal mitral annular early diastolic (E’), late diastolic 
(A’), and systolic (S’) velocities were obtained to provide indices of LV diastolic function, 
LA systolic function, and left ventricular systolic function, via standard TDI techniques 
(Nagueh, Middleton et al. 1997, Prasad, Popovic et al. 2007). TDI measurements were 
obtained from the apical 4 chamber view with a 2.0 mm sample volume positioned at the 
junction of the septal mitral annulus and the LV wall. The mitral annulus at the septum was 
examined because, while the cardiac apex remains relatively fixed, it moves in a direction 
approximately parallel to the ultrasound beam and is relatively unaffected by movement of 
the heart within the chest cavity (Sohn, Chai et al. 1997). The E’ value was subsequently used 
for a calculation of E/E’ ratio, which is a strong correlate of LVfilling pressure measured 
invasively (Nagueh, Middleton et al. 1997). S’ velocity is representative of the peak velocity 
of mitral annular movement during systole, and has been validated as a measure of cardiac 
systolic function (Gorcsan 1998, Shimizu 1998). 
 
6.4.5 Experimental Protocol 
All examinations were performed whilst participants were in the semi-recumbent 
position. A cuff was placed around the right upper arm, which was set to rapidly inflate to 
supra-systolic pressure (220 mmHg) to occlude both vascular inflow and outflow using an 
automated cuff inflator and air source (AG101, Hokanson Inc., Bellevue, WA, USA) as 
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required.  Following instrumentation, maximal voluntary contraction (MVC) was determined. 
They were given 3-5 attempts with a 1 min rest period between each. Participants performed 
4 bouts of handgrip exercise in total, performed at 25% of their MVC: 
Isolated Metaboreflex Activation: Participants rested for 3 min, then performed 3 min 
of IHG. Ten seconds before the end of contraction, the cuff on the upper arm was rapidly 
inflated to a supra-systolic level (>200 mmHg), and remained inflated for a further 3 min 
(PEI) before being deflated. An IHG control trial was also performed, which consisted of 3 
min rest, 3 min IHG, and 3 min of recovery under free-flow conditions. Trials were 
performed in a randomized order. 
Enhanced Metaboreflex Activation: Participants rested for 3 min and then performed 
RHG contraction guided by a metronome (1 s contraction, 1 s relaxation). Prior to the start of 
the RHG trial the upper arm cuff was rapidly inflated to a supra-systolic level. The purpose of 
this ischemic RHG trial was to enhance the muscle metaboreflex during exercise, to better 
represent the effects of activating metabolically sensitive muscle afferents during exercise. 
Participants continued performing the RHG contractions until volitional fatigue. 
Following this the upper arm cuff remained elevated for a further 3 min (PEI). A control bout 
of RHG was also performed without cuff inflation, so that contractions were performed under 
free-flow conditions. The duration of the free-flow RHG period was time-matched to the 
fatiguing ischemic RHG bout. As such the free-flow RHG trial was always performed after 
the ischemic rhythmic handgrip trial. Ratings of perceived exertion (RPE) during handgrip 
were obtained using the Borg Scale (6-20) (Borg 1982). 
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6.4.6 Data Analysis 
Mean HR and BP data were obtained on a beat-to-beat basis and averages calculated 
at baseline (3 min), end-exercise (last 1 min) and recovery (last 2 min of PEI or free-flow 
recovery). Echocardiographic images for calculation of aortic outflow, mitral inflow and 
mitral annular velocities were obtained from three cardiac cycles at, or around, end 
expiration. This acquisition procedure was undertaken in triplicate at baseline, once during 
the last minute of exercise, and in duplicate during the last 2 min of PEI or free-flow 
recovery. Measurements were then pooled to provide a mean value for each experimental 
phase. Aortic root diameter was obtained in triplicate prior to the beginning of the first 
handgrip trial. During post-acquisition analysis SV (ml) was calculated as VTI (cm) × aortic 
root area (cm2), CO (L/min) was calculated as SV (ml) × HR (b/min) / 1000, and TPR 
(mmHg/L/min) calculated as MAP (mmHg) / CO (L/min). Post-acquisition analysis was 
performed blinded to the condition to reduce selection bias. 
 
6.4.7 Statistical Analysis 
Comparisons of physiological variables were made using a two-way repeated-
measures ANOVA, in which experimental phase (baseline, handgrip, recovery [PEI, free-
flow]) and trial (metaboreflex isolation [PEI] vs. free-flow recovery; enhanced metaboreflex 
activation [ischemic rhythmic handgrip] vs. free-flow exercise) were the main factors. Post 
hoc analysis was employed using Student Newman Keuls tests to evaluate significant main 
effects and interactions. Paired t-tests were used to compare RPE during handgrip bouts. 
Statistical significance was set at P < 0.05. Analyses were conducted using SigmaStat (Jandel 
Scientific Software, SPSS, Chicago, IL) for Windows. 
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6.5 Results 
6.5.1 Isolated Metaboreflex Activation 
As expected, isometric handgrip exercise significantly increased MAP, CO and HR 
from baseline levels (P<0.05), whereas TPR and SV remained unchanged (Figure 6.1). 
During isolated muscle metaboreflex activation with PEI, MAP and TPR were elevated 
(P<0.05 vs. baseline), while CO and HR returned to baseline. During recovery under free-
flow conditions neither MAP, TPR, CO nor HR were significantly different from baseline 
(P>0.05; Figure 6.1). 
Peak E velocity remained unchanged from baseline during isometric handgrip, while 
peak A velocity increased (P<0.05 vs. baseline). E/A ratio was significantly decreased during 
IHG, and the relative contribution of A to LV filling significantly increased (P<0.05 vs. 
baseline; Figure 6.2). Peak A velocity, peak E velocity, E/A ratio and the relative contribution 
of A to LV filling were not significantly different from baseline during either PEI or free-
flow recovery (P>0.05). 
IHG significantly decreased TDI determined peak E’ velocity, and increased peak A’ 
velocity and E/E’ ratio (P<0.05 vs. baseline), whereas S’ velocity remained unchanged 
(P>0.05 vs. baseline; Table 6.1). During PEI, peak A’ velocity remained elevated above 
baseline (P<0.05), whereas during free-flow recovery A’ returned to baseline. PEI following 
isometric exercise had no significant effect on either peak E’ velocity, peak S’ velocity, or 
E/E’ (P>0.05 vs. baseline; Table 6.1). RPE was not significantly different between IHG trials 
(14.6 ± 0.5 vs. 14.4 ± 0.5 au, isometric handgrip with PEI vs., isometric handgrip with free-
flow recovery: P>0.05). 
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6.5.2 Enhanced Metaboreflex Activation 
RHG under free-flow conditions did not significantly alter MAP, CO, TPR, HR or 
SV. However, enhancement of the metaboreflex during ischemic RHG caused a significant 
increase in MAP, CO and HR (P<0.05 vs. baseline and free-flow rhythmic handgrip; Figure 
3), whereas TPR and SV remained unchanged. During PEI following ischemic RHG, MAP 
and TPR were elevated above baseline (P<0.05) while CO, HR and SV were at baseline 
levels (P>0.05; Figure 6.3). 
Peak E velocity was unchanged from baseline during RHG under either free-flow or 
ischemic conditions (P>0.05; Figure 6.4). During free-flow RHG exercise, peak A velocity 
remained unchanged (P>0.05 vs. baseline), but increased during ischemic exercise (P<0.05 
vs. baseline). E/A ratio was reduced during free-flow and ischemic RHG (P<0.05 vs. 
baseline), and the relative contribution of A to LV filling increased (P<0.05). All peak 
transmitral valve flow velocities were unchanged from baseline during PEI and free-flow 
recovery (P>0.05). 
TDI derived E’ and S’ velocities were unchanged from baseline during free-flow and 
ischemic RHG (P>0.05; Table 6.2). A’ was increased during both free-flow and ischemic 
RHG (P<0.05 vs. baseline), while E/E’ was increased during ischemic RHG and remained 
elevated during PEI (P<0.05 vs. baseline). All other TDI derived velocities of LV contraction 
(S’) or relaxation (E’, A’) were not significantly different from baseline during PEI (P>0.05; 
Table 2). RPE was significantly greater during ischemic RHG (19.1 ± 0.3 au) than RHG 
under free-flow conditions (10.7 ± 0.5 au: P<0.05). 
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Table 6.1 Tissue Doppler data during isometric handgrip (IHG) and either free-flow recovery or post exercise ischemia (PEI). 
 Rest IHG 
Free-flow 
recovery 
 Rest IHG PEI  Phase Trial Interaction 
E' (cm/s) 12.5 ± 0.5 11.2 ± 0.6 12.6 ± 0.4  13.0 ± 0.5 11.7 ± 0.7 12.9 ± 0.7  
< 
0.05 
0.196 0.915 
A' (cm/s) 5.2 ± 0.4 7.2 ± 0.7* 5.8 ± 0.5  5.4 ± 0.4 7.4 ± 0.5* 7.2 ± 0.6*†  
< 
0.05 
< 0.05 < 0.05 
E/E' 6.6 ± 0.3 7.5 ± 0.5 6.7 ± 0.2  6.4 ± 0.3 7.9 ± 0.6 7.0 ± 0.4  
< 
0.05 
0.589 0.328 
S’ (cm/s) 8.7 ± 0.6 8.3 ± 0.5 9.0 ± 0.5  8.6 ± 0.4 8.4 ± 0.4 8.5 ± 0.4  0.225 0.438 0.096 
 
E’, peak septal mitral annular early diastolic velocity; A’, peak septal mitral annular late diastolic velocity; E/E’, ratio between the peak mitral 
inflow velocity during the early phase of LV relaxation and peak septal mitral annular early diastolic velocity; S’, peak septal mitral annular 
systolic velocity. P values represent results of ANOVA. Data are expressed as mean ± SE. *P<0.05 versus baseline of the corresponding trial; 
†P<0.05 versus the corresponding time point of the opposing trial. 
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Table 6.2 Tissue Doppler measurements during rhythmic handgrip (RHG) and PEI 
 
 Rest RHG 
Free-flow 
recovery 
 Rest 
Ischemic 
RHG 
PEI  Phase Trial Interaction 
E' (cm/s) 12.5 ± 0.5 12.2 ± 0.7 12.9 ± 0.8  12.9 ± 0.8 11.9 ± 0.8 12.4 ± 0.7  0.214 0.689 0.326 
A' (cm/s) 5.1 ± 0.4 6.6 ± 0.6 5.6 ± 0.5  6.0 ± 0.4 8.0 ± 0.6 8.0 ± 0.7  < 0.05 < 0.05 0.148 
E/E' 6.8 ± 0.4 7.1 ± 0.4 6.7  ± 0.4  7.0 ± 0.5 8.2  ± 0.6*† 7.4 ± 0.4†  < 0.05 < 0.05 < 0.05 
S’ (cm/s) 8.3 ± 0.4 8.3 ± 0.3 8.4  ± 0.4  9.0  ± 0.5 9.0  ± 0.3 8.3  ± 0.3  0.468 < 0.05 0.131 
 
E’, peak septal mitral annular early diastolic velocity; A’, peak septal mitral annular late diastolic velocity; E/E’, ratio between the peak inflow 
velocity during the early phase of LV relaxation and peak septal mitral annular early diastolic velocity ; S’, peak septal mitral annular systolic 
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velocity. P values represent results of ANOVA. Data are expressed as mean ± SE. *P<0.05 versus baseline of the corresponding trial; †P<0.05 
versus the corresponding time point of the opposing trial. 
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Fig. 6.1 Hemodynamic data during isometric handgrip (IHG) and either free-flow recovery (FF) or post exercise ischemia (PEI). Mean arterial pressure (MAP; panel A), 
cardiac output (CO; panel B), total peripheral resistance (TPR; panel C), heart rate (HR; panel D), and stroke volume (SV; panel E). MAP, CO and HR were significantly 
increased during IHG, while TPR and SV were unchanged from baseline. During PEI, MAP and TPR were elevated above baseline, while CO, HR and SV were at baseline 
levels. *P<0.05 versus baseline of the corresponding trial; †P<0.05 versus the corresponding time point of the opposing trial. 
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Fig. 6.2 Mitral inflow velocities during isometric handgrip (IHG) and either free-flow recovery (FF) or post exercise ischemia (PEI). Peak E velocity (panel A), peak A 
velocity (panel B), E/A ratio (panel C), and the relative contribution of A to LV filling (panel D). During IHG, peak A velocity and the relative contribution of A to LV filling 
were increased, peak E velocity was unchanged, and E/A ratio decreased. During PEI, all mitral inflow velocities were at baseline levels. *P<0.05 versus baseline of the 
corresponding trial. 
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Fig.6. 3 Hemodynamic data during rhythmic handgrip (RHG) under free-flow (FF) conditions, and rhythmic handgrip with ischemia followed by post exercise ischemia 
(PEI). Mean arterial pressure (MAP; panel A), cardiac output (CO; panel B), total peripheral resistance (TPR; panel C), heart rate (HR; panel D), and stroke volume (SV; 
panel E). Ischemia augmented the RHG mediated increase in MAP, CO and HR, while TPR and SV were unchanged from baseline. During PEI, MAP and TPR were elevated 
above baseline, while CO, HR and SV remained at baseline levels.  *P<0.05 versus baseline of the corresponding trial; †P<0.05 versus the corresponding time point of the 
opposing trial. 
CHAPTER 6 
	
151	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.4 Mitral inflow velocity data during rhythmic handgrip (RHG) 
under free-flow (FF) conditions and rhythmic handgrip with ischemia 
followed by post exercise ischemia (PEI). Peak E velocity (panel A), peak A velocity (panel B), E/A ratio (panel C), and the relative contribution of A to LV filling (panel D). 
During RHG and RHG with ischemia, the relative contribution of A to LV filling increased, peak E velocity was unchanged, and E/A ratio decreased. Peak A velocity was 
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increased during ischemic RHG. During PEI, all mitral inflow velocities were at baseline levels. *P<0.05 versus baseline of the corresponding trial; †P<0.05 versus the 
corresponding time point of the opposing trial. 
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6.6 Discussion 
There are a number of salient findings resulting from this study. First, while the mode 
of metaboreflex activation determines the mechanism by which BP is elevated, neither was 
observed to alter SV as determined using Doppler echocardiography. During isolated 
metaboreflex activation (PEI) following handgrip the increase in BP is secondary to an 
elevation in TPR, whereas the increase in BP during enhanced metaboreflex activation 
(ischemic handgrip) is secondary to an elevation in CO, driven by increased HR. Second, LV 
contractility, assessed from left ventricle systolic wall velocity (S’), remained unchanged 
during either isolated or enhanced metaboreflex activation. Finally, LA systolic function, 
assessed from peak velocity of the mitral annulus at late diastolic filling (A’), was augmented 
by the enhanced metaboreflex activation and during PEI following IHG. Collectively, these 
findings indicate that the mode of muscle metaboreflex activation (during vs. post handgrip) 
determines whether the resultant pressor response is flow (CO) or vasoconstriction (TPR) 
mediated, and that enhanced LA systolic function can serve as a valuable means of 
preserving SV during enhanced and isolated muscle metaboreflex activation. 
 
6.6.1 Isolated Metaboreflex Activation 
It is well established that BP is increased during metaboreflex activation, but whether 
this response is due to an increase in CO or TPR is equivocal. We observed that during 
isolated metaboreflex activation with PEI following handgrip, HR and SV, and thus CO 
remained at baseline levels. Therefore, in line with the studies of Lykidis et al. and Bastos et 
al., the metaboreflex mediated increases in BP could be explained by increased TPR (Bastos, 
Williamson et al. 2000, Lykidis, White et al. 2008). In contrast, Spranger et al. reported a HR 
mediated elevation in CO during PEI following treadmill exercise in dogs (Spranger, Sala-
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Mercado et al. 2013), while Crisafulli and colleagues observed that the BP elevation during 
PEI was caused by an increase in CO, secondary to an elevation in SV (Crisafulli, Scott et al. 
2003, Crisafulli, Salis et al. 2006, Crisafulli 2011). Aside from potential species differences 
(dogs, humans), these heterogeneous findings may in part be explained by variations in the 
methods used to determine SV (Doppler echocardiography, thoracic impedance 
cardiography), and the exercise modality and intensity utilized. HR is typically elevated 
during PEI following dynamic exercise of a large muscle mass (Freund, Hobbs et al. 1978, 
Spranger, Sala-Mercado et al. 2013), due to muscle metaboreflex mediated increase in 
cardiac sympathetic nerve activity and withdrawal of cardiac parasympathetic activity 
(Fisher, Adlan et al. 2013), and consequently a flow-mediated pressor response is evoked by 
muscle metaboreflex activation (Spranger, Sala-Mercado et al. 2013). In contrast, when 
increases in CO are experimentally prevented (Sheriff, Augustyniak et al. 1998) or are 
attenuated as a consequence of congestive heart failure (Hammond, Augustyniak et al. 2000), 
the resultant pressor response to metaboreflex activation in treadmill exercising dogs is 
mediated by vasoconstriction. Similarly, we observed that during PEI following exercise of a 
relatively small muscle mass (e.g. handgrip), where an enhancement of cardiac 
parasympathetic tone likely restricts HR and CO from increasing (O'Leary 1993, Fisher, 
Seifert et al. 2010) the resultant pressor response is also mediated by vasoconstriction. 
Crisafulli and colleagues (Crisafulli, Scott et al. 2003, Crisafulli, Salis et al. 2006, 
Crisafulli 2011) have indicated that isolated muscle metaboreflex activation may augment LV 
contractility and thus augment SV during PEI particularly when accompanied by a relative 
increase in diastolic filling time due to a fall in HR below baseline levels. In these 
investigations contractility was determined on the basis of changes in pre-ejection period 
(PEP), LV ejection time (VET) and the PEP/VET ratio using impedance cardiography. To 
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further understand how the muscle metaboreflex activation affects myocardial systolic 
function and help explain the potential changes in SV during PEI, Doppler echocardiography 
velocity measurements were made of the left ventricle along its longitudinal axis during 
contraction and relaxation (TDI). Interestingly, LV systolic function as determined using TDI 
(S’) was unaltered from rest during PEI. Methodological differences in the assessment of 
cardiac function may partly explain the discrepant findings regarding the influence of isolated 
metaboreflex activation on myocardial contractility. However, given that systolic time 
intervals are reduced during PEI following dynamic knee exercise at 70% MVC, but not 30% 
MVC (Crisafulli, Salis et al. 2006), it is likely that exercise intensity and modality are 
important modulators of muscle metaboreflex mediated changes in systolic function. 
Although we did not observe an increase in LV systolic function during PEI following 
handgrip, the fact that SV was preserved despite the elevated afterload implies that cardiac 
work was enhanced. Notably, Bastos et al. reported that the increase in afterload during PEI 
following isometric handgrip was accompanied by an increase in end-systolic volume, 
however as end-diastolic volume was also concomitantly increased (i.e. greater preload) SV 
was preserved (Bastos, Williamson et al. 2000). As such, they suggested that an enhanced 
Frank-Starling effect made an important contribution to the maintenance of SV during PEI 
following handgrip, and that an increase in myocardial contractility was not requisite (Bastos, 
Williamson et al. 2000). In accordance with this suggestion, we observed that the peak 
velocity of the mitral annulus at late diastolic filling (A’) was increased during PEI following 
IHG. This is suggestive of an enhanced LA systolic function, and likely represents a valuable 
means of enhancing LV filling and thus preserving SV during isolated muscle metaboreflex 
activation with PEI. In addition, the muscle metaboreflex likely contributes to the 
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augmentation of cardiac preload via the redistribution of blood from the viscera to the central 
circulation (Bastos, Williamson et al. 2000). 
 
6.6.2 Enhanced Metaboreflex Activation 
In the present study, the enhancement of the metaboreflex by IHG augmented BP 
secondary to an increase in CO (i.e., not TPR). This augmented CO response was driven by 
an increase in HR while SV was unchanged. This concurs with studies in dogs where 
enhanced metaboreflex activation by partial occlusion of the terminal aorta during treadmill 
exercise increased BP and CO, secondary to an elevation in HR (O'Leary 1998, Spranger, 
Sala-Mercado et al. 2013). One possible explanation for the differential effects of PEI 
(isolated metaboreflex) and IHG (enhanced metaboreflex) on CO and HR relates to 
differences in cardiac autonomic neural activity. As mentioned above, during PEI following 
handgrip HR returns to resting levels as cardiac parasympathetic tone is reactivated (O'Leary 
1993, Fisher, Seifert et al. 2010), and seemingly as a consequence the elevation of BP during 
this isolated metaboreflex activation results from an increase in TPR. In contrast, ischemic 
exercise augments sympathetic activity and inhibits cardiac parasympathetic activity (Victor 
and Seals 1989, Hartwich, Dear et al. 2011, Fisher, Adlan et al. 2013, Hartwich, Aldred et al. 
2013), at a time when central command and the mechanoreflex activation also reduce cardiac 
parasympathetic activity (Mitchell, Reeves et al. 1989, Gladwell, Fletcher et al. 2005). As a 
result HR, and thus CO and BP are increased. 
It is notable that SV was preserved during IHG despite the increase in afterload 
(increased BP) and reduction in diastolic filling time (increased HR). Indeed, pacing studies 
in dogs (White, Patrick et al. 1971) and recently humans (Munch, Svendsen et al. 2013) have 
demonstrated that increases in HR can decrease SV, thus implying that cardiac systolic and/or 
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diastolic function is altered during enhanced muscle metaboreflex activation. Indeed, muscle 
metaboreflex activation during treadmill running in dogs elicits substantial increases in 
ventricular contractility as determined using invasive approaches (e.g. dP/dt max) (Sala-
Mercado, Hammond et al. 2006). However, we observed that S’ velocity (peak mitral annular 
systolic velocity) was unchanged from rest during RHG or RHG with ischemia. This in part 
agrees with the findings of Muller et al., who reported that S’ velocity was unchanged from 
rest during fatiguing IHG in young individuals (Muller 2013), and Krzeminski who showed 
no change in systolic time intervals during IHG (Krzeminski 1990). 
Spranger et al. reported that enhanced muscle metaboreflex activation during 
treadmill exercise in dogs augmented LV relaxation (Spranger, Sala-Mercado et al. 2013). To 
investigate this in humans LV diastolic function was assessed by determination of the peak 
transmitral flow velocity during early (E) and late (A) filling of the left ventricle. E is 
associated with relaxation and suction of the left ventricle, while A represents blood flow in 
to the left ventricle secondary to the contraction of the left atrium and is associated with LV 
compliance (Cohen 1996). The ratio of E/A is commonly used as a measure of LV diastolic 
function (George, Naylor et al. 2010), and at baseline E/A ratio was >1.0 as a majority of LV 
filling occurs during the early phase (George, Naylor et al. 2010). During IHG E/A ratio was 
markedly decreased, as the relative contribution of A to overall LV filling increased. During 
ischemic RHG both A and A’ (the peak velocity of the mitral annulus during late diastolic 
filling determined with TDI) were greater than under free-flow conditions, suggestive of 
enhanced LA systolic function with augmented muscle metaboreflex activation. It is  
speculated that increases in HR caused by either IHG or ischemic RHG to enhance the 
muscle metaboreflex, increase in the relative contribution of LA contraction to LV filling to 
compensate for the reduction in LV filling time, and represent an important means of aiding 
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the preservation of SV under these conditions by maintaining or enhancing EDV (Bastos, 
Williamson et al. 2000). 
Similar to the findings of Muller et al., a decrease in E’ velocity during isometric 
handgrip was observed, however this measure of peak early diastolic mitral annular velocity 
was not different from baseline during PEI or during RHG with or without ischemia. Of note, 
E/E’ ratio was significantly increased during IHG, RHG with ischemia and PEI following 
ischemic RHG (Muller 2013). This index of left ventricle active relaxation and compliance 
has been shown to correlate well with LV filling pressure both at rest and during exercise 
(Burgess, Jenkins et al. 2006), but it is difficult to discern the precise underlying mechanisms 
for the apparent exercise-induced increase in E/E’ ratio. However, the fact that it is 
exacerbated by robust muscle metaboreflex activation is noteworthy. The activation of the 
metaboreflex produces a robust increase in sympathetic nerve activity to the heart and 
peripheral vasculature. An increase in cardiac sympathetic nerve activity may not only induce 
coronary vasodilatation via β-adrenergic mediated dilatation and an increase in cardiac work, 
but has the capacity to induce coronary vasoconstriction via an effect on α1-adrenergic 
receptors (O'Leary, Sala-Mercado et al. 2007, Coutsos, Sala-Mercado et al. 2010). Studies in 
exercising canines have indicated that muscle metaboreflex mediated α-adrenergic 
vasoconstriction limits increases in coronary blood flow thus impairing cardiac function 
(O'Leary, Sala-Mercado et al. 2007, Coutsos, Sala-Mercado et al. 2010). These observations 
may have particular importance for patient populations in which heightened skeletal muscle 
afferent sensitivity has been identified, such as heart failure (Piepoli, Clark et al. 1996, 
Coutsos, Sala-Mercado et al. 2013). Furthermore, an enhanced muscle metaboreflex mediated 
increase in peripheral sympathetic vasoconstrictor tone has the potential to impair cardiac 
function via an acute change in cardiac afterload. Indeed, recent research by Weiner et al.  
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examining LV twist mechanics, found that the increase in afterload during isometric exercise 
can impair diastolic function (Weiner, Weyman et al. 2012). In the present study we observed 
that enhanced muscle metaboreflex activation was associated with an increase in E/E’. 
Interestingly, patients with an exaggerated exercise-induced increase in the ratio of early 
diastolic transmitral velocity to early diastolic mitral annular velocity have reduced exercise 
capacity (Burgess, Jenkins et al. 2006). However, it is acknowledged that the present 
investigations were all undertaken in young healthy individuals and additional studies are 
required examining the links between muscle afferent sensitivity, cardiac function and 
exercise capacity in patient populations and elderly. 
 
6.6.3 Muscle Metaboreflex Control of the Heart: Implications for Ageing 
Resting SNA is elevated in aging (Ng, Callister et al. 1993), in addition to other 
cardiovascular alterations.  Muller et al. examined cardiac mechanics in both young (mean 
age = 26 ± 1 year) and older adults (mean age = 64 ± 1 year) during isometric fatiguing 
handgrip exercise (Muller 2013). They observed that there was an exaggerated pressor 
response in older adults, however LV contractility and early diastolic filling was impaired. It 
was speculated that the reasons for these LV impairments may be due to; (i) cardiac 
ischemia; (ii) increased afterload and arterial stiffness which are known to affect LV 
function; (iii) β-adrenergic desensitisation (sympathetic activity increases LV contraction and 
relaxation via β-receptors). In terms of performance, some extremely sedentary elderly 
individuals  may be at a disadvantage due to baseline impairments in cardiovascular function 
(Muller 2013) and exercise capacity is attenuated. A greater cardiovascular response to 
exercise or in fact activities of daily living occurs resulting in higher BP, which could have 
clinical significance (Muller 2013). The findings of Muller need to be extended, by 
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consideration of the specific role that the muscle metaboreflex makes in elderly individuals. 
Elderly individuals who are physically active however may not have cardiovascular 
impairments to the same extent as sedentary elderly, and may therefore not exert the same 
magnitude of pressor response. A reduced pressor response to exercise could in part explain 
higher exercise capacity and improved quality of life observed in active elderly individuals. 
 
 
6.6.4 Methodological Considerations 
There are several limitations to the present work. Handgrip was the only exercise 
modality used in the present study and although both rhythmic and isometric paradigms were 
utilized care should be taken in extrapolating our findings to exercise of other muscle groups. 
Cardiac function was non-invasively investigated using Doppler echocardiography and we 
recognise that these may be affected by several factors that were not measured, including 
volume status, central venous pressure, intra-cardiac pressure and arterial stiffness. 
Furthermore, while TDI measurements are less preload dependent than mitral inflow 
velocities (George, Naylor et al. 2010), the effect of HR on tissue velocities has been debated 
(Stugaard, Risoe et al. 1994, Giannaki, Oxborough et al. 2008). Studies in humans examining 
the influence of muscle metaboreflex activation using more direct methods of assessing 
cardiac function (Bada, Svendsen et al. 2012) remain to be undertaken. Finally, despite the 
demonstration in exercising dogs that the cardiovascular response to restricted hindlimb 
blood flow is virtually abolished with muscle afferent blockade (Pomeroy, Ardell et al. 1986, 
Kozelka, Christy et al. 1987), we cannot rule out the possibility that ischemic exercise 
augments central command along with skeletal muscle afferent feedback. Nevertheless, the 
application of ischemic exercise to augment the activation of the muscle metaboreflex is well 
CHAPTER 6 
	
161	
	
established (Alam 1937) and as it engages metabolically sensitive skeletal muscle afferents 
while central command and the muscle mechanoreflex are operant, in this respect it is 
arguably more representative than PEI of normal exercise, particularly in individuals with 
chronic conditions where skeletal muscle blood flow is compromised (e.g. peripheral 
vascular disease). 
 
6.6.5 Conclusion 
In summary, the results of the present study indicate that the mode of metaboreflex 
activation determines the mechanism by which BP is elevated, but SV was unaltered by 
either isolated (PEI) or augmented metaboreflex activation (ischemic handgrip). Furthermore, 
while LV contractility remained unchanged, LA systolic function was enhanced during IHG 
and following period of PEI, suggesting that this is a valuable means of preserving SV under 
these conditions. Additional studies are required in elderly humans examining the influence 
of muscle metaboreflex activation on cardiac function, and populations where enhanced 
muscle afferent sensitivity has been identified.
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As we age we develop dysfunction of multiple systems in the body including the 
musculoskeletal, immune, and cardiovascular system (Fried, Tangen et al. 2001). Body 
composition also changes including an increase in visceral adiposity and a decrease in muscle 
mass and strength (Baumgartner, Heymsfield et al. 1995, Gallagher, Ruts et al. 2000, Harris 
2002, Wannamethee, Shaper et al. 2007). Age-related immune dysfunction results in an 
increase in chronic systemic inflammation and oxidative stress, which has been associated 
with vascular and cardiac stiffening (Pawelec 2002, Panda, Arjona et al. 2009). These 
detrimental structural changes result in cardiovascular dysfunction. Attenuated cardiovascular 
ability coupled with a weakened muscle system limits exercise capacity and even the ability 
of performing normal daily tasks, e.g. walking, reaching, and carrying. If left un-noticed and 
untreated, these age-related changes lead to the development of frailty and disease, reducing 
the quality of life and increasing the risk of mortality. Physical inactivity also increases as we 
age, and has been associated with the age-related changes discussed above (Mattusch, Dufaux 
et al. 2000, Taaffe, Harris et al. 2000, Geffken, Cushman et al. 2001). What is unknown 
however is whether the onset of dysfunction of these multiple systems with age causes 
reduced physical activity due to increased visceral adiposity, muscle weakness and low 
exercise capacity, or is the reduced physical activity causing a downward spiral of increased 
visceral adiposity, muscle weakness and low exercise capacity. 
In the first study of this thesis (Chapter 4), a cross-sectional experiment of a cohort of 
211 elderly individuals (mean age = 67 ± 5 years) was performed to examine the associations 
between a number of variables including habitual physical activity, physical functioning, total 
and visceral adiposity, muscle mass, cardiovascular function and plasma biomarkers regarded 
to be related to cardiovascular disease development. It was demonstrated that (i) individuals 
with higher physical activity were associated with faster walking speeds and a faster 
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completion of the TUG test (Table 4.5); (ii) higher levels of physical activity were associated 
with a lower total body fat, body fat % and estimated visceral fat mass, however lean body 
mass was not affected (Table 4.4); (iii) plasma concentrations of the cardiovascular risk 
factor PAI-1 were lower in higher physically active individuals, however the remaining 
plasma biomarkers of inflammation (MIF, endothelin-1, C-RP, IL-1β, IL-4, IL-6, IL-10, IL-
13, IL-17a) and oxidative stress were not associated with physical activity (Table 4.6 & 4.7); 
(iv) cardiovascular function represented by resting HR, BP, central pulse pressure and large 
artery stiffness were not associated with physical activity (Table 4.8). This is the first study to 
examine the associations between physical functioning, body composition, inflammation, 
cardiovascular function and habitual physical activity concomitantly in a single cohort of 
elderly individuals.  Although physical activity did have significant beneficial effects on 
walking speed, whole body and visceral adiposity, and PAI-1 concentration, no identifiable 
differences were observed for the remaining plasma biomarkers associated with increased 
cardiovascular risk, cardiovascular function or lean muscle mass, contradicting previous 
evidence (Paffenbarger, Hyde et al. 1986, Hakim, Curb et al. 1999, Sesso, Paffenbarger et al. 
2000, Tanaka, Dinenno et al. 2000, Geffken, Cushman et al. 2001, Myers, Prakash et al. 
2002).  It is possible to speculate that the physical activity range in this cohort may not be 
broad enough to expose minor differences of physiological homeostasis in healthy elderly 
individuals. However, the observation that differences in physical functioning and body 
composition were present between the lowest and highest physical activity groups, suggests 
that these age-related changes precede other functional loss such as cardiovascular 
dysfunction, and that physical activity can attenuate these detrimental changes.  
In the second study of this thesis (Chapter 5), a cross-sectional experiment of a cohort 
of 175 elderly individuals (mean age = 67 ± 5 years) from the original 211 was developed to 
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examine the associations between LV diastolic function and the following variables: physical 
activity, inflammation, central and visceral adiposity, and resting arterial stiffness, HR, MAP 
and TPR. It was demonstrated that (i) LV diastolic function was negatively associated with 
estimated visceral fat mass, however not associated with waist:hip ratio and BMI; (ii) LV 
diastolic function was not associated with inflammatory status or oxidative stress, as index 
using plasma C-RP and lipid peroxide concentration, and plasma leptin:adiponectin ratio; (iii) 
LV diastolic function was not associated with arterial stiffness, TPR or resting HR, however 
was negatively associated with MAP; (iv) LV diastolic function was not significantly 
associated with physical activity. Firstly, this study showsthat MAP was the major negative 
predictor of LV diastolic function, above all other variables examined. Interestingly, when 
controlling for age, gender and anti-hypertensive medication, estimated visceral adipose 
tissue mass also had a significant negative association with LV diastolic function, second 
only in importance to MAP. This study is the first to measure and demonstrate that visceral 
adipose tissue mass is an independent predictor of the variance in LV diastolic dysfunction, 
measured as E/A ratio, in a single elderly cohort, suggesting a detrimental association of 
visceral adipose tissue mass with LV function in ageing populations. Given that visceral 
adipose tissue produces inflammatory cytokines, it is somewhat unexpected that in this cohort 
no association between LV diastolic function and inflammation was observed. Systemic 
inflammation and oxidative stress have previously been associated with cardiovascular 
dysfunction (Heitzer, Schlinzig et al. 2001) contradicting the current study findings. MAP 
was negatively associated with LV diastolic function; therefore it was unanticipated that 
arterial stiffness and TPR were not related. However, arterial stiffness is known to be 
associated with an increase in inflammatory cytokines and oxidative stress, tying in with the 
lack of association of systemic plasma inflammatory and oxidative markers with LV diastolic 
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function. The results may suggest that an alternative mechanism, possibly renal dysfunction, 
give rise for the association between MAP and LV diastolic function. Given previous 
evidence (Arbab-Zadeh, Dijk et al. 2004, Prasad, Popovic et al. 2007), it was expected that 
physical activity be positively associated with LV diastolic function. The findings of this 
study reject this hypothesis as physical activity was not associated. A possible explanation for 
this could be the physical activity range, as in Chapter 4 of this thesis, as none of the 
participants fell in to extreme activity behaviour such as completely sedentary or highly 
endurance trained, as was the case in previous research (Arbab-Zadeh, Dijk et al. 2004). The 
inclusion criteria may be too restricted resulting in exclusion of individuals who live an 
extremely sedentary lifestyle but have disease diagnosis. However, the approach adopted is 
that used in many clinical trials where comorbidities represent the main reason to exclude 
elderly individuals (Ferrucci, Guralnik et al. 2004). Given the findings that MAP and visceral 
adiposity had significant associations, it is proposed that the underlying mechanism may 
include the onset of fibrosis potentially resulting from increased inflammation and oxidative 
stress. However, inflammatory markers and oxidative stress were measured in this cohort and 
presented in Chapter 4, whereby the only significant association with physical activity was 
with PAI-1 concentration. It could be possible that a number of predictor associations have 
been missed in this cohort as the sample size and physical activity range may have been too 
small, therefore underlying pathologies such as renal dysfunction and variety of inflammatory 
diseases could have potentially been missed. 
The third study of this thesis (Chapter 6) sought to better understand the neural 
mechanisms underpinning the circulatory responses to exercise in a ‘normal’ young 
population, as the first step to investigating the effects of ageing. Much scientific interest has 
been focused on the metaboreflex, due to its role in cardiovascular regulation during exercise 
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(Crisafulli, Salis et al. 2006, Boushel 2010, Crisafulli 2011), but also its over-activation in 
heart failure patients, which consequentially limits exercise capacity (O'Leary, Sala-Mercado 
et al. 2004, Ansorge, Augustyniak et al. 2005, Crisafulli, Salis et al. 2007, Piepoli, 
Dimopoulos et al. 2008). Previous research has used different approaches to investigate the 
effects of metaboreflex activation on circulatory responses, providing equivocal results. Our 
aim therefore was to investigate how the mode of muscle metaboreflex activation (i.e. during 
[ischemic exercise] vs. following [PEI] handgrip) affects the central hemodynamic response 
and cardiac systolic and diastolic function in 10 healthy male participants (mean age = 20 ± 1 
year). It was demonstrated that (i) during isolated metaboreflex activation (PEI) following 
handgrip the increase in BP was secondary to an elevation in systemic vasoconstriction 
(TPR) (Figure 6.1); (ii) the increase in BP during enhanced metaboreflex activation (ischemic 
handgrip) was secondary to an elevation in CO, driven by increased HR (Figure 6.3); (iii) SV 
was not altered by either metaboreflex activation mechanism (Figure 6.1 & 6.3); (iv) LV 
contractility remained unchanged during either isolated or enhanced metaboreflex activation 
(Figure 6.2 & 6.4); (v) LA systolic function was augmented by the enhanced metaboreflex 
activation and during PEI following isometric handgrip (Figure 6.2 & 6.4). These findings 
add to previous research by identifying that the mode of muscle metaboreflex activation 
(during vs. post handgrip) determines whether the resultant pressor response is flow (CO) or 
vasoconstriction (TPR) mediated, and that enhanced LA systolic function can serve as a 
valuable means of preserving SV during enhanced and isolated muscle metaboreflex 
activation. Activation of the metaboreflex produces a substantial increase in sympathetic 
nerve activity to the heart and peripheral vasculature. An increase in cardiac sympathetic 
nerve activity may not only induce coronary vasodilatation via β-adrenergic mediated 
dilatation and an increase in cardiac work, but has the capacity to induce coronary 
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vasoconstriction via an effect on α1-adrenergic receptors (O'Leary, Sala-Mercado et al. 2007, 
Coutsos, Sala-Mercado et al. 2010). Studies in exercising canines have indicated that muscle 
metaboreflex mediated α-adrenergic vasoconstriction limits increases in coronary blood flow 
thus impairing cardiac function (O'Leary, Sala-Mercado et al. 2007, Coutsos, Sala-Mercado 
et al. 2010). These observations may have particular importance for patient populations in 
which heightened skeletal muscle afferent sensitivity has been identified, such as heart failure 
(Piepoli, Clark et al. 1996, Coutsos, Sala-Mercado et al. 2013).  
However, it is acknowledged that this study was undertaken in young healthy 
individuals and additional studies are required examining the links between muscle afferent 
sensitivity, cardiac function and exercise capacity in patient populations, or populations who 
are at an increased risk of heart failure, such as elderly individuals. Muller et al. has 
previously shown that over-activation of the sympathetic nervous system in healthy elderly 
individuals reduces systolic and diastolic function during exercise (Muller 2013). Exercise 
capacity in elderly individuals is limited, and has prognostic effects on cardiovascular 
mortality (Nylen, Kokkinos et al. 2010). Mechanisms by how the metaboreflex increases BP 
during exercise in ageing may be different than in young due to increased arterial stiffness 
and reduced LV diastolic function. Inflammatory cytokines such as TNF-α and IL-6, which 
are elevated during ageing, have been shown to increase activation of the metaboreflex 
resulting in further vasoconstriction (Vila and Salaices 2005, Granger 2006). Therefore, 
understanding the mechanisms of metaboreflex over-activity on the BP response to exercise 
capacity may identify other potential mechanisms of reduced exercise capacity in elderly 
individuals. Repeating this study in sedentary and highly active elderly individuals would be 
beneficial to also understand the impact of physical activity on sympathetic control of the 
pressor response and cardiac mechanics in ageing, due to the inflammatory lowering effect 
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physical activity has (Mattusch, Dufaux et al. 2000, Taaffe, Harris et al. 2000, Geffken, 
Cushman et al. 2001). 
The work in this thesis has enhanced the knowledge regarding habitual physical 
activity and multi-system function in a single elderly cohort. For the first time the 
associations between physical function, systemic inflammation and ROS, body composition 
including visceral adiposity, cardiovascular function, and physical activity were assessed to 
better understand the potential complex mechanisms that lead from ageing to cardiovascular 
dysfunction. First, high habitual physical activity is associated with faster walking speed, 
lower body fat and visceral adiposity, and lower systemic PAI-1 concentration. Muscle mass, 
systemic inflammation, ROS and cardiovascular function including arterial stiffness, resting 
HR, MAP and TPR however were not associated with physical activity. Second, LV diastolic 
function was associated with higher MAP and visceral adiposity, however physical activity, 
arterial stiffness, systemic inflammation and ROS, and resting HR and TPR were not 
associated. 
A possible ‘tipping point’ phenomenon of ageing may be present whereby minor 
perturbations in individual systems of the body reach a threshold level to cause the onset of 
physiological function loss, which may not be detected in recreationally active healthy 
elderly individuals. In order to investigate deeper the multitude of mechanisms that cause 
cardiovascular dysfunction with ageing, recruiting more directly high physically active 
individuals and sedentary individuals would be advantageous. Another possibility would be 
an exercise intervention study on healthy sedentary elderly individuals and investigate 
cardiovascular function, inflammatory status, visceral adiposity and cardiovascular risk 
factors pre and post intervention.
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MidREC general practice letter to patient 
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Patient X 
X Street 
X Town 
X County 
XXXX XXX 
 
Dear Mr/Ms. X, 
 
 
Invitation to take part in Physical Activity and Healthy Ageing study 
 
We are writing on behalf of The University of Birmingham who are running a study to assess 
whether a high activity level is important to keep healthy. The researchers are currently 
looking to recruit volunteers between 60 and 80 years old. 
 
Study Summary 
The study has been designed to investigate the influence of physical activity levels on health 
and well-being in individuals between 60 to 80 years of age.  We are interested in looking at 
whether inflammation, which occurs with increasing age, is less pronounced in individuals 
who incorporate a greater amount of physical activity into their lifestyle.  Also we will be 
looking at whether physically active persons show better functioning in examinations of the 
heart, blood vessels, muscle, immunity, cognition and psychological status.  The research will 
provide insights into the effects of an active lifestyle on many of the body’s systems in 
individuals in this age range. 
 
If you are interested in this study, please send back the enclosed slip in the freepost envelope 
with your name and phone number.  One of the researchers from the University of 
Birmingham will then contact you by telephone to ask you some questions related to your 
health to see if you are eligible for the study.  You will also be able to ask any questions you 
may have about the study.  All information will be kept confidential. 
 
Thank you for your time and we hope to hear from you shortly. 
 
Yours sincerely 
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Please complete the following contact details: 
Your initials and surname: 
Street address: 
City: 
Postcode: 
Telephone number: 
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Birmingham 
B15	2TH 
 
Research study: Physical Activity and Healthy Ageing 
 
Thank you for taking the time to read this leaflet. We would like to invite you to 
take part in this study. You Before you decide if you want to participate or not, it 
is important for you to understand why the research is being done and what it 
will involve.  Please take the time to read the following information carefully and 
discuss it with friends, relatives or your GP, if you wish.  Please ask us if there is 
anything that is not clear or if you would like more information. 
 
1. What is the purpose of the study? 
To investigate whether physical activity levels with increased age are related to 
health and well being.  
 
2. Why have I been chosen? 
You have been chosen because you are: 
● Between 60 and 80 years of age 
● Able to walk for 2 minutes or more without stopping 
● Do not have medical conditions (for instance angina pectoris or high blood 
pressure) that prevent you from doing exercise and take part in this study 
● Able to decide if you want to take part in the study 
 
 
3. Do I have to take part? 
No. Taking part in this study is entirely voluntary. If you would like to 
participate, you will be given this information sheet to keep and be asked to 
sign a consent form, but you are still free to withdraw at any time and without 
giving a reason. The care from your GP will not be affected. 
 
4. What will happen to me if I agree to take part? 
You will be invited to a the Queen Elizabeth Hospital (QE) for a first visit. 
During this visit a qualified nurse will first: 
● Check your health and ability to do some exercise with a series of 
questions 
● Measure your blood pressure 
● Take a drop of blood to measure the sugar (glucose) level in your blood 
● Check whether you have understood this leaflet and whether the 
researchers of the University have answered all your questions 
● Check whether you voluntarily wish to take part in this study without 
pressure from anybody that you spoke before on the telephone 
● The nurse will then ask you to sign a form confirming that you take part 
well informed and voluntarily 
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If all of the above is fine then your participation in the study starts and a first 
series of measurements will be made during the remainder of the visit to the 
hospital (total time of this first visit is about 2 hours). One week later you will be 
asked to come to a special laboratory in the School of Sport and Exercise 
Sciences where more measurements will be made (duration of this second visit 
will be about 2 ½ hours). There also will be 3 questionnaires that you need to 
complete at home, and you will also be asked to wear a small device at home for 
a full week that is able to detect movement and can estimate your physical 
activity (daytime) and sleep pattern (at night). 
 
5. What do I have to do for the measurements made during the visit 
to the Hospital (visit -1)? 
Before visit -1 
 
For these measurements you will be asked to not eat anything and only drink 
water in the previous 8 hours (that is in the overnight period). 
 
During visit-1 
 
Following the health check by the nurse explained above the following will happen: 
Blood sample: The nurse will take several tubes of blood from a vein in your 
arm. 
Bone density and body composition: You will have to lay on a bed for 
approximately 30 minutes and the machine will pass over you to scan the bones, 
fat and some muscles in your body. The machine uses very low radiation equal to 
1/10 of a chest x-ray. 
Questionnaire Pack A: At the end of the visit you will be given a questionnaire 
pack to take home. 
Rest: You will be given a small lunch and some time to recover in a comfortable 
chair before you go home. 
Travel home: You either need to arrange that somebody picks you up with a car 
or we will ring a taxi for you. 
 
After visit-1 
 
In the week after visit 1 you are asked to complete questionnaire pack A at home 
at your leisure. You are asked to bring the completed questionnaires during the 
visit to the School of Sport and Exercise Sciences (visit 2).  
 
6. What do I have to do for the measurements made during the visit 
to the School of Sport and Exercise Sciences (visit-2)? 
 
Before visit-2 
 
You will be asked to have your breakfast about 2 hours before you arrive in the 
School of Sport and Exercise Sciences. For the purpose of this visit, we advise 
that you wear loose fitting comfortable clothing, shorts and T-shirt would be 
ideal however loose long legged/armed clothing is acceptable. The reason for 
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this is explained below. 
 
During visit-2 
 
You will be welcomed by 2 research nurses and a team of 4 University 
researchers, who are experts in making the special measurements explained 
below. The reason that we ask you to wear loose fitting clothing on arrival is that 
it will allow the researchers to conveniently place pads (kind of stickers that pick 
up signals from your body) on your collar bones and lower ribs, and to assess 
your heart, and femoral artery (near your hip bone). To ensure you are as 
comfortable as possible the experimenter will be of the same sex, and the 
measurements will be taken in privacy. The following measurements will be 
made:  
● Arterial stiffness measurement: you will be asked to lie on a bed for 
approximately 30 minutes while a small light weight plastic pen probe is 
placed at your wrist, neck and just below your hip bone.  
● Heart scan: whilst still lying on the bed, a small ultrasound probe will be 
placed just below the chest area (7th-9th rib space), and then in the high-
mid chest area. This procedure will take approximately 20 minutes. 
● Artery wall thickness measurement: immediately following the heart 
scan, whilst you are still lying on the bed, a slightly longer ultrasound 
probe will be placed on your neck, which will take approximately 5 
minutes. 
● Brain blood flow measurement: whilst you are lying down, a small 
circular probe will be fitted to the side of your head, near the ear. A 
special holder that fits around your head will be used to keep the probe in 
place. This procedure will take approximately 30 minutes. 
● Hand-grip and leg muscle strength: You will be asked to sit in a 
custom made chair for approximately 10 minutes whilst your strength is 
measured. 
● 4 minute exercise test: You will be asked to sit on an exercise bike and 
cycle at a low intensity for 4 minutes. After this, you will remain seated on 
the bike for approximately 10 minutes. Your heart rate and blood pressure 
will be measured throughout the test. 
● Mobility and balance measurements: You will be asked to perform a 
series of standing balance tests. A measurement of how long it takes for 
you to stand up, walk a short distance, turn around, walk back and sit 
down will also be taken. Thes procedures will take approximately 20 
minutes. 
 
At the end of the visit you will be given instructions on how to use a device that 
can measure movement (physical activity monitor) which you will be asked to 
wear over the following 7 days (explained below) and you also will be given 
questionnaire pack B with some instructions how to complete it at home in the 
following week. One of the researchers will also make an appointment with you 
to come and visit you at home (see home visit below). Finally the nurses will 
offer you a chance to rest in a comfortable chair while enjoying a cup of tea and 
a sandwich until you feel ready to go home by car or taxi. 
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Following visit-2 
 
In the week after visit-2 you will be asked to continuously wear the physical 
activity monitor (except while showering). The device is very small so nobody 
will see that you are wearing it and you also will hardly notice it yourself. In 
daytime the device will be fixed to a belt around your waist to measure daytime 
physical activity during 7 days covering both week and weekend days. During 
the night the device will be moved to a strap around your lower leg to measure 
the sleep pattern. You are also asked to complete the questionnaire pack B at 
your leisure. 
 
Home visit: 
 
Before the home visit you are asked to collect all the vitamin and nutrition 
supplements that you are using and keep them at hand for inspection. 
 
One of the members of the research team will visit you at home about 10 days 
after visit 2. A remainder of this visit will be given via telephone 2 days earlier. 
During this visit the researcher will collect and check the physical activity 
monitor and the completed questionnaire pack B. During this visit you will also 
be asked to go through a questionnaire (pack C), which also includes a series of 
learning and memory tests, all of which can be done whilst you are seated in the 
comfort of your own home. At the end the researchers will ask you to show the 
vitamin and nutrition supplements that you are using and make notes of make 
and dosage used. This visit should last no longer than 90 minutes. 
 
Optional recall visit and follow up research 
 
The physical activity measurement will tell us how physically active you are. If 
you are in the group with the lowest or highest physical activity levels (whole 
group split in 5 activity levels) then we will contact you to ask whether you 
would like to volunteer for a last and final visit to the School of Sport and 
Exercise Sciences. Full details of the purpose of this visit will only be given when 
you are in one of these groups. We also may approach you to enquire whether 
you would be interested in follow up research that might involve additional 
specialised measurements or questionnaires in volunteers of the different 
physical activity levels. For this follow up research we will ask you for your 
permission to keep your contact details on record for a period of 20 years. An 
example of a question that we will have is whether the group with the highest 
physical activity level will develop disease at a higher age, than those with 
lowest activity level. 
 
 
7. What are the possible disadvantages and risks of taking part? 
You may experience some discomfort during the taking of the blood sample. 
You will feel a sharp pain when the needle is inserted, but this will ease off 
quite fast. As the blood samples will be taken by an experienced nurse, the risk 
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that this will be very unpleasant is minimal. We cannot exclude though that a 
bruise may develop on your arm following the blood taking, which could cause 
some pain the days after. 
The exercise testing may cause you to experience mild fatigue, which will be 
short lived and you should have fully recovered within 30 minutes. However 
during any exercise there is a minimal risk of unforeseen heart complications. 
In order to minimise this risk we will ask you to only perform low-intensity 
exercise. In addition, you will be carefully monitored throughout by the trained 
research nurses. During the bone density and body composition measurements 
there is a minimal exposure to radiation. The risks of this is minimal as the 
dose received during the measurements is comparable to the dose that you 
receive during 1 week of the natural background radiation in the UK.  
All other procedures and measurements are safe and should not cause pain. 
However, if at any point during the protocol you feel uncomfortable or unable 
to continue, testing will be ceased immediately. 
 
 
8. What are the possible benefits of taking part? 
 
There are no direct benefits for research participants. 
 
However, during the testing you will undergo a thorough health check that 
normally could only be offered by specialised clinics. You also may find it 
important to know where you are on the physical activity scale and whether 
you should become more physically active. We will also provide each 
participant, who expresses this interest, with a brief personalised report, which 
will be translated into life style advice. 
 
 
9. Will my travel expenses be reimbursed? 
 
For visit-1 and visit-2 we will offer you a contribution of £10 toward transport 
expenses. The nurses will provide you with a claim form when you ask for it. 
10. What if something goes wrong? 
 
In the unlikely case that something will go wrong the nurses will be there to 
provide help is needed. The University of Birmingham has in place a Public 
Liability Insurance and if you are harmed in any way by taking part in this 
research project your normal rights apply. 
 
 
11. Will my taking part in this study be kept confidential? 
We will only inform your GP of your taking part in this study. 
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12. What will happen to the results of the research study? 
The results of this study are expected to be published anonymously in a 
scientific journal and names of participants will never be published. 
 
 
13. Who is organising and funding the research? 
The University of Birmingham is organising this study in collaboration with the 
University Hospital Birmingham who will provide nurse and clinical support. The 
study is funded by the Biotechnology and Biological Sciences Research Council 
(BBSRC) as a doctoral training grant to educate Ageing Researchers. 
 
 
14. Who has reviewed the study? 
This study has been reviewed by BBSRC, an internal scientific committee of the 
University of Birmingham and University Hospital Birmingham and by the Black 
Country Research Ethics Committee. 
 
 
15. Do you have any further questions? 
If you have any further questions about the study please feel free to 
contact the investigator (s) listed below. 
 
Prof. Anton Wagenmakers 
School of Sport and Exercise Sciences                  
The University of Birmingham                                 
Edgbaston                                                               
Birmingham                                                             
B15 2TT                                                                                         
T:
E:  
 
PhD Students: 
● David Bartlett:  
● Clare McNulty:  
● Rebecca Booth:  
● Kim Clarke:  
 
Independent Contact: 
Ros Salter – Primary Care Research Network Manager for Central England 
T:
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Thank you for taking the time to consider taking part in this research 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 3 
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Echocardiography guidelines for valve quantification 
poster, British Heart Foundation, 2011.
